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The epidemiological success of M. tuberculosis strains, dominant in different geographic 
regions globally, may be ascribed to a subversion of the host‟s protective immune response. 
The increasing prevalence of F15/LAM4/KZN, Beijing, F11 and F28 Mycobacterium 
tuberculosis strain families, coupled with rapidly evolving drug resistance within the 
KwaZulu-Natal province of South Africa population has resulted in a need to characterize 
host response associated with infection by these strains. Therefore, in this study, 
cytokine/chemokine production and host transcriptomics were investigated in A549 
pulmonary epithelial cells infected with the F15/LAM4/KZN, Beijing, F28, F11, Unique and 
H37Rv strains.  
Cytokines/chemokines were quantified using the Bio-Plex Pro Human Cytokine 27-Plex 
assay at 0, 24, 48 and 72 hr post-infection. Changes in host gene expression were determined 
by whole genome RNA Sequencing (RNA-Seq) using the Illumina HiSeq 2000 platform. The 
50 bp reads were mapped to the human genome (hg19) using Tophat (2.0.10). Differential 
expression was quantified using Cufflinks (2.1.0) with false discovery rate (FDR) of 0.05 and 
a log fold change cutoff of ≥2. R commands (Bioconductor), MeV and Ingenuity Pathway 
Analysis (IPA) were used to generate heat maps, network and pathways analysis.  
Twenty-three out of 27 analytes were detected. All strains, except the F28 strain induced an 
increased production of 18, and a decrease in 5 cytokines/chemokines at 24, 48 and 72 hr 
post-infection, compared to the uninfected control.  Increased production of all 23 analytes by 
the F28 strain occurred at 48 and 72 hr. Among the 23 cytokines/chemokines that were 
detected, anti-inflammatory and pro-inflammatory cytokines, as well as chemokines were 
produced at the different time intervals. Compared to the other strains, high cytokine levels 
were induced by the F28 strain at 48 hr and F15/LAM4/KZN strain at 72 hr for most 




time intervals. In the case of the laboratory strain H37Rv either a higher or lower 
cytokine/chemokine production was observed, compared to the clinical strains.  
RNA-Seq revealed differential gene expression that varied among the strains with respect to 
both up- and down-regulated genes: F15/LAM4/KZN (1187), Beijing (1252), F11 (1639), 
F28 (870), Unique (886) and H37Rv (1179). A total of 292 genes were commonly induced by 
all strains, of which 52 were down-regulated and 240 were up-regulated. Different strain 
combinations induced different genes that were involved in a variety of pathways, including 
immune response and apoptosis pathways. Furthermore, strain specific genes were activated 
by each strain as follows: F15/LAM4/KZN (138), Beijing (52), F11 (255), F28 (55), Unique 
(185) and H37Rv (125). The F15/LAM4/KZN, Unique and H37Rv were the only strains that 
had molecular signatures with overlapping functional Kegg and Reactome pathways for their 
specific genes.  
IPA analysis revealed canonical pathways that differed among the strains, with the interferon 
signalling and hepatic fibrosis/hepatic stellate cell activation pathways being among the top 5 
pathways in all the strains. Cholesterol biosynthesis and immune related pathway enrichment 
was similar in the Beijing and Unique strains whilst the F15/LAM4/KZN strain showed 
closer relatedness to the F11 strain, and the F28 strain closely clustered to the H37Rv strain. 
The Beijing and Unique strains highly enriched cholesterol biosynthesis pathways compared 
to other clinical and laboratory H37Rv strain. The top scoring networks induced by these 
clinical strains varied among the strains with the associated functions. These gene networks 
were involved in antimicrobial response, developmental disorder, organismal injury, 
infectious disease and cellular development. Among the transcriptional factors, only EHL, 
IRF7, PML, STAT1, STAT2 and VDR were induced by all clinical strains, while other factors 




In conclusion, low cytokine/chemokine production and activation of immune associated 
pathways by the Beijing and Unique strains suggest a higher virulence for these strains 
compared to the F15/LAM4/KZN, F11 and F28 strains. These characteristics may explain the 
high transmissibility and prevalence of the Beijing strains. A similar pattern exhibited by the 
less prevalent, non-clustering Unique strain, may suggest some virulence attributes in 
common with the Beijing strain. Findings in this study have the potential to reveal useful 
biomarkers that can be used as targets for alternative TB therapeutics including immuno-
modulators that take into consideration network regulations and strain-specific pathways and 
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Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) remains one of the major 
causes of mortality worldwide, causing infections in ~2 billion people worldwide, leading to 1.5 
million deaths each year (WHO, 2014; WHO, 2015). Even though TB results from the failure of 
the host to eliminate the pathogen, there are different protective mechanisms within the human 
immune system against M. tuberculosis. These include cell mediated immunity as well as innate 
immunity (Bhatt and Salgame, 2007; van Crevel et al., 2002). The success of cell mediated 





) that secrete cytokines and other intermediates to kill the infected 
cells (van Crevel et al., 2002). On the other hand, the success of M. tuberculosis as a pathogen 
lies in its ability to survive and persist within lung macrophages and epithelial cells and avoid 
killing by the immune system, thus leading to  acute disease (Chuquimia et al., 2012; van Crevel 
et al., 2002). 
 
The effectiveness of the host immune system is driven by the production of a range of 
cytokines/chemokines by both immune (macrophages, T-cells, dendritic cells, γδ T cells, and 
natural killer (NK) cells) and non-immune cells, e.g., epithelial cells (Lee et al., 2009; Sharma et 
al., 2007). Epithelial cells are abundant in the lung, when compared to macrophages (Chuquimia 
et al., 2012; Lutay et al., 2014), and are likely to be the first cells to encounter M. tuberculosis 
during infection. Epithelial cells and macrophages are part of the innate immune system and they 
are responsible for recruitment of T-cells that are required for cytokine production. These cells 




bacterial clearance or survival (Sharma et al., 2007). Pulmonary epithelial cells were shown to 
have the ability to produce a variety of cytokines and chemokines during M. tuberculosis 
infection (Lee et al., 2009; Lin et al., 1998; Sharma et al., 2007).  
 
M. tuberculosis strains of varying pathogenicity have been shown to induce differential cytokine 
production in monocytes (Manca et al., 2004; Tanveer et al., 2009), macrophages (Koo et al., 
2012), epithelial cells (Lin et al., 1998) and mice models (Manca et al., 1999; Manca et al., 
2001) after infection. Differential cytokine patterns in macrophages were also associated with 
ancient and modern M. tuberculosis strain lineages (Portevin et al., 2011) indicating an 
evolutionary relationship between the strains and host inflammatory response. Strains, such as 
the Beijing and CAS strains, associated with higher virulence, induced lower cytokine levels 
compared to ancient East African-Indian strains (Rakotosamimanana et al., 2010). Differential 
cytokine patterns were also observed in a mouse model, and were  associated with the reduction 
of TH1 response leading to more severe disease and significantly reduced time of death (Manca 
et al., 1999). The susceptibility/resistant characteristics of M. tuberculosis strains to anti-
tuberculosis drugs can also influence the type and the level of cytokines produced by the host. 
Higher levels of IFN-γ were shown to be induced by drug susceptible strains compared to drug 
resistant strains (Cabral et al., 2010). Furthermore, strain specific characteristics were also 






Studies employing different molecular techniques have been used to understand host responses 
to M. tuberculosis infection in vitro (Jang et al., 2008; Lin et al., 1998; Sato et al., 2002; Tailleux 
et al., 2008; Volpe et al., 2006) and in vivo (Manca et al., 1999; Manca et al., 2001). The advent 
of advanced RNA-Seq technology in molecular studies now provides numerous advantages over 
existing molecular techniques and includes higher resolution, improved dynamic range of 
detection, genome-wide transcription, identification of novel transcripts, expression of small 
RNA molecules, analysis of transcribed but not translated regions, and novel isoforms expression 
during transcription (Nookaew et al., 2012).  
 
Only a limited number of pro- and anti-inflammatory cytokines, as well as chemokines, have 
been analyzed and detected in previous studies on epithelial cells and mycobacterial infection 
(Chuquimia et al., 2012; Lee et al., 2009; Lin et al., 1998; Méndez-Samperio et al., 2006; 
Sharma et al., 2007; Wickremasinghe et al., 1999; Zhang et al., 1997). These studies were 
further limited to using the laboratory control H37Rv strain and some uncharacterized clinical 
strains (Lin et al., 1998). The major disadvantage in elucidating inflammatory response with the 
laboratory strain might be the absence of different virulent factors that may be present in clinical 
strains, thereby resulting in an inability to detect strain-specific and differential cytokine 
production and gene expression. Furthermore, transcriptomics has not been used to study gene 
expression and pathway changes of M. tuberculosis which have been shown to play important 
role in host immune response. A better understanding of strain-specific cytokine/chemokine 
patterns, molecular signatures and pathway changes would potentially facilitate the identification 
of novel host biomarkers associated with clinical strains of M. tuberculosis and host directed 




evaluated the host response to infection by the clinically relevant M. tuberculosis 
F15/LAM4/KZN, Beijing, F11 and F28 strains in a pulmonary epithelial cell model by 
investigating cytokine/chemokine production using the Bio-Plex Pro Human Cytokine 27-Plex 























CHAPTER 1: LITERATURE REVIEW 
TB epidemiology 
World TB statistics 
The global TB burden has been increasing over the past decade, with an estimated 2 billion 
people infected and ~9.6 million new cases estimated in 2014. Low income countries have a high 
TB incidence that is fueled by high HIV-TB co-infections. In 2014, Africa was estimated to have 
28% of the world‟s TB burden while India, Indonesia and China had 23%, 10% and 10% of the 
global estimate, respectively. Twelve percent of the new cases with active  TB were estimated to 
be HIV-TB co-infected in 2014 (WHO, 2015).   
 
South African TB statistics 
South Africa has been classified as one of the 22 countries with high TB burdens globally, with 
estimated incidence and prevalence of 380 000 and 450 000 (cases for 53 969 000 population), 
respectively (WHO, 2015). It is estimated that about 60% of individuals with active TB are also 
co-infected with HIV in this country. HIV-TB co-infection is the driving force of high mortality 
(72 000) estimated in 2014. Among the nine provinces in South Africa, the KwaZulu-Natal, 
Eastern Cape and Western Cape provinces are estimated to have 922; 782 and 730 TB cases per 
100 000 population, respectively. The Mpumalanga (467/100 000); Gauteng (388/100 000) and 
Limpopo (354/100 000) provinces are the three lowest ranking provinces in this country. It is 
estimated that more than 80% of the South African population is latently infected with M. 





Drug resistant TB 
TB is of global public health concern, with  the current drug treatment regime failing to eradicate 
the pathogen, resulting in the emergence of multi drug resistant (MDR) (Chihota et al., 2012), 
extensively drug resistant (XDR) (Pillay and Sturm, 2007; Udwadia, 2012) and total drug 
resistant (TDR) (Klopper et al., 2013; Udwadia et al., 2012; Velayati et al., 2009) cases globally, 
making TB control efforts difficult (Dye et al., 2002; Magana-Arachchi, 2013). MDR is defined 
as resistance to isoniazid and rifampicin together with or without resistance to other first line 
drugs. XDR results from resistance to isoniazid, rifampicin and any fluoroquinolones as well as 
one of the three-second line injectables. TDR-TB results from in vitro resistance to all first and 
second line drugs used to treat TB (Velayati et al., 2009). These dangerous forms of TB have  
been identified in Iran (Velayati et al., 2009), India (Udwadia et al., 2012), South Africa 
(Klopper et al., 2013) and Italy (Migliori et al., 2007). 
Drug resistant TB was initially recognized shortly after the introduction of anti-TB treatment  
through the emergence of streptomycin resistance in 1947  (Pyle, 1947). In the early 1990s, 
emergence of clinical strains of MDR M. tuberculosis resistant to at least isoniazid and rifampin 
was reported in the United States (Frieden et al., 1993). Post 1990, MDR-TB, reported in both 
HIV-infected and uninfected individuals (Coninx et al., 1999; Espinal et al., 2000; Goble et al., 
1993) was recognized as a catastrophic global challenge (Nachega and Chaisson, 2003).  
In 2014, MDR-TB had been detected in 3.3% of new and 20% of previously treated TB cases. 
Out of 480 000 people living with MDR-TB, 190 000 deaths worldwide were caused by drug 




2015). Drug resistant M. tuberculosis strains have been identified in both developing and 
developed countries (Banerjee et al., 2008; Rowland, 2012).  
South Africa has been reported as one of the countries with the highest prevalence of MDR-TB 
cases and drug resistant strains worldwide. In 2014, the number of MDR and XDR cases in 
South Africa were estimated to be 10,085 and ≥500, respectively (WHO, 2014; WHO, 2015). 
The first drug resistant case in South Africa was reported in 1985 in the Western Cape region, 
however, strain identity remained unknown (Chihota et al., 2012). Development and 
transmission of drug resistant strains in South Africa led to the XDR-TB outbreak such as the 
Tugela Ferry, in the KwaZulu-Natal province (Gandhi et al., 2006; Pillay and Sturm, 2007). 
These TB outbreaks are fueled by the high prevalence of HIV-TB co-infections making TB 
control efforts difficult.   
 
M. tuberculosis lineages and strain families 
Mycobacterium tuberculosis complex (MTBC) includes M. tuberculosis and M. africanum that 
have adapted to the human host (Smith et al., 2006)  and animal adapted M. bovis, M. caprae, M. 
microti, M. pinnipedii, M. origys, M. mungi, M. suricattae, the “dassie”, as well as the 
chimpanzee bacillus (Alexander et al., 2010; Coscolla et al., 2013; Cousins et al., 1994; Parsons 
et al., 2013). Other members of the MTBC comprise M. canettii and “smooth tuberculosis bacilli 
(STBs) (Canetti, 1970; Supply et al., 2013; Van Soolingen et al., 1997). Among the MTBC, one 
of the early and distinguishable feature was the deletion in the genomic region known as TbD1 
(Brosch et al., 2002). Strains harbouring this deletion are collectively known as “modern” strains 




2014). Changes in these clinical strains over the years have given rise to seven well characterized 
lineages (lineage 1-7).  
MTBC are classified using the IS6110 RFLP analysis that groups clinical strains according to 
genotype families (Filliol et al., 2006; Gutacker et al., 2006). The recent Large Sequence 
Polymorphism (LSP) and Whole Genome Sequencing (WGS) techniques grouped human-
adapted clinical strains into seven lineages that are distributed over different regions globally 
(Homolka et al., 2012; Stucki et al., 2012; Tsolaki et al., 2005). These lineages are named as 
lineage 1-7 and they are phylogenetically grouped together based on their genomic deletion 
referred to as region of difference (RD) and TbD1. Widespread distribution of these lineages and 
their phylogenetic groupings are shown in Fig. 1. Other two animal adapted lineages within the 
MTBC (which include M. bovis, M. caprae, M. microti, M. pinnipedii and M. orygis) infect wild 
and domestic animals (Coscolla and Gagneux, 2014).  
 
Fig. 1. Phylogenetic groupings of seven major M. tuberculosis strain lineages and other members 





Among the strain lineages, clinical strains can also be grouped into different strain families using 
the IS6110 RFLP genotyping technique. These strain families have been shown to dominate in 
different regions globally (Coscolla and Gagneux, 2014; Gagneux and Small, 2007). They 
include the CDC1551 (Valway et al., 1998), CAS (Ali et al., 2014), Beijing (Bifani et al., 2002; 
Glynn et al., 2002), Haarlem (Bazira et al., 2010), F11 (Victor et al., 2004), F28 (Chihota et al., 
2012), and LAM (Soares et al., 2013) strains, respectively. The Beijing is the most dominant 
family of strains identified in different countries of low, middle and high income resources 
(Bifani et al., 2002). The distribution of MDR, XDR (Chihota et al., 2012) and TDR (Klopper et 
al., 2013) strain families within the South African population vary in different provinces. The 
Western and Eastern Cape provinces reported a high proportion of MDR cases associated with 
the Beijing isolates, while the KwaZulu-Natal and Gauteng regions are dominated by high 
prevalence of the LAM4 strain family. The F11 and F28 strain families were also associated with 
drug resistance in the Western Cape province (Chihota et al., 2012; Victor et al., 2004).  
In KwaZulu-Natal, increasing cases of drug resistance have been reported since 1994 with peak 
MDR cases in 2007 and XDR cases in 2009 (Streicher et al., 2012). In 2005, the 
F15/LAM4/KZN strain was associated with the highest percentage of both MDR- and XDR-TB 
in Tugela Ferry (KwaZulu-Natal) with high mortality rates, especially among  HIV co-infected  
patients (Gandhi et al., 2006; Pillay and Sturm, 2007; Streicher et al., 2004). Other strains 
families such as Beijing, F11 (LAM3) and F28 (S) are also found in this province and associated 
with either MDR or XDR cases (Fig. 2) (Chihota et al., 2012). Recently, diverse non-Beijing 
strain genotypes were  associated with the MDR- and XDR-TB epidemic in KwaZulu-Natal 






Fig. 2. Population structure of M. tuberculosis drug susceptible and resistant strains that are 
predominantly found in KwaZulu-Natal, Eastern Cape and Western Cape provinces in South 
Africa. The F11 strains belong to the LAM3 clade while F28 family belongs to the S spoligotype 
clade (Muller et al., 2013). 
 
Pathogenesis of tuberculosis 
Most TB pathogenesis studies are performed in an in vitro or in vivo model using cell lines, 
mice, rats, rabbits, guinea pigs and other non-human primates. Despite the fact that these models 
don‟t resemble true reflections of human infections, they serve as a good starting point when 
trying to understand host response and other complex interactions of the “key players” of the 
immune system which is usually extrapolated into human infections. One of the major limitation 
in using animal models for TB studies is the failure to address transmission of the pathogen 




disease between humans and animal models (Lenaerts et al., 2015). In vitro systems such as cell 
lines and other in vitro lung models can also be used to study TB pathogenesis when trying to 
isolate and understand the single cell response during infection. This can include trying to 
elucidate cytokine/chemokine response and other cell specific response that contribute to the 
outcome of infection. However, this model can be limiting since it is an isolated system lacking 
the lung structure and full tissue microenvironment which is ideal for understanding TB infection 
(Guirado and Schlesinger, 2013) 
 
The human respiratory system is divided into the upper (nose, sinus cavities, and pharynx) and 
lower (larynx, trachea, bronchi and lungs) respiratory tract. Innate defences are present in the 
upper respiratory system that should prevent colonization of the lower respiratory tract by 
pathogens such as M. tuberculosis. The upper respiratory tract has  a microciliary clearance 
rendered by ciliated epithelial cells that can trap and filter particles that are bigger than 2 µm in a 
mucus layer during breathing (Ellis, 1998). If these mechanisms fail during TB infection, the 
lower respiratory tract has abundant epithelial cells in the airway passage to serve as a physical 
barrier. These epithelial cells are connected by tight junctions, adherens junctions, and 
desmosomes (Davies and Garrod, 1997) that are relatively impermeable (Eisele and Anderson, 
2011). Despite these intrinsic mechanisms to prevent TB, M. tuberculosis has adopted different 
mechanisms to invade and replicate in the lungs of susceptible individuals. TB results from four 
basic stages due to the failure of the host immune system to eliminate the pathogen (van Crevel 





In the first stage, the primary contact of the M. tuberculosis bacilli is with the alveolar epithelial 
cells (Ahmad, 2010; Lin et al., 1998; van Crevel et al., 2002), alveolar macrophages (van Crevel 
et al., 2002; Zuniga et al., 2012) and dendritic cells (Cooper, 2009). Pulmonary macrophages and 
dendritic cells often ingest and digest M. tuberculosis. The intrinsic mechanisms of the host to 
produce reactive oxygen intermediate (ROI) and reactive nitrogen intermediate (RNI) may result 
in the killing of the M. tuberculosis depending on the virulence of the strain, ability of 
macrophages to effectively respond to infection and the inflammatory microenvironment at the 
site of the disease as part of the innate immune response (Dannenberg Jr and Rook, 1994; Zuniga 
et al., 2012). This stage lasts between 3-8 weeks with M. tuberculosis being implanted in the 
alveoli and disseminated by the lymphatic system to the lymph nodes within the lungs to form 
the Ghon complex (Reece and Kaufmann, 2012).  
 
In the second stage, the intracellular M. tuberculosis begins to multiply within macrophages and 
dendritic cells (Zuniga et al., 2012) leading to disruption of macrophages and attraction of 
monocytes towards the lungs (van Crevel et al., 2002). This is also referred to as an 
inflammatory cell recruitment stage due to production of cytokines/chemokines by infected 
epithelial cells, macrophages and dendritic cells crucial for attracting circulating immune cells 
(Blomgran and Ernst, 2011; van Crevel et al., 2002; Zuniga et al., 2012). Infection of the 
resident macrophages and epithelial cells results in the secretion of cytokines and chemokines 
that effectively recruit immune cells including innate cells such as γδ T-cells, NK-cells, DCs, 
monocyte  derived macrophages as well as neutrophils to the lungs (Guirado et al., 2013; Kang 
et al., 2011). These cytokines and chemokines ensure effective control of M. tuberculosis while 




cytokine/chemokine production in the lung during infection, excessive production and 
expression of the respective cytokine/chemokine receptors can result in severe lung pathology. 
This can cause lack of proper lung function which subsequently leads to respiratory failure, thus 
increasing mortality among TB patients (Sacks and Pendle, 1998). This suggests that production 
of cytokines/chemokines needs to be a tightly controlled mechanism to avoid immunopathology 
which can result in progressive TB disease.  
 
The main characteristic of the second stage is the invasion of other organs and infection of most 
parts of the lungs leading to the granuloma formation (Fig. 3) (Sasindran and Torrelles, 2011; 
Torrado and Cooper, 2010). It lasts for approximately three months and can be fatal due to the 
development of TB meningitis or miliary TB. During this period, severe chest pain can be 
experienced due to pleurisy or inflammation of the pleural surfaces which can last for up to two 






Fig. 3. Formation of the granuloma and involvement of lymph nodes and immune cells (TH1 and 
TH17) in stages of M. tuberculosis infection (Torrado and Cooper, 2010). A: initial stages of 
infection, B: formation of a mononuclear granuloma, C: setting of immunopathology. 
 
The third stage involves the recruitment of T-lymphocytes that proliferate within the early 
lesions of tubercles. Macrophages are activated to kill intracellular mycobacteria and produce 
cytokines. Lesions and T-lymphocytes inhibit the extracellular growth of M. tuberculosis, which 
remains in a dormant stage (Ahmad, 2010; Zuniga et al., 2012). The main characteristic of the 
third stage is the granuloma containing aggregated T-cells and infected macrophages (Zuniga et 
al., 2012). When conditions become conducive or if the host is immuno-compromised, M. 




the lungs, which characterize the last stage of TB (Smith, 2003; van Crevel et al., 2002; Zuniga 




Innate cells in TB pathogenesis  
Pulmonary epithelial cells 
Pulmonary epithelial cells are probably the first cells to encounter pathogens such as M. 
tuberculosis because they form part of the lining the lung alveolus (Li et al., 2012). Epithelial 
cells were long thought to be a passive barrier against pathogens, however, recent evidence has 
shown that these cells are involved in shaping local inflammatory response during M. 
tuberculosis infection (Lee et al., 2009). The functions of  pulmonary epithelial cells  range from 
absorbing substances to the lung tissue (Horvath et al., 2007), protecting the lungs by acting as a 
physical barrier for pathogens (Eisele and Anderson, 2011), and production of cytokines and 
chemokines to increase host defence mechanisms (Fig. 4) (Holt et al., 2008). Furthermore, they 
are known as a “defender of the alveolus” due to variety of functions including modulation of 
macrophage release of radical oxygen species (Fehrenbach, 2001; Mason and Williams, 1977). 
They are known to inhibit M. tuberculosis replication and attract other cell types (mainly 
immune cells) to the site of infection (Chuquimia et al., 2012; Lee et al., 2009; Lin et al., 1998; 





Fig. 4. Overview of pulmonary epithelial cells in the respiratory tract and alveolus with other 
associated immune cells (Holt et al., 2008). During infection with M. tuberculosis, the first point 
of contact is with pulmonary epithelial cells with residing macrophages. Together, these cells 
form part of the innate immune response.  
 
Macrophages 
Macrophages, which are matured monocytes, also play an important role during M. tuberculosis 
infection (Podinovskaia et al., 2013). These cells are  among the largest phagocytic cells, each of 
which can engulf more than 100 bacteria (Guyton and Hall, 2006). Interaction of M. tuberculosis 
and the macrophages results in different types of actions, i.e., cytokine/chemokine production 




2005), as well as granuloma formation (Flynn et al., 2011). During infection with M. 
tuberculosis, macrophages and epithelial cells respond by producing cytokines and chemokines 
using different mechanisms. It has been proposed that these cells produce cytokines by the 
process known as exocytosis (Stanley and Lacy, 2010). The common method of cytokine release 
in macrophage is constitutive exocytosis. This comes from most constitutively expressed 
cytokines such as tumor necrosis factor alpha (TNF-α) that resides in the membrane as 
transmembrane TNF-α precursor until stimulated for its release (Lacy and Stow, 2011). TNF-α  
is first secreted into the Golgi apparatus and then transported by a carrier protein known as p230 
to the cell membrane where it is released to the extracellular space (Stanley and Lacy, 2010).  
 
Dendritic cells 
Dendritic cells (DCs) are regarded as professional antigen presenting cells due to their principal 
role in antigen processing and presentation  to naïve T-cells (Wieder, 2003).  These cells were 
first identified by Ralph Steinman and colleagues in the 1970s in  spleen tissue (Steinman and 
Cohn, 1973). DCs are found in the tissue surfaces that are exposed to the external environment. 
They play a crucial role in the antigen uptake, processing and presentation in both major 
histocompatibility complex (MHC) I and II molecules, bridging a gap between innate and 
adaptive immunity (Merad et al., 2013). The lung surface is lined with different cell types, 
including DCs (Havenith et al., 1993). During M. tuberculosis infection, DCs are present in high 
numbers at the site of infection (Holt and Schon-Hegrad, 1987; Sertl et al., 1986; Van Haarst et 
al., 1994) and have been shown to increase the strength of cellular response against 
Mycobacterium infections (Henderson et al., 1997; Mohagheghpour et al., 2000; Tascon et al., 




adaptive immune response through modulating DC adhesion and migration (Roberts and 
Robinson, 2014). 
 
Natural Killer cells 
Natural killer (NK) cells are among the largest granular lymphocytes with both cytotoxicity and 
cytokine production ability (Trinchieri, 1989). NK cells expressed different ligands such as 
NKG2D during stress (Lanier, 2005) and toll like receptors (TLRs) during infection (Sivori et 
al., 2004). They are found in different lymphoid and non-lymphoid tissues, with 10% localized 
in the mouse lung (Grégoire et al., 2007). These cells play a crucial role in the innate immune 
response by controlling microbial infections prior to their spreading to other tissues (Vivier et al., 
2008). NK cells demonstrated the ability to fight M. tuberculosis infection when stimulated with 
cytokines and N-acetyl cysteine to induce inflammation and contribute to the innate response. 
This was through an increase expression of cytotoxic ligands (FasL and CD40L) and reduced 
bacterial growth in monocytes (Guerra et al., 2012). In a mouse model, NK cells were shown to 
be potent producers of IFN-γ and greatly contribute to early response to M. tuberculosis infection 




Neutrophils are the most abundant type of white blood cells in the mammalian body. They are 
normally found in large blood vessels and axial stream of small vessels. However, they can 
migrate into tissues for immune surveillance and removal of infectious microorganisms (Witko-




Spagnuolo, 1987) including TLR2 in recognition of pathogens such as Mycobacteria (Feng et al., 
2003). During M. tuberculosis infection, neutrophils were shown to be abundant in the infection 
site, but failed to control mycobacterial growth contributing to the spread of the bacilli in vivo. 
Therefore, they were thought to contribute to the host tissue pathology and not protection of the 
host during M. tuberculosis infection (Eruslanov et al., 2005). However, other studies reported 
that neutrophils contribute to the innate control of M. tuberculosis (Martineau et al., 2007), and 
reduced bacterial load (Sugawara et al., 2004), while M. tuberculosis colony forming units were 
increased in granulocyte depleted mice (Barrios-Payan et al., 2005).  
 
T cells 
T-cells are among the major players of cell mediated immune response and derived their name 
from the site of maturing (thymus). They can be differentiated from other white blood cells by 
the T-cell receptor on the surface (Alberts et al., 2002). Naïve T-cells are involved in the 
adaptive immune response  after encountering  a pathogen, and differentiating to become effector 




 and γδT 
lymphocytes have been shown to be required for control and protection from M. tuberculosis 
(Kaufmann, 2001). Recognition of the M. tuberculosis antigens by peripheral T-cells can result 
in the production of pro-inflammatory cytokines such as IFN-γ and TNF-α (Caccamo et al., 
2006; Fenhalls et al., 2002; Peng et al., 2008). The population of γδT T-cells contribute to both 
the innate and adaptive immune responses during TB (Zuniga et al., 2012), even though the 
mechanism is not completely understood. Patients with active TB had reduced Vγ9/Vδ2T cells 
compared to their healthy counterparts (Szereday et al., 2003) indicating the importance of these 




mycobacterial infections. Within this family, Vγ9Vδ2 T-cells are secreted in high quantities in 
blood in response to M. tuberculosis infections and can also be stimulated by mycobacterial 
antigens (Meraviglia et al., 2011). The γδ T-cells also produce IL-17 and play a role in the early 
stages of M. bovis infection through the production of two major cytokines (IFN-γ and TNF-α) 
and chemokines, promoting cytotoxicity, and modulate other immune cells as demonstrated in a 
mouse model (Dieli et al., 2003).  
 
Mucosal Associated Invariant T-cells (MAIT) 




 co-receptors and are monoclonal in 
their expression of T-cell receptor. One subset within this group is known as invariant natural 
killer cells while the second one is named Mucosal associated invariant T-cells (MAIT). Both 
these subsets are known to express a singular TCRα chain with limited sequence diversity (Gold 
and Lewinsohn, 2011). MAIT cells are known to play a role in early detection of intracellular 
infection in DCs, macrophages, monocytes and epithelial cells (Gold et al., 2010; Le Bourhis et 
al., 2010). MAIT cells can be useful in detecting infected epithelial cells that lack MHC-II 
molecules which cannot be recognized by CD4 T-cells. Infected airway epithelial cells were 
shown to be lysed by M. tuberculosis-reactive MAIT clones via the granule exocytosis pathway 
that effectively contributes to the clearance of intracellular M. tuberculosis infection prior to the 
acquisition of an adaptive immune response (Gold and Lewinsohn, unpublished). Recognition of 
infection to non-antigen presenting cells by MAIT cells provides early control of the infection in 
innate cells at the site of infection (Gold and Lewinsohn, 2011). MAIT cells were decreased in 
patients with active TB and other lung bacterial infections compared to healthy individuals and 




resulting in their depletion in blood.   
 
Invasion of the innate cells by M. tuberculosis  
Even though epithelial cells and macrophages have been shown to increase the host response to 
infection, M. tuberculosis has adopted various mechanisms to invade and even replicate within 
these cells (Ashiru et al., 2010; Ashiru et al., 2012; Chakraborty et al., 2013; Mehta et al., 1996). 
The initial crucial step occurs when M. tuberculosis interacts with cell receptors “negotiating” an 
entry into the cells. Complement, mannose and other surface receptors are present on 
macrophages and allow for phagocytosis of M. tuberculosis into these cells (Raja, 2004). In 
epithelial cells, microfilament and microtubule pathways were proposed to facilitate the entry of 
M. tuberculosis into the cell, via by integrin and vitronectin receptors on the cell surface. 
Blocking these receptors led to a significant reduction of M. tuberculosis uptake by epithelial 
cells (Bermudez and Goodman, 1996).  
Increasing interest and research on pulmonary epithelial cells have led to the  discovery of a 
variety of other surface receptors (Li et al., 2012) that are complementary to the mycobacterial 
cell wall and other surface appendages. Pathogen associated molecular patterns (PAMPs) can 
range from lipoproteins (Chambers et al., 2010; Randhawa et al., 2011), cellular appendages 
such as flagellin (Koff et al., 2008) and nucleic acid (Numata et al., 2011; Torres et al., 2010). 
These molecular patterns are used by the pathogen to interact with epithelial cell receptors. TLRs 
(Mayer et al., 2007), Dectin-1 (Lee et al., 2009), nucleotide-binding-oligomerization-domain 
(NOD), mannose, dendritic cell specific intercellular adhesion molecule grabbing nonintegrin 
(DC-SIGN), and c-type lectin receptors (Ferguson and Schlesinger, 2000) are known to be 




surface receptors results in a series of pathways required for a defensive response and 
antimicrobial peptide production by epithelial cells (Li et al., 2012). 
Some of the receptors used by macrophages are similar to those of epithelial cells, while others 
are macrophage specific. These receptors are used for phagocytosis of M. tuberculosis as a mode 
of entry into these cells (Hossain and Norazmi, 2013),  and  include complement receptors 
(Velasco-Velázquez et al., 2003), TLRs (Harding and Boom, 2010), mannose (Rajaram et al., 
2011), scavenger, NOD, surfactant protein A and DC-SIGN receptors (Guirado et al., 2013). 
After initial interaction with macrophage receptors, M. tuberculosis is phagocytosed and 
subjected to intra-lysosomal hydrolase degradation once the phagosome fuses with the lysosome. 
However, M. tuberculosis survives within macrophages using different mechanisms (Welin, 
2011). These include inhibition of phago-lysosome fusion and acidification of the phagosome, 
resistance to killing by ROIs and RNIs and modification of the bacterial lipid composition, 
which indirectly alters the efficiency of M. tuberculosis to interact with the immune cells 
(Sasindran and Torrelles, 2011; Vandal et al., 2009; Welin, 2011). 
Upon invasion of both macrophages and epithelial cells, M. tuberculosis starts replicating 
depending on the virulence of the strain. Highly virulent Beijing and F15/LAM4/KZN strains 
were shown to replicate at a higher rate in pulmonary epithelial cells compared to less virulent 
Unique strains in aerobic (Ashiru et al., 2010) and anaerobic conditions (Ashiru et al., 2012). 
This replication causes increased cytotoxicity induced by both the F15/LAM4/KZN and Beijing 
strains in pulmonary epithelial cells (Ashiru and Sturm, 2015). In contrast, the avirulent H37Ra 
strain induced higher apoptosis levels compared to the virulent H37Rv strain (Danelishvili et al., 
2003) in macrophages, demonstrating cell-specific response upon infection by diverse M. 




Cytokine and chemokine production upon M. tuberculosis infection 
Involvement of the circulating T-cells during infection can be class specific depending on the 
cytokines they produce. Increasing understanding and appreciation of the different cytokine 
families began before 1977 when IL-1 was discovered (Dinarello et al., 1977). Cytokines are 
classified into different families based on sequence homology, receptor chain similarities and 
functional properties with other proteins. Cytokine profiles have been used to divide CD4
+
 T 
cells into different subsets. Major influences of the cytokine profiles in their microenvironment 
depends on the presentation of antigens by antigen presenting cells resulting in differentiation of 
CD4
+
 naïve T-cells into TH1, TH2, TH9, TH17, TH22 and T-follicular effector cells (Fig. 5). 
TH2 response and inflammation occurs through the production of IL-4, IL-5, IL-9, IL-13 (Akdis, 
2006; Larché et al., 2006) resulting in production of IL-25, IL-31 and IL-33 (Bilsborough et al., 
2006; Dillon et al., 2004; Kakkar and Lee, 2008; Kang et al., 2005). TH1 immune response 
results through the production of IFN-γ by TH1 cells that provide protection from invading 
parasites (Akdis, 2006; Akkoc et al., 2008). The major characteristic of TH17 is the expression 
of IL-17A, IL-17F, IL-6, IL-8, TNF-α, IL-22 and IL-26 (Burgler et al., 2009; Harrington et al., 
2005). TH9 cells are produced from TH2 by the combination of IL-4 and TGF-β resulting in 
production of IL-9 and IL-10 (Veldhoen et al., 2008). The largest subsets of T-cells are presented 
in the lymphoid tissues by T-follicular helper cells while providing helper functions to B cells 
(King et al., 2008). Other well characterized regulatory T-cells (Treg) are known to regulate and 
counter balance the immune response. T-reg phenotypes include CD4
+
 CD25 forkhead box 3 
(FoxP3)
+
 Treg cells as well as type1 (Tr1) cells, with distinct mechanisms of action (Akdis and 






 T-cells), IL-10 producing B-cells, IL-10 producing NK-cells, DCs as well as 
macrophages (Akdis et al., 2011).  
 
Fig. 5. Differentiation of naïve T-cells into different sub-sets that results in production of variety 
of cytokines that are involved in both innate and adaptive immune responses during infection or 
other inflammatory diseases (Akdis et al., 2011).  
 
TH1 cytokines are required for protective immunity against TB. Individuals with mutations in 
the genes coding for TH1 cytokines are highly susceptible to M. tuberculosis infections (Cooke 
et al., 2006; Correa et al., 2005; Ding et al., 2008; Stein et al., 2008). TH2 cytokines inhibit the 
production of IFN-γ and activation of macrophages, thus weakening the host defence system. 




al., 2000) cytokines that will prolong effective early response during M. tuberculosis infection. 
Both TH1 and TH2 cytokines are required for effective clearance of M. tuberculosis, provided 
they manifest at the right time of infection (Infante-Duarte and Kamradt, 1999). This TH1/TH2 
balance is very critical for the outcome of M. tuberculosis infection and is required for an 
effective immune response while maintaining proper lung function.  
The different components of bacterial cells that can elicit cytokine production include 
extracellular fimbriae, lipopolysaccharide and other extracellular components such as ESAT-6 
(Rakotosamimanana et al., 2010). These bacterial components provoke the network involved in 
cytokine production in a way that one cytokine can signal the induction of others. Different 
immune and non-immune cells produced specific cytokines and chemokines during M. 
tuberculosis infection (Carmona et al., 2013; Lee et al., 2009; Manca et al., 2004) . 
There are two major classes, pro- and anti-inflammatory cytokine production that are driven by 
M. tuberculosis infection, which determine the outcome of the infection. The release of pro-
inflammatory cytokines leads to an inflammatory response through the cascade of pathways and 
networks that regulate their release and their action. The anti-inflammatory cytokines are 
released in order to antagonize the action of pro-inflammatory cytokines and to prevent 
inflammatory disorders such as severe lung pathology associated with excessive production of 
pro-inflammatory cytokines  (Elenkov and Chrousos, 1999; van Crevel et al., 2002). In addition 
to pro- and anti-inflammatory cytokines, chemokines are also produced during M. tuberculosis 
infection and these are crucial for a chemotactic effect of other cell types such as circulating 
granulocytes, macrophages, T-cells and dendritic cells (Algood et al., 2003; Jang et al., 2008; 





Pro-inflammatory cytokines are produced in response to M. tuberculosis infection and greatly 
contribute to the outcome of infection through induction of inflammation and recruitment of 
immune cells to the site of infection to control infection (van Crevel et al., 2002). Epithelial cells 
and macrophages lining the alveolar surfaces are the first cells to encounter M. tuberculosis 
(Chuquimia et al., 2012), and their contribution to the local inflammatory response is through the 
production of pro-inflammatory cytokines (Lee et al., 2009; Lin et al., 1998; Sato et al., 2002). 
Pro-inflammatory cytokines are also produced by other immune cells such as T-cells, dendritic 
cells and NK cells which play a significant role during exposure to M. tuberculosis (Akdis et al., 
2011), however over production can result in severe immunopathology that can compromise 
normal lung function (Moreira et al., 1997). 
 
Interleukin-1 (IL-1) 
IL-1 belongs to a family of pro-inflammatory cytokines that plays an important role in immune 
response by causing cell proliferation, differentiation and immune response to infection. This 
family consist of IL-1α, IL-1β as well as IL-18 that have minimal sequence homology but play 
an important role in the immune response (Akdis et al., 2011). IL-1α is produced as a 
biologically active molecule while IL-1β and IL-18 need to be activated by caspase-1. IL-1 
cytokines are produced by a variety of innate immune and non-immune cells including 
macrophages, epithelial cells, keratinocytes, dendritic cells, osteoblasts, endothelial cells and 
others especially those providing protection to underlying tissues. They tend to act on different 
types of cells causing hypotension, fever, and other immunological responses. They promote 
differentiation of CD4
+
 T cells into TH17 cells in synergy with other cytokines (Akdis et al., 




expression of IL-1β at the site of infection observed in patients with active TB (Bergeron et al., 
1997; Law et al., 1996; Schauf et al., 1993) suggest an important role of this cytokine in 
effective immune response. This cytokine may also be associated with directing T-cells towards 
a TH1 response as significantly high secretion was observed in TB patients compared to healthy 
individuals (Katti, 2011). IL-1 production is crucial in development of early phase immune 
response to M. tuberculosis infection, as IL-1α/-β double knockout mice developed a 
significantly larger granulomatous response compared to the wild-type mice (Yamada et al., 
2000). Despite the crucial role of IL-1 in early response, excessive production of IL-1β was 
suggested to contribute to exacerbated pathology characterized by increased neutrophil influx to 
the lungs in IL-1 deficient mice treated (Mishra et al., 2013). Decreased TH1 response was 
observed in IL-18 knockout mice during M. tuberculosis infection, resulting in uncontrolled 
intracellular growth. These findings suggest that IL-18 contribute to protection against 
mycobacterial infection while the balance is shifted towards TH2-biased immune response in the 
absence of IL-18 (Schneider et al., 2010).  
 
Interleukin-2 (IL-2) 





cells, NK and DCs that have been stimulated by foreign antigens (Akdis et al., 2011). IL-2 
functions mainly by increasing T-cell response, even though excess production of this cytokine 
can lead to induced cell death as part of the protection against antigens. The role of IL-2 in 
growth and differentiation of B-cells allows for rapid response to previously exposed antigens 









Mannering and Cheers (2002) showed that in early stages of infection of mice with M. avium, 
there was high expression and production of IL-2 which acts in synergy with IFN-γ to restore 
immune response mainly by T-cells. However, in the late stages of infection, the mice could not 
restore an immune response and production of IFN-γ regardless of IL-2, which indicates that the 
latter is important during early response of the host to mycobacterial infections (Mannering and 
Cheers, 2002). Individuals infected with Mycobacteria have a reduced ability to respond to IL-2. 
Their peripheral blood mononuclear cells displayed a defective IL-2 receptor response especially 
in immune-compromised individuals (Toossi et al., 1986) and those with polymorphisms in IL-2 
gene (Sivangala et al., 2014) indicating its importance in cell mediated immunity. In addition to 
IFN-γ detection, IL-2 can be used as a diagnostic marker to detect and discriminate between 
active TB cases and latently infected individuals. This may provide better control of the disease 
due to early detection of latent infections (Biselli et al., 2010) 
 
Interleukin-6 (IL-6) 
IL-6 is produced in significant quantities at the site of infection at the early stages of M. 
tuberculosis infection. A variety of cells including T-cells, B-cells, smooth muscles, eosinophils, 
chondrocytes, osteoblast (Akdis et al., 2011) and epithelial cells (Lee et al., 2009) produce IL-6 
that has properties of both pro- and anti-inflammatory cytokines (VanHeyningen et al., 1997). It 
can be harmful when produced in large quantities since it appeared to suppress production of 
TNF-α and IL-1β by interfering with their transcription (Schindler et al., 1990) even though both 
cytokines provides protection during mycobacterial infections. It behaves like an anti-
inflammatory cytokine because it binds to a gp130 receptor ligand much like other major anti-




promoting B-cell differentiation, proliferation and production of immunoglobulins by B-cells 
(Akdis et al., 2011; van Crevel et al., 2002) and it ability to induce TH17 cells with other 
cytokines (Burgler et al., 2009). IL-6 is one of the cytokines produced early during 
mycobacterial infection at the site of infection (Bellamy et al., 1998; Law et al., 1996; Okamura 
et al., 1998) while another study suggested that IL-6 can be used as a potential diagnostic marker 
for TB infection (Singh and Goyal, 2013). IL-6 has also been suggested to have protective roles 
during M. tuberculosis infection as IL-6 deficient mice were more susceptible to infection 
compared to the wild type mice (Ladel et al., 1997). This increased susceptibility might be 
related to the failure of early IFN-γ production before the development of adaptive T-cell 
immunity (Saunders et al., 2000). Patients with large cavities secreted significantly higher levels 
of TNF-α, IL-1β and IL-6 compared to individual with smaller cavities. These findings suggests 
an inflammatory role of these cytokines in inducing tissue necrosis at the site of infection (Tsao 
et al., 1999) 
 
Interleukin-7 (IL-7)   
IL-7 is a lymphopoetic cytokine produced by epithelial cells, keratinocytes, macrophages, as 
well as B and dendritic cells (Akdis et al., 2011). IL-7 promotes the synthesis of other 
inflammatory cytokines in macrophages (Akdis et al., 2011), and induces bcl-2 expression in 
pre-T-cells prolonging their survival (Kim et al., 1998; Niu and Qin, 2013). M. tuberculosis 
infected mice were shown to survive longer than controls when treated with IL-7. This was due 
to its ability to activate immune effector cells, mainly T-cells, and enhancing antimicrobial 
activity observed in infected macrophages compared to mice treated with IL-2, IL-4 and 




survival, it can also cause a deleterious effect. In mice treated with IL-7, anti-inflammatory 
cytokines (IL-4 and IL-10) were increased while IFN-γ was decreased in early infection in these 
mice (Maeurer et al., 2000). Proliferation of memory phenotype CD8
+
 cells is jointly promoted 
by IL-7 and IL-15, however, these cytokines were shown not to be required for the development 
of  memory phenotype CD4
+
 cells (Tan et al., 2002). Mice treated with IL-7 and IL-15 showed 
significantly improved CD4 and CD8 T-cell memory response, enhanced T-cell proliferation, 
TH1 type cytokine production and increased production of multi-functional M. tuberculosis-
specific memory T-cells (Singh et al., 2010) demonstrating the role of both cytokines in T-cell 
memory functions and differentiation. 
 
Interleukin-8 (IL-8) 
IL-8 is a chemokine produced by epithelial cells, monocytes, lymphocytes, neutrophils and other 
immune and non-immune cells. The cytokine network and interaction is important during IL-8 
production, which is stimulated by IL-1α, IL-1β, and TNF-α (Akdis et al., 2011). IL-8 
production can be driven by stimulation of both immune and non-immune cells exposed to M. 
tuberculosis lipopolysaccharides. Lin et al. (1998) showed that IL-8 production increases 
significantly and was maximal after day 6, post-infection. It was also shown to be strain specific 
in pulmonary epithelial cells infected with clinical and laboratory M. tuberculosis strains (Lin et 
al., 1998). 
Epithelial cells are important producers of IL-8 which serves as a chemo-attractant of T-cells, 
neutrophils, NK cells, basophils as well as eosinophils during infections (Akdis et al., 2011; Lin 
et al., 1998). Song et al. (2003) demonstrated increased IL-8 production during early M. 




cells and macrophages allows for the rapid response by recruiting other immune cells to the site 
of infection. Intracellular growth rate is also important during IL-8 production as M. 
tuberculosis-infected macrophages produce lower levels of IL-8 compared to the fast growing M. 
smegmatis strain (Song et al., 2003). 
 
Interleukin-12 (IL-12) 
Once infected with M. tuberculosis, phagocytic cells produce IL-12 that is known to induce IFN-
γ production by the lymphoid cells at the site of infection, thereby connecting the innate and the 
adaptive immune responses. Sources of IL-12 production are antigen presenting cells usually at 
the site of infection (Hamza et al., 2010). Mutations in IL-12p40 gene or IL-12R gene for IL-12 
protein production in humans were associated with increased susceptibility to M. tuberculosis 
infections due to reduced IFN-γ production and T-cell associated response (Raja, 2004). IL-12 is 
known as one of the immunoregulatory cytokines that induces differentiation of CD4
+
 T cells 
into TH1 helper cells (Hamza et al., 2010). Early expression of mRNA for the production of IL-
12 compared to other cytokines during the T-cell differentiation has been shown to favour a TH1 
over TH2 immune response. This was observed in mice infected with the highly virulent M. 
tuberculosis CDC1551 strain that induced an early production of IL-12 and IFN-γ, which were 
responsible for the control of mycobacterial growth resulting in longer survival times (Manca et 
al., 1999).  
 
Interleukin-15 (IL-15) 
Activation and recruitment of T-cells and NK cells are stimulated by IL-15 production by 




macrophages and non-immune cells such as keratinocytes and skeletal smooth muscles. Different 
types of stimuli, including bacterial LPS, trigger the activation of innate immunity. It shares 
some functions with IL-2 such as activation of T-cells indicating its role in the cytokine network 
(Akdis et al., 2011). One of the important functions associated with IL-15 during M. tuberculosis 
infection is to induce differentiation of γδ T-cells into Vγ9Vδ2 T-cells that later become part of 
the memory cell pool. The effector memory cells have anti-mycobacterial activities hence the 
viability of the intracellular M. tuberculosis was reduced in their presence (Meraviglia et al., 
2010).  
 
Tumor necrosis factor alpha (TNF-α) 
TNF-α is released in response to M. tuberculosis stimulation of monocytes, macrophage (Valone 
et al., 1988), dendritic cells (Henderson et al., 1997) and pulmonary epithelial cells (Lee et al., 
2009). This suggests an important role of TNF-α in granuloma formation (Kindler et al., 1989; 
Senaldi et al., 1996), macrophage activation and immuno-regulatory properties (Orme and 
Cooper, 1999; Thurnher et al., 1997), walling-off of the infection and prevention of 
dissemination of the pathogen (Raja, 2004). Since granulomatous response plays a crucial role in 
the control of TB, early production of TNF-α may account for increased survival of M. 
tuberculosis CDC1551 infected- compared to Beijing infected- mice with low TNF-α levels 
(Manca et al., 1999). Production of TNF-α by epithelial cells stimulated with M. tuberculosis 
peaked at 18 hr and was reduced at subsequent incubation times (Lee et al., 2009). Despite its 
advantages, and even though it has been thought to be important in preventing latent TB 
activation, elevated TNF-α in hosts infected with less virulent strains of TB may account for the 




1999; van Crevel et al., 2002) and destruction of the lung tissue (Moreira et al., 1997) that can 
compromise the lung function. This suggests that even though pro-inflammatory cytokines can 
be beneficial during infection, their overproduction can result in severe inflammation 
compromising proper lung function. TB patients have been observed to recover rapidly from 
deterioration through the reduction of TNF-α in plasma (Hsieh et al., 1999). The negative effect 
of TNF-α can be limited by down-regulating the TNF-α gene (Friedland et al., 1995) and 
increasing TNF-α receptors to reduce its level in blood plasma (Juffermans et al., 1998) .  
 
Interferon gamma (IFN-γ) 
One of the important pro-inflammatory cytokines produced in response to mycobacterial 
infection is IFN-γ (also known as type II). IFN-γ is produced by NK cells, macrophages, T-cells 
bearing γ/δ T-cell receptors (Hedges et al., 1995) and epithelial cells (Sharma et al., 2007). 
Epithelial cells produce IFN-γ during M. tuberculosis infection, suggesting an important role for 
these cells in both innate (Sharma et al., 2007) and adaptive immune responses (Nagabhushanam 
et al., 2003). T-cell receptors respond rapidly to mycobacterial proteins and other non-protein 
components of M. tuberculosis. IFN-γ is known to up-regulate expression of the MHC class II 
antigens, secretory components and other intracellular adhesion molecules which are important 
for antigen presenting cells (Hedges et al., 1995). It was observed that some M. tuberculosis 
strains have the ability to reduce the response of macrophages to IFN-γ reflecting the survival 
mechanism that has been adapted by this pathogen to survive in the presence of IFN-γ (Ting et 
al., 1999). Interferon alpha (IFNI) and Beta (IFNIII) are also produced upon mycobacterial 
infections in both in vitro and in vivo infection models. Production of IFN-α was shown to 




to wild type (McNab et al., 2013). IFN-β interferon was suggested to play an important role in 
epithelial cells immunity during M. tuberculosis infection (Bierne et al., 2012). 
Other important cytokines produced during M. tuberculosis include IL-17 and IL-23. IL-17 is an 
inflammatory cytokine that can induce production of other chemokines and recruiting cells to 
parenchymal tissues. IL-23 is the driving force of both IL-17 and Th17 cells through induction of 
Th17 production from naïve CD4+ T cells (Khader and Cooper, 2008). IL-23 is produced by 
dendritic cells exposed to M. tuberculosis (Khader et al., 2005; Lockhart et al., 2006), and 
together with IL-17, they contribute to the early control of infection. However it has been 
reported that over production of IL-17 may result in severe immunopathology of the lungs due to 
increased tissue damage and reduced fibrin deposition (Dragon et al., 2008) and together with 
IL-23, they can alter the functional profile of neutrophils (Zelante et al., 2007). This suggests 
that a crucial balance needs to be reached for production of both cytokines to effectively respond 
and control M. tuberculosis infections without compromising lung function.  
Some pro-inflammatory cytokines are beneficial, while others are harmful during mycobacterial 
infection. Many pro-inflammatory cytokines have been observed to act in synergy forming a 
cytokine network to provide a more efficient immune response during M. tuberculosis infection 








Fig. 6. Response of macrophage and dendritic cells infected with M. tuberculosis (van Crevel et 
al., 2002). When innate cells are infected with M. tuberculosis, they secrete cytokines and trigger 
cascades of events that results in granuloma formation and involvement of other cells to render 
immunity at the site of infection.  
 
Anti-inflammatory cytokines 
Anti-inflammatory cytokines antagonize the action of the pro-inflammatory cytokines, making 
individuals more susceptible to M. tuberculosis infections. These include IL-1ra, IL-4, IL-10, IL-
11, IL-13 and transforming growth factor beta (TGF-β) (Opal and DePalo, 2000). Anti-
inflammatory cytokines may be produced at the site of infection by macrophages, T-cells, 
dendritic cells (Jin et al., 2014; Opal and DePalo, 2000) and epithelial cells (Lutay et al., 2014). 
Some of the pro-inflammatory cytokines such as IL-6 and IL-11 have both pro- and anti-






IL-1ra belongs to the IL-1 family and its release is activated by the same stimulus that causes IL-
1 production. It is commonly known to be effective in inhibiting IL-1 cytokine activity by 
binding to either IL-1RI or IL-1RII receptors. This causes the failure of IL-1 binding by 
competitive inhibition, thus reducing its production (Akdis et al., 2011; Arend and Guthridge, 
2000) and contribute to the control of increased inflammation caused by IL-1. IL-1ra is secreted 
by a variety of cells including monocytes, endothelial and epithelial cells (Akdis et al., 2011). To 
be an effective inhibitor, at least 100-fold should be secreted due to the high number of free IL-
1RI and IL-1RII receptors in a variety of cells (Arend and Guthridge, 2000). Maintenance of the 
IL-1 and IL-1ra in the body is important because an imbalance between these two causes 
progressive diseases such as lupus and increased susceptibility to viral infections (Akdis et al., 
2011). The role of IL-1ra in TB infection was demonstrated by Wilkinson et al. (1999) where 
polymorphism in the gene coding for IL-1ra resulted in an increased production of anti-
inflammatory cytokines IL-4 and IL-10 (Wilkinson et al., 1999). Since IL-1ra is secreted at high 
levels in individuals with TB, it was shown to be one of promising biomarker targets for TB 
infections (Ruhwald et al., 2009). 
 
Interleukin-4 (IL-4) 
IL-4 is predominantly produced by TH2 and other immune cells which include basophils, 
eosinophils, mast cells and other CD-1 cells (Akdis et al., 2011). Production of IL-4 causes 
suppression of IFN-γ and macrophage activation, thus suppressing cell-mediated immunity and 
weakening the host defence mechanism and can also serve as an effector cytokines for TH2 cells 




was demonstrated in M. tuberculosis infected mice with anti-IL-4 treatment that caused 
reduction in the lungs bacillary load, thus activating TH1 response (Buccheri et al., 2007). 
Similar results were also seen with the IL-4 knockout mice that had reduced bacterial burden 
compared to the wild type (Roy et al., 2008). This supports numerous hypotheses that cytokines 
inducing an anti-inflammatory response such as IL-4can enhance the pathological state of the 
host, thus reducing the ability to fight infections (Roy et al., 2008). Therefore, in order to 
successfully fight M. tuberculosis infections more pro- instead of anti-inflammatory cytokines 
should be secreted by the host. However, this needs to be a tightly controlled process since 
excessive inflammation may cause immunopathology to the host lung tissue (Saunders and 
Britton, 2007).  
 
Interleukin-10 (IL-10) 
Most cells including B-cells, T-cells, macrophages and dendritic cells have the ability to produce 
IL-10. Compared to other TH2 cytokines, IL-10 is different in that it is produced by TH1, TH2 
and TH17 cells and this is beneficial to the body to neutralize the net inflammatory effect of TH1 
cytokines. IL-10 prevents immuno-pathology that is associated with the production of high levels 
of pro-inflammatory cytokines. Gene expression and production of IL-10 in M. tuberculosis 
strain infected monocytes/macrophages was shown to be dependent on the type of infecting 
strain (Manca et al., 2004; Tanveer et al., 2009; Wang et al., 2010). 
IL-10 production provides protection against an uncontrolled immune response during infections 
to prevent autoimmune diseases. The effectiveness of IL-10 as an anti-inflammatory cytokine 
lies in its ability to inhibit myeloid cells (which are macrophages and DCs), to activate TH1 




12, IL-18, TNF-α), as well as beneficial chemokines such as [monocyte chemo-attractant 
protein-1, macrophage inflammatory protein (MIP)-1 (α and β), Rantes, inducible protein (IP)-
10] that contribute to the TH1 response (Akdis et al., 2011; Redford et al., 2010). Though 
beneficial during inflammation, IL-10 can induce down-regulation of surface expression of class 
II MHC molecules and co-stimulatory molecules CD80/CD86 on monocytes and macrophages 
(de Waal Malefyt et al., 1991). Similar to other anti-inflammatory cytokines, IL-10 production 
during M. tuberculosis infection is not beneficial to the host since it was reported to increase 
susceptibility of the host to infection (Boussiotis et al., 2000). Beamer et al. (2008) showed 
enhanced survival of the mice treated with anti-IL10RI antibodies. This led to an increased 
production of CD4 and CD8 cells that have the ability to produce beneficial cytokines such as 
IFN-γ during infection (Beamer et al., 2008). Increased IL-10 production was observed in serum 
and lungs of individuals with pulmonary TB (Almeida et al., 2009; Deventer et al., 1999), 
indicating its involvement during M. tuberculosis infection. 
Failure to respond to TH1 cytokines may be associated with the growth rate of a particular 
mycobacterial species (Mege et al., 2006). Compared to actively reproducing strains, slow-
growing and latent M. tuberculosis strains induce diminished production of IL-10, allowing the 
host to respond and control the infection. This also holds true for HIV-TB co-infected patients 
with low IL-10 production when compared to patients with advanced AIDS. This indicates that 
IL-10 production is associated with the host‟s failure to fight infection due to its anti-








IL-11 has both pro- and anti-inflammatory properties and performs a variety of functions which 
include immuno-modulation and epithelial cell protection (Kapina et al., 2011). This cytokine is 
produced mainly by epithelial cells, stromal cells, fibroblasts, osteoblasts, synoviocytes and 
tumor cell lines. Like other anti-inflammatory cytokines, IL-11 suppresses the production of pro-
inflammatory cytokines such as TNF-α, IL-1, IL-12 as well as IFN-γ (Akdis et al., 2011). 
Despite this, IL-11 is associated with important functions such as neuronal development, 
adipogenesis, and bone marrow recovery as well as platelet production (Akdis et al., 2011; 
Kapina et al., 2011). One of the well-known function of IL-11 is involvement in stimulating 
hematopoiesis by supporting the proliferation of myeloid, erythroid, and megakaryocyte 
progenitor cells (Paul and Schendel, 1992). In an M. tuberculosis infected mouse model, Kapina 
et al. (2011) showed that the lung pathology and other key cytokines (IL-6, TNF-α and MIP-2) 
diminished when IL-11 was neutralized with anti-IL-11 antibodies. This reduction indicates that 
IL-11 has both pro- and anti-inflammatory properties and might be involved in the cytokine 
network for production of both TH1 and TH2 cytokines (Kapina et al., 2011). 
 
Interleukin-13 (IL-13) 
IL-13 is a well-known anti-inflammatory cytokine belonging to TH2 family, however it may also 
be involved in recruitment of eosinophils and mast cells during parasite infection (Akdis et al., 
2011) and can serve as effector cytokine through regulating B-cell mediated immunity (Wynn, 
2003). It functions by directly inhibiting macrophage activity and inducing down-regulation of 
the nitric oxide synthesis as well as the Toll like receptor-2 pathway (Ghadimi et al., 2010). The 




anti-inflammatory properties of this cytokine was seen in IL-13 deficient mice that secrete low 
levels of other TH2 cytokines such as IL-4, IL-5 and IL-10 (Akdis et al., 2011). High levels of 
IL-13 were associated with increased susceptibility of mice to Chlamydia muridarum, reduced 
uptake of the pathogen by epithelial cells and increased intracellular bacterial growth in vitro 
(Asquith et al., 2011). Like other pathogens such as Chlamydia, M. tuberculosis uses multiple 
strategies to survive within the host. One such strategy is to inhibit protective autophagy in the 
immune cells by inducing high levels of TH2 cytokines. This was observed in macrophages 
derived from peripheral blood mononuclear cells (PBMCs) where M. tuberculosis infection 
inhibited protective cell death with an increased induction of IL-4 and IL-13. This suppressed the 
TH1 immune response rendering the host more susceptible to infections (Ghadimi et al., 2010). 
 
Chemokines 
During infection, there is constant communication of the different cell types resulting in immune 
cell trafficking into the affected tissues to confer increased immunity. This communication and 
movement is facilitated by adhesins, selectins, chemokines as well as chemokine receptors 
(Algood et al., 2003). There are four chemokines subfamilies that are classified according to the 
location of their cysteine residues. These families are C, CC, CXC and CX3C (Zlotnik et al., 
2006), and they bind to their respective receptors that are expressed in different cell types (Slight 
and Khader, 2013) (Fig. 7). The CC chemokines commonly act on CCR receptors while the CXC 
chemokines bind to CXCR receptors (Borish and Steinke, 2003; Slight and Khader, 2013). Other 
chemokine receptors include XCR and CX3CR which are used by chemokines belonging to 




The common stimulus that results in chemokine production by both immune and non-immune 
cells as well as mice models is an inflammation that occurs when cells are infected (Algood et 
al., 2003; Chuquimia et al., 2012; Lin et al., 1998). M. tuberculosis has antigens to stimulate 
production of different chemokines in macrophages (Sadek et al., 1998; Saukkonen et al., 2002), 
pulmonary epithelial cells (Chuquimia et al., 2012; Lee et al., 2009; Lin et al., 1998; Sato et al., 
2002) and mice models (Jang et al., 2008; Manca et al., 2004; Vesosky et al., 2010). Production 
of different chemokines at the site of infection (mostly lung tissue) lined by macrophages and 
different types of epithelial cells ensures an effective involvement of circulating monocytes (Shi 
and Pamer, 2011), T-cells (Lee et al., 2009; Lin et al., 1998), as well as formation of the 
granuloma (Algood et al., 2003; Silva Miranda et al., 2012) during M. tuberculosis infection.  
 
 
Fig. 7. Communication between the lungs and circulating immune cells using chemokines and 




Chemokines that significantly contribute to TH1 immune response were produced in murine 
dendritic cells and macrophages during M. tuberculosis infection (Jang et al., 2008) indicating a 
cell specific chemokine response in different immune cells. Lung epithelial cells were shown to 
be a source of CCL5 in vitro (Nouailles et al., 2014), while in a mouse model, it provided early 
protection against M. tuberculosis infection (Vesosky et al., 2010). This demonstrates a crucial 
role played by the CCL5 chemokine during M. tuberculosis infection both in vitro and in vivo 
infection models (Nouailles et al., 2014; Vesosky et al., 2010). Chemokines can also be an 
indication of M. tuberculosis infection and disease occurrence as they were shown to be elevated 
in individuals with tuberculosis compared to healthy controls (Yu et al., 2012).  
 
Transcriptomics and cytokine/chemokine profiling  
 
Techniques to study gene expression 
The use of recent and newly improved molecular techniques has revealed complex molecular 
mechanisms that are involved in cell  differentiation (Harrison, 1990; Lin et al., 2011; Luo et al., 
2014; Uskokovic et al., 2009), specific plant molecular markers (Thavamanikumar et al., 2014), 
single nucleotide mutations (Morin et al., 2008) and more complex isoform switching during 
gene expression (Trapnell et al., 2010). This began with the introduction of polymerase chain 
reaction (PCR) (Mullis, 1990; Saiki et al., 1985) that allowed quantifying a single gene in a 
sample. It was one of the great discoveries in molecular biology that was able to reveal the 
presence or absence of a gene and its abundance between samples (Garibyan and Avashia, 2013; 





PCR was a widely used technique over the years (Bustin, 2000; Kotik, 2009; Steffan and Atlas, 
1991) and still being used to date (Rak et al., 2014). Quantitative reverse transcriptase PCR 
(qRT-PCR) was introduced after standard PCR (Higuchi et al., 1993) and used for several 
applications (Raja et al., 2002; Timken et al., 2005). The major limitation with PCR and qRT-
PCR is in the number of genes that can be analysed per sample. This shortcoming was alleviated 
by the use of microarray that was able to show differential expression of the known genes in the 
organism‟s transcriptome (Sinicropi et al., 2007). This is very important when trying to 
understand not only changes in the genes but their interactions which results in complex 
pathways during infection. The  microarray technique was used for years and is still being used 
for different applications, however the major drawbacks  are the inability to detect small changes 
in gene expression due to low sensitivity (Czechowski et al., 2004), and not all genes of interest 
may be immobilized as probes in the microarray tile. In addition, the challenges with microarray 
data analysis include trying to optimize different brands of library pre-processing methods that 
giving rise to heterogeneous data formats. Moreover, standard analysis tools cannot be applied to 
different types of microarrays such as gene expression, SNPs and miRNA arrays tools which 
requires specific type of data analysis (Guzzi and Cannataro, 2011). 
 
Next Generation Sequencing (NGS) technology is able to overcome some of the microarray 
limitations, and has allowed better understanding of microbial physiology (Sorek and Cossart, 
2010), human genetics (Pickrell et al., 2010), plant diversity (Martin et al., 2013) and also “key 
players” that are involved during the disease state of the organism (Prasopdee et al., 2014). 




ability to interrogate and quantify the organism‟s whole transcriptome without background signal 
that interferes with the down-stream analysis (Nookaew et al., 2012).  
The use of NGS has created endless possibilities in biomedical research (Elingarami et al., 
2013), drug discovery (Dopazo, 2014), metagenomics (Hu et al., 2011) and human-pathogen 
interaction (Westermann et al., 2012). RNA-Seq is an NGS based technology that allows 
quantifying different types of RNA molecules in different tissues (Guo et al., 2014; McGettigan, 
2013), detect transcripts that are expressed at a low levels (Zhao et al., 2014), identify novel 
transcripts, alternative splicing and novel isoforms switching (Park et al., 2013; Trapnell et al., 
2010), studying complex transcriptomics (Wang et al., 2009) and analysing of DNA-binding 
proteins (Kechavarzi and Janga, 2014). 
Furthermore, RNA-Seq can detect unannotated exons, determine overall and exon-specific 
expression, and to assay allele specific expression levels that was not possible with previous 
molecular techniques (Pickrell et al., 2010). The disadvantages associated with the use of RNA-
Seq include the need for high quality RNA samples, high cost of deep sequencing of RNA 
transcripts and extensive bioinformatics support required to analyse the huge volume of data 
generated in order to obtain differential gene expression of targeted transcripts (Wang et al., 
2009). Gene expression studies are essential to support the data obtained from different protein 
(e.g. cytokine) assays that may not be sensitive enough to be detected in culture supernatant or 
blood samples due to being used by cells themselves or produced in an undetectable form 
(Bienvenu et al., 2000). 
 
Techniques to study cytokine/chemokine profiling 




known and validated Enzyme-Linked Immuno-Sorbent Assay (ELISA). The use of ELISA is 
considered as a gold standard for sensitive detection of the cytokine of interest in samples with 
quantitative and reproducible results. Despite the global use of ELISA for cytokine detection, 
this technique is limited to detecting only one or very few proteins in samples. Other 
disadvantages include variability that can be introduced because of differences in antibody 
quality from different manufacturers and inability to detect cytokines that are out of range in a 
linear relationship between cytokine concentrations and absorbance reading. Moreover, limited 
number of cytokines detectable in a single sample by ELISA can limit the understanding of 
complex interplay of different immunological markers in clinical and biomedical research (Leng 
et al., 2008).  
 
The recent and highly appreciated cytokine multiplexing technology has been used to detect 
multiple analytes in the same sample. The Luminex technology apply the use of hundreds of 
specially prepared micrometer beads internally stained with a mixture of red or infrared 
fluorescent dyes. The different levels at which these beads are dyed creates hundreds of different 
fluorescence profiles that can be interrogated individually and classified into different samples 
(Tighe et al., 2013). Excitation of these beads by a laser from the flow cytometry-based 
instruments results in emission of light at different wavelengths. The bead surfaces are then 
conjugated with specific capture antibody for each cytokine which is then differentiated from 
other beads by its specific spectral light emission. Each of these beads is then incubated with 
samples (supernatants, blood, etc) for multiplexing purposes in a 96-well plate. These beads can 
be mixed for detecting up to 100 samples in each well through specific light emission for each 




which are conjugated with fluorescent dyes are added providing distinctions among cytokines of 
interest. Interaction between cytokines and unique “dyes” within beads allows differentiation 
between cytokines while the intensity of fluorescence in reporter dye–conjugated detection 
antibody quantify relative abundance of the cytokines (Khalifian et al., 2015; Tighe et al., 2013). 
The data analysis plan is usually included within the Luminex software that is used to quantify 
analytes of interest. Graphical presentations of the data with replicates variations can be used 
within the software installed on the Bioplex machine (BioRad). The data can also be exported 
from the software and be analyzed with other statistical software programmes such as SPSS, 
Genestat and Graph-pad prism.  
 
The advantages offered by the Luminex technology include higher sensitivity and detection 
ranges (Quinn et al., 2008), less volume of sample needed, high throughput multiplex analysis, 
reduced time and cost required for data acquisition, evaluation of one analyte in relation to  
others in a same sample and lastly detecting multiple analytes with dynamic ranges of detection 
in one sample (Leng et al., 2008; Wang et al., 2005). Therefore, this technology has been used in 
studying inflammatory response in chronic allergic diseases (Leonardi et al., 2006), 
immunological changes during mycobacterial infection (Singh and Goyal, 2013) and 
understanding complex interplays of cytokines in the immune system (Szodoray et al., 2007). 
One of the major disadvantages of using the Luminex technology is the need for expensive 
analysis instrument (Khalifian et al., 2015). Variations in sample concentrations can be observed 
with the use of kits from different manufacturers, product number and assay preparation by 






Host transcriptome changes during M. tuberculosis infection 
Changes to the overall transcriptional profiles of the immune and non-immune cells occur in 
response to M. tuberculosis infections. These changes may include different molecular networks, 
transcriptional factors and pathways that are regulated to determine the outcome of the infection.  
Transcriptomics revealed diverse molecular changes in blood samples between healthy, Bacillus 
Calmette-Guerin (BCG) vaccinated and patients with active tuberculosis. All three clinical 
groups were able to show different molecular signatures that can be explored for biomarker 
discoveries (Lesho et al., 2011). The study by Cliff et al. (2012) revealed changes in immune 
regulation and gene expression in patient‟s blood under anti-mycobacterial treatment. Their 
findings demonstrated an early down-regulation of the inflammatory mediators  suggested to be 
linked to killing of the actively dividing bacilli (Cliff et al., 2012). Another in vivo study 
describing global transcriptome analysis of human blood samples provided evidence of 
molecular signatures that were promising for vaccine discovery and drug therapies. These 
interferon inducible signatures were also able to discriminate  tuberculosis from other similar 
infectious diseases (Berry et al., 2010). Molecular signatures identified in pathogenesis studies 
demonstrate “unique” immunological changes observed during M. tuberculosis infection. These 
signatures can also reveal different stages of infection that can potentially be explored for TB 
biomarkers or monitoring anti-TB response.  
The response of cells that are at the site of infection is important because they alert the host to 
invasion by a foreign antigen. Broncho-Alveolar Lavage (BAL) fluids (Raju et al., 2008) and 
Peripheral blood mononuclear cells (PBMCs) (Grassi et al., 2006) have been used to study the 
host response to infection and overall transcriptional response at the site of infection. Raju et al. 




individuals. They reported an increase in expression of many immunologically relevant genes in 
BAL cells. Up-regulated genes included surface markers ranging from CD9-CD68, some 
belonging to TH1 and TH2 immune response, cytokines, chemokines and immune relevant 
transcriptional factors. These surface markers are important in increasing the response efficiency 
of the cells to cytokines and chemokines that are produced during the infection. Most 
transcriptional factors that were expressed belong to TH1 immunity. These included signal 
transducer and activator of transcription-4 (STAT-4) and STAT-1 genes, while for the TH2 
immunity, only the STAT-6 gene was expressed and phosphorylated. This reflects the imbalance 
observed in transcriptional factors that will allow the shift in the type of cytokines that will be 
produced during TB infection (Raju et al., 2008).  
Grassi et al. (2006) also analysed the BAL fluid and reported a two-fold increase in expression 
of a variety of genes coding for cytokine production, cytokine/chemokine receptors, signal 
transduction, protease and apoptosis related genes in infected patients compared to their healthy 
counterparts. This indicates that cytokines of the TH1 immunity are expressed during infection 
(Grassi et al., 2006).  Failure of the host to eradicate the pathogen may be due to the inability to 
express the necessary transcriptional factors required for effective immune response. This was 
observed in three IFN-γ genes, whose expression was not changed because of the failure to 
activate interferon regulatory factor-1 (IRF-1) and STAT-1 required for IFN-γ expression. This 
resulted in a lack of responsiveness by the host to the cytokines produced and subsequent failure 
to eliminate M. tuberculosis (Grassi et al., 2006).  
Gene expression profiling using real time PCR and microarray analysis have been used to 
understand the macrophage cell response to M. tuberculosis infection. Increased mRNA 




proteins, adhesion molecules and different signal transducers in M. tuberculosis infected 
macrophages (Volpe et al., 2006). Pro- (IFN-γ and TNF-α), anti-inflammatory (IL-10) associated 
genes, and chemokines were also expressed in macrophages in response to M. tuberculosis 
infection (Almeida et al., 2009). Expression levels of IL-10 increased only for one day and 
declined in the subsequent days with no interaction observed between IL-10 production and 
inhibition of the IFN-γ, which is an active and important cytokine to inhibit mycobacterial 
growth in vivo (Volpe et al., 2006).  
In an in vitro study, DCs had higher expression of immune associated genes compared to 
macrophages as well as different expression signatures that are specific for these cell types 
during M. tuberculosis infection (Tailleux et al., 2008). To date, only qRT-PCR has been used to 
study cytokine/chemokine genes in M. tuberculosis infected pulmonary epithelial cells. Lin et al. 
(1998) evaluated the expression of five cytokine/chemokine genes by A549 epithelial cells 
infected with H37Ra strain using qRT-PCR. Increased mRNA levels of MCP-1 and IL-8, while 
three chemokine transcripts Rantes, MIP-1α and MIP-1β could not be detected. Similarly, Sato et 
al. (2002), showed increased expression of both MCP-1 and IL-8 in TB-infected A549 cells. In 
addition, increased mRNA expression of the pro-inflammatory cytokines, TNF-α, and 
granulocyte-macrophage colony-stimulating factor (GM-CSF) were also observed in these 
studies. Lee et al. (2009) observed increased expression of IL-6, IL-8 and TNF-α when epithelial 
cells where exposed to M. tuberculosis using qRT-PCR (Lee et al., 2009), while Sharma et al. 
(2007) detected increase in IFN-γ expression using flow cytometry. These findings indicate that 
epithelial cells respond rapidly to infection by increasing cytokine gene expression and possible 
production, thereby attracting macrophages to the infected site (Lee et al., 2009; Lin et al., 1998; 




Rationale for present study 
The prevalence and spread of M. tuberculosis drug susceptible and resistant strains within the 
South African population (Muller et al., 2013; Streicher et al., 2004; Streicher et al., 2012) and 
globally (de Viedma et al., 2005; Glynn et al., 2010; Glynn et al., 2002; Valway et al., 1998) has 
motivated an increasing necessity for a better understanding of the host response during infection 
by these strains. Several studies (Chen et al., 2014; Lin et al., 1998; Manca et al., 1999; Portevin 
et al., 2011; Rakotosamimanana et al., 2010) have reported differential host response during 
infection by clinical strains of M. tuberculosis belonging to different genotype families and 
lineages. Moreover, host response has been reported during infection with either a laboratory 
strain H37Rv or few clinically relevant strains in vivo (Lopez et al., 2003; Manca et al., 1999; 
Schaale et al., 2013) and in vitro (Carmona et al., 2013; Chakraborty et al., 2013; Chuquimia et 
al., 2012; Faksri et al., 2014; Lee et al., 2009; Lin et al., 1998; Sharma et al., 2007).  
The clinical manifestation of M. tuberculosis complex is highly conserved during infection 
(Homolka et al., 2010). However, several virulence factors have been associated with 
hypervirulent clinical strains such as those belonging to the Beijing genotype (Reed et al., 2004), 
causing differential and strain specific response in in vitro and in vivo pathogenesis studies (Koo 
et al., 2012; Manca et al., 2004; Subbian et al., 2013). Despite the extensive work on in vitro and 
in vivo studies using clinical strains of M. tuberculosis, very limited studies  have focused on 
pulmonary epithelial cells infected with such  strains (Lin et al., 1998), despite their abundance 
in the alveolar space. To date, no study had reported on comprehensive transcriptomics in 
pulmonary epithelial cells infected with clinical strains of M. tuberculosis belonging to different 




This study investigated the response of pulmonary epithelial cells during infection with clinical 
strains of M. tuberculosis by measuring cytokine/chemokine kinetics over time using the Bio-
Plex assay. The epithelial cell global gene expression, pathways, networks and transcriptional 
factors induced by different strains were elucidated using the highly sensitive RNA-Seq 
technique and different downstream bioinformatics software programmes. Furthermore, strain 
specific molecular signatures and other molecular mechanisms induced by these different strain 




To study host-pathogen interactions induced by different clinical strains of M. tuberculosis in an 




To decipher immune responses in pulmonary alveolar epithelial cells infected with M. 
tuberculosis by measuring cytokine/chemokine kinetics over time;  
 
To measure global gene expression of human, including immune response genes in pulmonary 
alveolar epithelial cells infected with clinical strains of M. tuberculosis at 48 hr post-infection; 
and 
 
To decipher the datasets in terms of pathways, networks and transcriptional factors in pulmonary 






Chapter 1: Review of relevant literature 
 
Chapter 2: Virulent Mycobacterium tuberculosis strains induce strain specific in vitro cytokine 
and chemokine responses in pulmonary epithelial cells. 
Clinical strains of M. tuberculosis belonging to 4 genotype families and Unique genotype were 
used to infect pulmonary epithelial cells and supernatants were collected at 24, 48 and 72 hr 
post-infection. Cytokine production increased gradually with peak production at 48 or 72 hr after 
infection. All strains induced a strain specific cytokine/chemokine production at different times 
post-infection. The Beijing and Unique strain induced lowest concentration of 
cytokines/chemokines compared to other clinical strains. These findings may suggest the 
presence of different virulence factors among clinical strains and can explain transmissibility of 
Beijing strain globally, while similar patterns were unexplained for the Unique strain. These 
findings also suggest that the F15/LAM4/KZN, F11 and F28 strains may be less virulent than the 
Beijing strain, and that their enhanced transmission may be due to the lack of stringent TB 
control measures rather than hypervirulence. 
 
Chapter 3: Mycobacterium tuberculosis clinical strains exhibit differential gene expression and 
strain-specific molecular signatures in pulmonary epithelial cells.  
Total RNA was extracted from pulmonary epithelial cells infected with clinical strains of M. 




were compared among clinical strains. Lowest fold changes were induced by the Unique strain 
while the highest were induced by the F15/LAM4/KZN and F11 strains. The highly virulent 
strains of M. tuberculosis hierarchically clustered separately compared to the less virulent 
Unique strain suggesting a relationship between strain virulence and gene expression. Strain 
specific genes varied among the strains, along with their associated Kegg and Reactome 
pathways that have a potential to be explored for biomarker applications in future studies. 
 
Chapter 4: Canonical pathways, networks and transcriptional factors induced by clinical strains 
of M. tuberculosis in pulmonary alveolar epithelial cells 
Differentially expressed genes in pulmonary epithelial cells were used to investigate different 
canonical pathways, networks and transcriptional factor changes that are regulated by clinical 
strains. The interferon signalling and Hepatic Fribrosis/Hepatic Stellate Cell Activation pathways 
were among the top 5 activated pathway by all strains. The Beijing and Unique strains induced 
increased enrichment in all cholesterol biosynthesis pathways while other strains induced low 
enrichment of these pathways. Network activation/down-regulation also differed among the 
strains indicating diversity in gene expression and network enrichment among clinical strains. 
There were common transcriptional factors among the strains while others were strain specific 
and might be responsible for down-stream changes and complex pathway enrichment that occur 
within the host due to infection by different clinical strains of M. tuberculosis. Strain specific 
molecular mechanisms may be explored for host-directed therapy during infection with M. 





CHAPTER 2: VIRULENT Mycobacterium tuberculosis STRAINS INDUCE STRAIN 





The M. tuberculosis F15/LAM4/KZN, F11, F28 and Beijing strain families have been associated 
with high transmission rates within the South African population. The current study focused on 
elucidating the cytokine/chemokine response induced by these strain families of M. tuberculosis 
in pulmonary epithelial cells. The A549 pulmonary epithelial cell line was infected with the 
F15/LAM4/KZN, F28, F11, Beijing, Unique and H37Rv strains and the supernatant harvested at 
0, 24, 48 and 72 hr for cytokine/chemokine analysis using  the Bio-Plex Pro Human Cytokine 
Group 27-Plex Assay. Among the 23 cytokines/chemokines that were detected, a significant 
production of anti-inflammatory and pro-inflammatory cytokines, as well as chemokines was 
observed at different time intervals. All strains induced a gradual increase in 
cytokines/chemokines that peaked mostly at either 48 or 72 hr post-infection. However, 
production of each cytokine/chemokine was observed to be strain and time specific. High 
cytokine levels were induced by the F28 strain at 48 hr and F15/LAM4/KZN strain at 72 hr for 
most analytes. Lower cytokine production was induced by the Beijing and Unique strains at all-
time intervals, suggesting a higher virulence of these strains compared to other strain families. 
On the other hand, the F15/LAM4/KZN strain induced high protective cytokine production, 
suggesting a lower virulence for this strain. Cytokine/chemokine production by the laboratory 




clinical strains. These findings would suggest that the widespread transmission of the 
F15/LAM4/KZN strain within SA population may not be directly associated with the virulence 
of the strain, but rather to the failure of proper control measures. The results of this study make a 
strong case to conclude that virulent M. tuberculosis strains induce specific in vitro cytokine and 
chemokine responses in pulmonary epithelial cells.  




TB remains one of the major causes of mortality worldwide, leading to approximately 1.5 
million deaths each year (WHO, 2015). This burden may, in part, be attributed to the presence of 
highly transmissible strains of the causative agent, M. tuberculosis, such as CDC1551 (Valway et 
al., 1998), CAS (Ali et al., 2009), Beijing (Glynn et al., 2002), Type 1 (Sharma et al., 2003), 
Haarlem (Mardassi et al., 2005), F11, F28 (Victor et al., 2004) and F15/LAM4/KZN (Pillay and 
Sturm, 2007) that have the capacity to infect and cause disease in large proportions of the 
population in different geographic regions globally. In South Africa, the Beijing family of strains 
is largely associated with drug resistance in the Western Cape, Eastern Cape and Gauteng, whilst 
the susceptible forms dominate in KwaZulu-Natal (Chihota et al., 2012). The F11 and F28 strain 
families are also present in Western Cape, Eastern Cape and Gauteng provinces, with the former 
representing the largest proportion of all isolates in the Western Cape (Victor et al., 2004). In 
KwaZulu-Natal, the F15/LAM4/KZN strain, largely associated with drug resistance since 1994 




in 2005 (Gandhi et al., 2006). MDR F11 and F28 strains are also present in significant 
proportions in KwaZulu-Natal (Chihota et al., 2012).  
 
Highly transmissible M. tuberculosis strains are characterized by their ability to infect large 
numbers of patients in a population within defined geographical settings or globally.  
Hypervirulent M. tuberculosis strains are usually characterized by rapid growth of the strain in 
the mice lungs followed by diminishing TH1 immunity over time (Ordway et al., 2007).  A 
positive correlation was observed between highly transmissible and hypervirulent strains of M. 
tuberculosis in mouse models.  Virulent strains induced lower-protective immune responses. 
This was further correlated with other community markers of transmission such as tuberculin 
reactivity among contacts, rapid progression to disease and cluster status associated with highly 
transmissible and hypervirulent strains (Marquina-Castillo et al., 2009). The Beijing family of 
strains has been shown to be both hypervirulent (Manca et al., 2001) as well as highly 
transmissible compared to other clinical strains (Bifani et al., 2002). Studies have linked the 
hyper-transmissibility of the Beijing strains with the constitutive expression of the DosR regulon 
(Reed et al., 2007) resulting in early death of infected mice (Manca et al., 2001).  
 
M. tuberculosis strains have been shown to invade and replicate in pulmonary epithelial cells that 
were previously regarded as non-immune cells. Epithelial cells may not be hematopoietic, 
however they act as physical barrier against pathogens since they are present in large proportions 
in the lungs compared to other cells (Chuquimia et al., 2012; Lutay et al., 2014). Strains of 
different genotypes adhere to, invade, and replicate in these cells under both aerobic (Ashiru et 




addition to their protective barrier functions (Chuquimia et al., 2012), epithelial cells produce a 
variety of cytokines and chemokines (Chuquimia et al., 2012; Stadnyk, 1994) and play a role in 
granuloma formation during TB infection (Lin et al., 1998). This reflects their importance in 
modulating the host innate immune response during TB infection (Stadnyk, 1994). Several 
cytokines and chemokines, including interleukin (IL)-4 and interferon gamma induced protein 10 
(IP-10) (Méndez-Samperio et al., 2006), IL-6 (Lee et al., 2009), IL-8 (Lin et al., 1998; 
Wickremasinghe et al., 1999), IFN-γ (Sharma et al., 2007), TNF-α (Lee et al., 2009; Zhang et 
al., 1997), and monocyte chemotactic protein 1 (MCP-1) (Lin et al., 1998) were shown to be 
produced by epithelial cells infected with Mycobacteria. Uncharacterized M. tuberculosis strains 
have been shown to induce differential cytokine/chemokine responses in pulmonary epithelial 
cells (Lin et al., 1998). Cytokine responses have been inversely associated with strain virulence 
in various infection models (Koo et al., 2012; Manca et al., 2004; Manca et al., 1999).  
 
Previous studies on in vitro (Lee et al., 2009; Lin et al., 1998; Manca et al., 2004; Sharma et al., 
2007) and in vivo (Manca et al., 1999; Manca et al., 2001) host response have reported on only a 
limited number of cytokines/chemokines. These studies were limited to only using the laboratory 
H37Rv strain and a few characterized and uncharacterized clinical strains. Understanding a wide 
range of other cytokines/chemokines produced by epithelial cells might provide a better 
understanding of role played by these cells in both innate and adaptive immune response. 
Despite major advances in the understanding of TB pathogenesis, there is still a lack of 
knowledge on the range of cytokines/chemokines induced by highly transmissible strains of M. 
tuberculosis in KwaZulu-Natal. Furthermore, no report is available on cytokine/chemokine 




dominate within the South African population. We therefore hypothesized that different virulent 
strains of M. tuberculosis elicit differential and strain specific host cytokine/chemokine response 
in epithelial cells at different time intervals. In this study we evaluated the response of 27 
cytokines/chemokines in pulmonary alveolar epithelial cells infected with 4 well characterized, 
dominant strains of M. tuberculosis in KwaZulu-Natal (South Africa) compared to the laboratory 
H37Rv strain.  
 




The study was approved by the Biomedical Research Ethics Committee, University of KwaZulu-




Representatives of M. tuberculosis F15/LAM4/KZN, Beijing, F11, F28 and a Unique strain were 
isolated in our previous studies from sputum specimens of patients in KwaZulu-Natal, South 
Africa and characterized in Medical Microbiology and Infection Control, University of 
KwaZulu-Natal. Strain identity had been previously established by means of IS6110-restriction 
fragment length polymorphism analysis (RFLP) and spoligotyping. The Unique strain 
represented a genotype that was identified in only a single patient, in contrast to the other 4 




were selected for this study as they represented the 4 major strain families isolated from patients 
in KwaZulu-Natal and other provinces in South Africa. Their high transmissibility inferred 
higher virulence, whereas the Unique strain was inferred to be less virulent. Drug susceptibility 
testing established that these representative F15/LAM4/KZN, F11 and F28 were XDR strains 
while the Beijing and Unique were MDR strains. The laboratory strain M. tuberculosis H37Rv 
(ATCC 25618) was obtained from UKZN (Medical Microbiology and Infection Control) culture 
collection and included in the study as a virulent control. Stock cultures of all strains had been 
stored in storage media containing 40% glycerol (Larsen et al., 2007) at -80
o
C, prior to retrieval 
and subculture.  
 
Growth and maintenance of bacterial isolates and infection of A549 cells 
  
Culturing of M. tuberculosis clinical strains and infection of pulmonary epithelial cells were 
carried out under biosafety level 2+ (BSL2+) conditions in the TB laboratory, Medical 
Microbiology and Infection Control, UKZN. Strict safety precautions, such as gloves, N95 mask 
or PAPYR were utilized during experiments involving M. tuberculosis.   
 
Preparation of M. tuberculosis stock cultures 
 
Clinical and laboratory strains of M. tuberculosis were cultured aerobically in 10 ml 
Middlebrook 7H9 broth (Becton, Dickinson and Company, South Africa) supplemented with 
50% glycerol (Merck, South Africa), 20% Tween-80 (Merck, South Africa) and 10% Oleic acid 




for 3-6 weeks to a mid-log phase (OD 0.8-1600nm). Thereafter, cells were centrifuged for 20 min 
at 4 000 g at 4 ºC. The pellet was washed thrice with PBS and re-suspended in 1 ml of the 
Middlebrook 7H9 broth medium containing 40% glycerol (Larsen et al., 2007) and stored at -70 
ºC in order to prevent loss of virulence through multiple passages. Stock culture solutions and 
media were prepared according to the manufacturer‟s instructions (Becton, Dickinson and 
Company, South Africa). 
 
Culture of M. tuberculosis  
 
Stock cultures were revived in supplemented 7H9 broth and allowed to grow to a mid-log phase 
with an OD600nm of 0.8-1 (OD600nm of 1 = ~1X10
8
 Cfu/mL, (Larsen et al., 2007). The Cfu/mL of 
the cultures was confirmed by plating 10-fold serial dilutions onto Middlebrook 7H11 agar and 
incubation at 37
o
C for 3-4 weeks. 
 
Culture and infection of A549 pulmonary epithelial cells 
 
Stock cultures of A549 human pulmonary alveolar epithelial cells (ATCC CCL 185) were grown 
until they were  ≥90% (2.2 to 2.6 x 10
6
) confluent in 25 cm
2
 tissue culture flasks (TCFs) 
containing 5 ml of Eagle's Minimal Essential Medium (EMEM) (Lonza, South Africa), 
supplemented with 10% heat inactivated fetal calf serum (FCS) (Lonza, South Africa). The 
confluent A549 cells were counted using the Neubauer counting chamber to determine the 
accurate number of cells. Thereafter, 4-5 ml of M. tuberculosis culture, grown to a log phase was 






TCFs containing 5 ml of serum free EMEM medium. The inoculum was plated to confirm the 
initial Cfu/ml used to infect A549 cells. The flask containing infected cells were sealed and 
incubated at 37
o
C in 5% CO
2
. Nine to ten milliliters of supernatant samples, collected from 
separate flasks at 0, 24, 48 and 72 hr post-infection, were filtered and stored at -70
0
C in 0.5% 
bovine serum albumin (BSA) as a carrier protein prior to cytokine analysis.  In a separate flask, 
the infected epithelial cells were lysed with triton-X and 10-fold serial dilutions were plated out 
on 7H11 agar plates to determine Cfu/ml in order to calculate the number of invaded/replicating 




Supernatant samples were analyzed using the Bio-Plex Pro
TM
 Human Cytokine 27-plex Assay 
(Bio-Rad) with the Bio-Plex
R
 200 (Bio-Rad) in a standard microbiology laboratory in 
Microbiology, University of KwaZulu-Natal (Westville campus). The 27-Plex assay (Bio-Rad) 
was chosen because it contained a combination of analytes that were shown previously to 
contribute to the innate immune response together with some analytes that had not been tested 
and detected in the epithelial cell line that was used in the current study. The detection limits 
(pg/ml) of these analytes were: IL-1β (2.05-2283.67), IL-1ra (8.91-30032.7), IL-2 (3.92-
15286.77), IL-4 (0.91-3987.72), IL-5 (1.86-2088.53), IL-6 (1.15-4727.29), IL-7 (2.77-45398.65), 
IL-8 (1.95-22091.85), IL-9 (2.96-10739.4), IL-10 (1.5-6774.42), IL-12 p70 (9.18-35207.24), IL-
13 (1.96-24456.64), IL-15 (6.19-5992.8), IL-17 (5.6-24741.17), Fibroblast Growth Factor (FGF) 
(4.77-4214.15), Rantes (6.38-1772.28), Eotaxin (8.79-23748.07), Granulocyte colony-




(GM-CSF) (12.41-14225.07), TNF-α (5.04-60209.41), IFN-γ (8.46-30645.43), MIP-1α (1.34-
1408.05), MIP-1β (4.75-1314.77), MCP-1 (1.42-1529.68), IP-10 (10.13-33863.61), Platelet 
derived growth factor (PDGF)-BB (6.19-25944.25) and Vascular Endothelial Growth Factor 
(VEGF) (8.23-28877.51). 
 
Analytes were measured by multiplexed microbead analysis as follows: 
Fifty microliters of magnetic beads in a 96-well plate were washed twice with 100 µl of assay 
buffer. After the addition of 50 µl of standards, blanks and a 1 in 4 diluted culture supernatant 
samples in their respective wells the magnetic beads were incubated with shaking at 850 rpm for 
1 hr. Following three washes with 100 µl of assay buffer, 25 µl of detection antibody were added 
followed by incubation at room temperature for 30 min with shaking at 850 rpm. The wells were 
again washed as previously followed by the addition of 50 µl streptavidin-PE and incubated for 
10 min with shaking at 850 rpm.  Prior to reading, beads were again washed three times and re-
suspended in 125 µl of assay buffer. The concentrations of the standards and samples were read 
using EMEM medium to normalize concentrations of the different analytes against the 
background by a five-parameter logistic regression algorithm (5PL) provided by the Bio-Rad 
software (Bio-Plex Manager 6.1). 
 
Statistical analysis, hierarchical clustering and Principal Component Analysis (PCA)  
 
Statistical analysis and graphical representation of the data was carried out using the Graph-Pad 
prism software (v5). The cytokine data at each point is presented as heat maps of fold changes 




time intervals. The unpaired student t-test was used to compare the level of cytokine production 
induced by the clinical strains with the uninfected control and among the strains. A P<0.05 was 
considered significant. Cytokine production patterns among clinical strains were compared using 
hierarchical clustering within the MeV software (v4.9) and principal component analysis (PCA) 
was performed using the Canoco software (v4.56). Multiple regression analysis following 
Pearson correlation between analytes was used to test if our dependent variable 
(cytokine/chemokine) is controlled by independent variable (strain identity, cfu/ml and sampling 




The level of infection achieved in pulmonary epithelial cells varied between 8-9.8 CFU/mL. This 
was determined by plating initial inoculum and intracellular bacteria and at 24 hr post-infection. 
The coefficient of variance for the MOI was between 0 and 0.580756495. Therefore, the inter-
experimental variations were between 0 and 58%. Due to differences in MOI as well intracellular 
replication of the clinical strains, Multi-regression analysis was used to test   whether different 
variables  influence cytokine production in epithelial cells. 
 
Twenty three out of twenty seven analytes were detected by the Bio-Plex Pro Human Cytokine 
27-Plex assay in the M. tuberculosis infected A549 supernatants: IL-1rα, -2, -4, -6, -7, -8, -9, -10, 
-12p70, -13, -17, TNF-α, IFN-γ, Rantes, Eotaxin, G-CSF, GM-CSF, MIP-1α, MIP-1β, MCP-1, 
IP-10, PDGF-bb and VEGF (Appendix A, Supplementary Table 1). IL-1β, -5, -15 and FGF were 




detected at 10 min and are expressed as a fold increase relative to the uninfected A549 cells 
(Appendix A, Supplementary Table 1). 
 
Cytokine/chemokine production patterns induced by clinical strains of M. tuberculosis 
Four out of 27 analytes were not detected at all intervals. The concentration of the 23 analytes 
measured in the detectable range in the supernatants of infected epithelial cells were compared to 
the uninfected epithelial cells and depicted as fold changes for each strain at 24, 48 or 72 hr post-
infection. These fold changes are represented as heat maps at the different time intervals and the 
relationship among the clinical strains is shown by hierarchical clustering (Fig. 1). At 24 hr, 
Beijing and H37Rv cluster closely together, F11 and F28 closer to the Unique strain, while the 
F15/LAM4/KZN induces a pattern that differs from other strains. At 48 hr, the F11 strain 
induced lower fold changes for most analytes with patterns that differ compared to other strains. 
Diverse cytokine production patterns were observed for the Unique strain compared to other 
strains at 72 hr post-infection. Furthermore, the F15/LAM4/KZN and F11 induced similar 














Fig. 1. Heat map and hierarchical cluster analysis comparing  
fold changes of cytokine/chemokine production by A549 
pulmonary epithelial cells infected by the M. tuberculosis 
F15/LAM4/KZN, Beijing, F11, F28, Unique and H37Rv 
strains at 24, 48 and 72 hr interval. A549 pulmonary epithelial 
cells were infected at an MOI~10:1 and supernatant was 




between uninfected and infected cells were calculated and 
compared among clinical strains at 24, 48 and 72 hr after 
infection. Hierarchical clustering among the strains shows 
diverse patterns of cytokine/chemokine production induced by 
the F15/LAM4/KZN strain at 24 hr, F11 strain at 48 and 
Unique strain at 72 hr after infection. Clustering analysis and 





In addition to hierarchical clustering, PCA was performed to display patterns of 
cytokine/chemokine production at all-time intervals combined (Fig. 2). The most obvious 
distinguishable outliers were cytokine/chemokine patterns induced by the F15/LAM4/KZN 
strain at 48 and 72 hr, F28 strain at 48 and H37Rv strain at 48 hr. The 24 hr samples showed 
closer relatedness among strains compared to the 48 and 72 hr patterns with the exception of 
the F11 strain at 48 hr that was closer to the 24 hr samples. Other 48 and 72 hr patterns were 
specific among other clinical strains, showing strain specific patterns of cytokine production 
in pulmonary epithelial cells. There was no functional relationship observed for 
cytokines/chemokines as shown by closeness of PCA arrows for different analytes. Closer 
arrows indicate related production patterns of those analytes whilst distant arrows indicate 
differences among analytes. This is observed for the production of the anti-inflammatory 
cytokines IL-4, IL-9 that is closer to chemokines (MIP-1α, MIP-β, IP-10) and the pro-
inflammatory cytokine, IL-6. Despite closer patterns in the production of these 
cytokines/chemokines, they have diverse functions when produced in the host during 
infection. Compared to other cytokines/chemokines, IL-17, Eotaxin, IFN-γ and IL-13 showed 
distinctive patterns when compared to other cytokines/chemokines detected shown by their 







Fig. 2. Principal component analysis of 23 cytokines/chemokines produced at 24, 48 and 72 
hr post-infection. A549 pulmonary epithelial cells were infected at an MOI of ~10:1 and 
supernatant was collected at 24, 48 and 72 hr post-infected. Cytokine production was 
detected at all three time intervals and cytokine/chemokine patterns among clinical strains 
were analysed and plotted in a PCA diagram using Canoco software.   
 
We then compared the anti-inflammatory, pro-inflammatory, and chemokine responses 





M. tuberculosis strains induce differential anti-inflammatory cytokine response in pulmonary 
epithelial cells  
 
Varying concentrations of the anti-inflammatory cytokines IL-1ra, IL-4, IL-9, IL-10 and IL-
13 were detected in epithelial cells infected with a laboratory and clinical strains of M. 
tuberculosis (Fig. 3; Appendix A, Supplementary Table 1). All strains, except the 
F15/LAM4/KZN and the Unique strains, induced a significant reduction (P < 0.05) in IL-1ra 
at 24 hr compared to the uninfected cells. Production of IL-1ra was significantly increased by 
all strains (P < 0.05) except the Beijing and F11 strains at 48 hr and the Unique strain at 72 hr 
after infection. At 24 hr, highest concentrations of IL-1ra were induced by the 
F15/LAM4/KZN and Unique strains and these were significantly (P < 0.05) higher than the 
Beijing, F28 and H37Rv strains. At 48 hr, significantly higher concentrations were induced 
by the F28 while the highest concentrations by the F15/LAM4/KZN at 72 hr were only 
significant against the Unique (P = 0.0244) and F28 (P = 0.0378) strains. 
 
IL-4 production at 24 and 48 hr after infection was insignificant for all strains (Fig. 3; 
Supplementary Table 1) compared to uninfected A549 cells and among clinical strains. At 72 
hr, Beijing (P = 0.0118), F11 (P = 0.0270), F28 (P = 0.0404) and H37Rv (P = 0.0036) 
induced higher amounts of IL-4 production compared to the uninfected A549 cells, with no 
significant differences in concentrations between clinical strains (Appendix A, 
Supplementary Table 3).  
 
There was no significant increase in the production of IL-9 by any of the strains at 24 or 72 hr 
compared to the uninfected cells and among clinical strains with the exception of the higher 




compared to the Beijing (P = 0.0190) strain at 72 hr. IL-9 production by F15/LAM4/KZN (P 
= 0.0155), Unique (P  = 0.0055) and H37Rv (P = 0.0024) increased significantly only at 48 
hr, whilst this was significantly reduced by the F11 strain (P = 0.0010). IL-9 concentrations 
were significantly higher by the F15/LAM4/KZN strain compared to Beijing (P = 0.0459), 
F11 (P = 0.0073) and H37Rv (P = 0.0312) strains at 48 hr after infection.  
 
There was no significant difference in production of IL-10 between the uninfected and the 
infected cells at all-time intervals (Fig. 2; Supplementary Table 1). However, H37Rv induced 
significantly higher IL-10 compared to the Beijing (P = 0.0445) and F11 (P = 0.0197) strains, 
respectively, at 48 hr (Appendix A, Supplementary Table 3).  
 
IL-13 production was not induced by any of the strains at 24 hr.  Production was reduced at 
48 hr by the Beijing, Unique and the F11 strains but reached significance only for the latter 
strain (P = 0.0395). Significantly higher IL-13 was induced by the H37Rv compared to F11 
(P = 0.0257) strain at 48 hr. IL-13 production was reduced by all strains at 72 hr, although 
this was not significant.  
 
All strains induced a gradual increase in anti-inflammatory cytokines that peaked mostly at 
72 hr post-infection, the exception being the Unique strain in the production of IL-1ra and IL-
9 and F28 strain for all anti-inflammatory cytokines detected which peaked at 48 hr (Fig. 3; 














































































































































































































Fig. 3. Kinetics curves of anti-inflammatory cytokines produced by 
epithelial cells infected with the F15/LAM4/KZN, Beijing, Unique, 
F11, F28 and H37Rv strains. A549 cells were infected with clinical 
strains of M. tuberculosis and laboratory strain H37Rv at an 
MOI~10:1. Supernatant was collected at 24, 48 and 72 hr post-
infection. Cytokines and chemokines were measured by 
multiplexing 27-analytes using the Bio-Plex Manager 6.1. The data 
is presented as ±SEM of two independent experiments. Unpaired 




M. tuberculosis strains induce a differential pro-inflammatory cytokine response in 
pulmonary epithelial cells  
 
Varying concentrations of the pro-inflammatory cytokines, IL-2, IL-6, IL-7, IL-8, IL-12, IL-
17, IFN-γ and TNF-α were produced by epithelial cells infected by the different strains (Fig. 
4, Supplementary table 1). IL-2 production increased from 24 48 hr and peaked at 72 hr for 
all the strains except F28 at 48 hr and Unique at all-time intervals. Significant productions of 
IL-2 compared to the uninfected was induced by the F15/LAM4/KZN (0.0158) at 72 hr while 
significant differences between the strains were only observed between the F15/LAM4/KZN 
and F28 strain (P = 0.0221) at 72 hr. IL-6 production by infected cells was significantly 
higher than the uninfected cells (P < 0.05) at all-time intervals for all strains except at 48 hr 
for Unique and F11 strains. Significant differences in the concentrations were observed 
among most strains at most time intervals. Significant induction of IL-6 peaked at 72 hr for 
all strains except the Beijing strain, where the maximum levels were attained at 48 hr. The 
IL-6 concentration at 24 hr was significantly higher in cells infected with H37Rv and the F28 
strain compared to the other strains. F28 strain significantly induced the highest IL-6 
concentrations compared to other clinical strains at both 48 and 72 hr after infection 
(Appendix A, Supplementary Table 3).  
 
There was no significant difference in the production of IL-7 by infected compared to the 
uninfected A549 cells at 24 hr (Fig. 4). IL-7 production was reduced by the Beijing, F11 and 
Unique strains at 24 hr, but this did not reach significance. At 48 hr and 72 hr, Beijing and 
Unique strains significantly reduced production of IL-7, while an insignificant increase was 
observed for the F28 strain at 48 hr. F11 significantly reduced IL-7 at 48 hr while significant 




F28 strain compared to the Beijing (P = 0.0362), Unique (P = 0.0358) and F11 (P = 0.0249) 
strains. At 72 hr H37Rv induced significantly higher IL-7 compared to the Unique (P = 
0.0486) and F28 (P = 0.0288) strains, respectively.  
 
 IL-8 production was increased significantly by F15/LAM4/KZN (P = 0.0323), Beijing (P = 
0.0254), F28 (P = 0.0258) and H37Rv (P = 0.0173) at 24 hr, and by all strains at 48 and 72 hr 
with the exception of F11 at 48 hr, Beijing and H37Rv strains at 72 hr (Fig. 4; Supplementary 
Table 1). At 24 hr, F28 induced significantly higher IL-8 compared to the F15/LAM4/KZN 
(P = 0.0310), Beijing (P = 0.0400) and Unique (P = 0.0324) strains, while F15/LAM4/KZN 
peaked significantly at 48 and 72 hr after infection compared to the other strains.  
 
All strains induced gradual increase in IL-12p70 that peaked at 48 hr for the F28 and 72 hr 
for other strains. IL-12p70 was constitutively produced by the uninfected A549 cells with 
significant reduction induced by the Beijing (P = 0.0158), Unique (P = 0.0418) and F11 (P = 
0.0108) strains at 48 hr. Significant differences of IL-12p70 among the strains was observed 
between the Beijing vs F15/LAM4/KZN (P = 0.0144), F11 vs F15/LAM4/KZN (P = 0.0090), 
Beijing (P = 0.0198) and H37Rv (P = 0.0299) strains at 48 hr. At 72 hr, significance was only 
observed between the Beijing compared to the F28 (P = 0.0306) and H37Rv (P = 0.007) as 
well as between the F28 and H37Rv (P = 0.0457).   
 
IL-17 was also constitutively produced by the uninfected cells with highest concentration 
observed at 24 hr for A549 cells and at 72 hr for all the strains except F28 that peaked at 24 
hr. Significant reduction of IL-17 was induced by the F11 (P = 0.0285), F28 (P = 0.0361) and 
H37Rv (P = 0.0307) strains at 24 hr. Significantly higher concentrations was induced by 




significantly lower than IL-12p70 compared to the F15/LAM4/KZN (P = 0.0251) and Beijing 
(P = 0.0183) strains, respectively. At 48 hr, significant differences were observed between 
H37Rv and F15/LAM4/KZN (P = 0.0307), Beijing (P = 0.0397), F11 (P = 0.0472) and F28 
(P = 0.0257) strains, respectively. 
 
Production of IFN-γ was significantly higher in infected cells compared to the uninfected 
cells at all-time intervals except for the decreased induction by the F11 strain at both 24 and 
72 hr that did not reach significance for both time points (Fig. 4; Supplementary Table 1). 
Peak production of IFN-γ was significantly induced by the F28 strain at both 24 and 48 hr 
and by the F15/LAM4/KZN at 72 hr compared to other strains (Appendix A, Supplementary 
Table 3). 
 
Compared to the uninfected cells, TNF-α production was significantly higher only for F28 (P 
= 0.0063) and H37Rv (P = 0.0047) at 24 hr, F15/LAM4/KZN (P = 0.0008), Beijing (P = 
0.0029), F28 (P = 0.0006) and H37Rv (P = 0.0003) at 48 hr, and for F15/LAM4/KZN (P = 
0.0037), F11 (P = 0.0007), F28 (P < 0.0001) and H37Rv (P = 0.0008) at 72 hr. The highest 
TNF-α concentrations were induced significantly by H37Rv at 24 hr, F28 strain at 48 hr and 









































































































































































































































































































































Fig. 4. Kinetic curves of pro-inflammatory cytokine production by 
epithelial cells infected with the F15/LAM4/KZN, Beijing, Unique, 
F11, F28 and H37Rv strains. A549 cells were infected with clinical 
strains of M. tuberculosis and laboratory strain H37Rv at an 
MOI~10:1. Supernatant was collected at 24, 48 and 72 hr post-
infection. Cytokines and chemokines were measured by 
multiplexing 27-analytes using the Bio-Plex Manager 6.1. The data 
is presented as ±SEM of two independent experiments. Unpaired 




M. tuberculosis strains induce differential chemokine response in pulmonary epithelial cells 
Strain specific production of the chemokines Eotaxin, GM-CSF, G-CSF, IP-10, MCP-1, 
MIP-1γ, PDGF-bb, MIP-1β, Rantes and VEGF was observed at 24, 48 and 72 hr post-
infection (Fig. 5; Appendix A, Supplementary Table 1). The following strains induce 
significantly higher Eotaxin production compared to the A549 controls: F15/LAM4/KZN (P 
= 0.0072) at 24 hr; F15/LAM4/KZN N (P = 0.0018), Unique (P = 0.0043) and F28 (P = 
0.007) at 48 hr and lastly F15/LAM4/KZN (P = 0.0355), Beijing (P = 0.0031), Unique (P = 
0.0075) and F11 (P = 0.007) at 72 hr, respectively. 
 
A significant increase in IP-10 and G-CSF production at the different time intervals was 
induced by all strains with the exception of  the Unique at 24 hr and F11 at 48 hr for the 
former, and F11 at 48 hr and Beijing strains at 72 hr for the latter, respectively. Highest IP-10 
and G-CSF at 24 hr was induced by F28 and H37Rv, respectively, and both were 
significantly higher than other strains. At 48 hr, the highest levels of IP-10 and G-CSF were 
induced by the F15/LAM4/KZN and F28 strains, respectively. The F15/LAM4/KZN strain 
significantly induced the highest levels of IP-10 and G-CSF among clinical strain at 72 hr 
(Appendix A, Supplementary Table 3).  
 
GM-CSF production by all strains was insignificant at 24 hr. However, significantly elevated 
concentrations were induced by the F15/LAM4/KZN (P = 0.0290), F11 (P = 0.0027), F28 (P 
= 0.0002) and H37Rv (P = 0.0327) strains at 48 hr and F15/LAM4/KZN (P = 0.0275), F11 (P 
= 0.0285) and H37Rv (P = 0.0018) strains at 72 hr (Fig. 5; Appendix A, Supplementary 
Table 1). Significantly higher GM-CSF was induced by the F28 strain compared to other 





MCP-1 was produced in high concentrations (range 100.48±2.5 to 243.12±68pg/mL) by un-
infected epithelial cells compared to other chemokines. However, significant increases in 
MCP-1 production were induced by the Beijing (P = 0.0002), F11 (P = 0.0434) and H37Rv 
(P = 0.0141) strains at 24 hr, by F15/LAM4/KZN (P = 0.0001), Beijing (P = 0.0016), Unique 
(P = 0.0349), F28 (P = 0.0326) and H37Rv (P = 0.0041) at 48 hr, and by all strains at 72 hr, 
respectively, compared to the uninfected cells. The F11 strain induced significantly higher 
MCP at 72 hr compared to the other clinical strains. Only H37Rv (0.0051) induced 
significant MIP-1α at 24 hr, all strains at 48 hr and F15/LAM4/KZN (0.0444) and H37Rv 
(0.0111) at 72 hr compared to the controls. PDGF-bb increased significantly for the 
F15/LAM4/KZN (0.0270) and F28 (0.0418) at 24 hr, all strains at 48 hr and 72 hr except for 
the Unique strain at 72 hr. MIP-1β concentrations were significant compared to the 
uninfected controls for the following strains: F11 (0.0278), F28 (0.0135) and H37Rv (0.0015) 
at 24 hr; F15/LAM4/KZN (0.0023) and Beijing (0.003) at 48 hr and F15/LAM4/KZN 
(0.0421) at 72 hr. 
 
Rantes production was significantly increased for all strains with the exception of Unique at 
24 hr, F11 at 48 hr, and Beijing and Unique strains at 72 hr after infection (Fig. 5; Appendix 
A, Supplementary Table 1). The highest Rantes concentration was induced by the H37Rv 
strain at 24 hr, F28 strain at 48 hr (significant compared to the F11 strain) and by F11 strain 
at 72 hr (significant compared to the Beijing (0.0222), Unique (0.0216) and F28 (0.0421) 
strains, respectively). VEGF was significantly reduced by the strains compared to the control 
as follows: Beijing (0.006), Unique (0.0389), F11 (0.0148) and H37Rv at 24 hr, all strains at 



























































































































































































































































































































































































































Fig. 5. Kinetic curves of chemokine production by epithelial cells 
infected with the F15/LAM4/KZN, Beijing, Unique, F11, F28 and 
H37Rv strains. A549 cells were infected with clinical strains of M. 
tuberculosis and laboratory strain H37Rv at an MOI~10:1. 
Supernatant was collected at 24, 48 and 72 hr post-infection. 
Cytokines and chemokines were measured by multiplexing 27-
analytes using the Bio-Plex Manager 6.1. The data is presented as 
±SEM of two independent experiments. Unpaired student t-test was 





Clinical strains exhibited differential intracellular growth in pulmonary epithelial cells (Fig.  
6), with the highest by the Beijing strain at 24 hr, F11 strain at 48 hr and F28 strain at 72 hr. 
These intracellular bacillary loads were significantly higher compared to other clinical 
strains. At 24 hr, significant differences were observed in the intracellular CFU/ml among the 
strains with the following exceptions: F11 compared to F28 and H37Rv; and F28 compared 
to the Unique strains, respectively. At 48 hr, all strain exhibited significant differences in the 
intracellular growth except for the F15/LAM4/KZN and Beijing strain, as well as between 
Beijing and Unique strain. Lastly, significant differences were observed for all strains at 72 hr 
except for the following: Beijing vs H37Rv and H37Rv vs F11, respectively (Fig. 6, 
Supplementary Table 4 and 5).  







































Fig. 6. Invasion of A549 cell by clinical strains of M. tuberculosis at 24, 48 and 72 hr after 




The A549 pulmonary epithelial cells were infected with clinical (F15/LAM4/KZN, F11, F28, 
Beijing, Unique) and a laboratory (H37Rv) strain of M. tuberculosis at an MOI~10:1. 
Intracellular growth of these strains varied within epithelial cells at different time intervals 
with highest growth observed for the Beijing strain at 24 hr, F11 strain at 48 and F28 strain at 
72 hr. Paired t-test was performed among the strains and P < 0.05 was considered significant.  
 
Multi-regression analysis 
Different factors such as sampling intervals, variations in intracellular cfu/ml and strain 
identity were tested for their ability to influence cytokine/chemokine production by plotting 
analytes correlation matrix (Fig. 7) and computing significant influences of the variables of 
interest. The data was first normalized prior to regression and ANOVA analysis. It was 
observed that the sum of squares for the model used was greater than the residual sum of 
squares suggesting that factors were explained by the model that was fitted. From the three 
variables tested (cfu/ml, sampling intervals and strain identity), significant (P < 0.05) 
influences were caused by sampling intervals and not other factors. Using three factors that 





Fig. 7: Multi-regression analysis (Pearson) showing correlations between cytokine/chemokine production at all-time intervals. Strain identity, 
sampling intervals and intracellular Cfu/ml were tested in the ability to influence production of different analytes at all times tested using 
Genestat (v2.0) and SPSS (v16.0). Only sampling intervals significantly (P < 0.05) affected the production of different analytes compared to 




Discussion and conclusion 
 
Recent studies have provided increasingly compelling evidence, resulting in a paradigm shift, 
of the role of pulmonary epithelial cells from that of functioning largely as a protective 
barrier, to being intrinsically involved in the host immune response to TB infection (Lee et 
al., 2009; Lin et al., 1998; Sato et al., 2002; Sharma et al., 2007; Whitsett and Alenghat, 
2015). In addition to the well described immune cells such as macrophages and dendritic 
cells, epithelial cells, infected by different M. tuberculosis genotypes, have also been reported 
to induce in vitro and in vivo production of cytokines/chemokines (Lin et al., 1998). Their 
role in the adaptive immune response and granuloma formation was well described by 
Chuquimia et al. (2012). 
   
Most studies however, reported on a limited number of cytokines/chemokines induced in 
either epithelial cells (Chuquimia et al., 2012; Lee et al., 2009; Lin et al., 1998; Méndez-
Samperio et al., 2006; Sharma et al., 2007; Wickremasinghe et al., 1999; Zhang et al., 1997) 
or macrophages/monocytes by clinical strains (Carmona et al., 2013; Chakraborty et al., 
2013; Faksri et al., 2014; Rhoades et al., 1995), or non-clinical strains such as laboratory 
H37Ra, H37Rv and M. bovis (BCG) strain (Ameixa and Friedland, 2001; Andersson et al., 
2012; Chuquimia et al., 2012; Keane et al., 2000). Thus, the extent of the 
cytokine/chemokine response elicited by epithelial cells infected with characterized clinically 
relevant strains remained unexplored.  
 
We have shown that pulmonary alveolar epithelial cells induce the production of a wide 
repertoire of cytokines and chemokines, peaking at 48 or 72 hr, in response to in vitro 




laboratory and 5 clinical strains. The latter represent 4 strains belonging to well characterized, 
highly successful M. tuberculosis genotypes in several provinces of South Africa, including 
KwaZulu-Natal, and the Western and Eastern Cape (Chihota et al., 2012; Muller et al., 2013; 
Pillay and Sturm, 2007), as well as a Unique genotype. Strain families may be stratified by 
their level of virulence inferred by the magnitude of transmission within a population. Data 
from the KwaZulu-Natal Province in South Africa showed an over-representation of the drug 
resistant F15/LAM4/KZN followed by the F28, F11 and Beijing strains respectively between 
2004-2005 (Chihota et al., 2012). Hypervirulent or highly transmissible strains such as the 
Beijing strain, have been shown to induce low protective host cytokine responses (Manca et 
al., 1999; Manca et al., 2001; Ranjbar et al., 2009; Tanveer et al., 2009), that may explain the 
success of these strains epidemiologically (Chen et al., 2014). 
 
The production of anti-inflammatory cytokines (IL-1ra, IL-4 IL-9, IL-10, IL-13), pro-
inflammatory cytokines (IL-2, IL-6, IL-7, IL-8, IL-12p70, IL-17, TNF-α, IFN-γ) as well as 
chemokines (Eotaxin, G-CSF, GM-CSF, IP-10, MCP-1, MIP-1a, MIP-1b, PDGF-bb, Rantes 
VEGF) was differentially induced at different times post-infection. The analytes IL-7; 10; 
12p70, 13, 17 and VEGF were constitutively expressed by A549 cells.  
 
Early production of the anti-inflammatory cytokines IL-10 and IL-22 in M. bovis (BCG) 
infected primary human bronchial epithelial cells was associated with a time dependent 
increase in the pro-inflammatory cytokine IL-6, but total inhibition of TNF-α and IFN-γ 
(Lutay et al., 2014). In our study, IL-10 and IL-13 were produced at lower levels up to 72 hr. 
IL-22 was not included in the panel of analytes tested. A strong, early anti-inflammatory 
response was induced by the F28 strain as evidenced by peak concentrations of IL-1ra, IL-4 




from 24 to 72 hr by epithelial cells induced by the F15/LAM4/KZN strain. This response 
pattern was similar for the other 4 strains, but at lower concentrations. The highest 
concentration was induced by the F15/LAM4/KZN strain compared to the others at the last 
time point tested. Since anti-inflammatory cytokines were produced at much lower 
concentration compared to pro-inflammatory cytokines and chemokines, pulmonary 
epithelial cells might not possess a strong anti-inflammatory response in the lungs during 
infection by these strains at an earlier time of infection. These anti-inflammatory cytokines 
from pulmonary epithelial cells are less likely to inhibit the protective Th1 response during 
early infection by clinical strains tested in the study. 
 
IL-6, produced by many cell types (Akdis et al., 2011) and capable of both pro- and anti-
inflammatory activity (VanHeyningen et al., 1997) is essential to induce IFN-γ during early 
lung infection (Saunders et al., 2000). It has also been implicated in inhibition of macrophage 
response to IFN-γ, resulting in unsuccessful control of M. tuberculosis (Nagabhushanam et 
al., 2003). Lee et al. (2009) reported on increased IL-6 production by epithelial cells that 
peaked at 48 hr and was reduced at 96 hr (Lee et al., 2009). Our study also showed that 
epithelial cells infected by M. tuberculosis strains of different families induce substantial 
amounts of IL-6 at 48 and/or 72 hr, with the F15/LAM4/KZN and F28 inducing the highest 
production. This pattern was also observed for the induction of IFN-γ production. In contrast, 
the F11 strain induced high IL-6, but low IFN-γ. Notably, low concentrations of both 
cytokines were induced by the Beijing strain, similar to the Unique strain. This observation 
for the Beijing strain, as a hyper-virulent genotype (Caws et al., 2008; Glynn et al., 2002) is 
hardly surprising. Similar findings have been reported in monocyte/macrophage and animal 





It is likely that the low IFN-γ induction in epithelial cells by the Beijing strain acts in concert 
with the low response of macrophages, resulting in an inability to control M. tuberculosis in 
the early stages of infection (Reiling et al., 2013), thus contributing to its capacity for 
extensive transmission. However, the low IFN-γ induction by the F11 and Unique strains 
remains unexplained. Unlike these 3 strains, the capacity to induce the release of high 
concentrations of IFN-γ may indicate the greater effectiveness of the STAT-1 pathway 
activated by the F15/LAM4/KZN and F28 strains, as reported for the laboratory strain, 
H37Rv (Sharma et al., 2007).  Furthermore, our findings were similar to that of Sharma et al. 
(2007), whereby induction of IFN-γ in epithelial cells progressed with the duration of 
infection and was maximal at 72 hr.  However, higher concentrations of IFN-γ were detected 
in our study. This was observed for all strains with the exception of the F28 strain that peaked 
at 48hr and decreased by 72hr. The spread of the F15/LAM4/KZN and F28 strains in our 
KwaZulu-Natal population may be explained by delayed detection of drug resistance and 
initiation of appropriate treatment, rather than hypervirulence, whilst our data may suggest 
increased virulence of the F11 and the Unique strain due to induction of low IFN-γ compared 
to other clinical strains, despite the apparent lack of transmission of the latter. An alternate 
explanation may be that the Beijing strain family, unlike the F15/LAM4/KZN family, has had 
the opportunity through transmission in high risk settings, to co-evolve in humans 
substantially over time into “modern” strains, capable of subverting the TH1 response (Chen 
et al., 2014; Rakotosamimanana et al., 2010).  
 
IL-7 plays a role in the development of B and T-cells, expansion of T-cells that is important 
for the control of M. tuberculosis (Maeurer et al., 2000). The release of IL-7, despite being 




by the Beijing and Unique strains, unlike the other 3 clinical strains, which may further 
contribute to the success of the Beijing strain.  
 
The repertoire of protective functions of TNF-α includes granuloma formation and 
maintenance, and induction of specific chemokines (Algood et al., 2004), macrophage 
activation in conjunction with IFN-γ (Flesch and Kaufmann, 1990) and apoptosis control in 
infected cells (Keane et al., 2000). TNF-α production by M. tuberculosis infected pulmonary 
epithelial cells was previously associated with the innate immune control and containment of 
TB infection (Lee et al., 2009). As with the other cytokines, low amounts of TNF-α were 
induced by the Beijing and Unique strains at all time-points after infection in our study. In 
contrast, the F11, F28 and F15/LAM4/KZN strains induced high levels of TNF-α that peaked 
at either 48 or 72 hr after infection.  
 
Low production of TNF-α could be detrimental to the host (Miller and Ernst, 2009) and is 
one of the survival strategies employed by M. tuberculosis (Balcewicz-Sablinska et al., 1998; 
Keane et al., 2000), including the highly pathogenic Beijing strain (Faksri et al., 2014). The 
similarity in the behavior between the Beijing and Unique strains supports our hypothesis that 
the latter may share certain virulent factors to induce comparable behavior to the former 
strain. Different virulence factors harbored by clinical strains may explain complex and 
differential host response observed in epithelial cells in the production of protective cytokines 
such as TNF-α and IFN-γ.  
 
IL-8 has anti-mycobacterial properties with the potential of inhibiting M. tuberculosis 
replication at the site of infection (O'Kane et al., 2007). The production of IL-8 by epithelial 




strains has been previously documented (Lee et al., 2009; Lin et al., 1998; Wickremasinghe 
et al., 1999). The production of the chemokine IL-8, elicited by both clinical and laboratory 
strains of M. tuberculosis but not avirulent M. avium and killed M. tuberculosis, was 
attributed not to virulence, but the ability to grow intracellularly (Lin et al., 1998). In our 
study, similar concentrations of IL-8 were induced by all clinical strains at 48/72 hr, with the 
exception of the significantly increased and decreased amounts by the F15/LAM4/KZN and 
Beijing strains, respectively, at 72 hr post-infection. IL-8 secretion links the innate and 
adaptive immune response by serving as a chemo-attractant for leukocytes, mostly 
neutrophils, as well as other granulocytes (Andersson et al., 2012). Increased neutrophil 
migration was observed in the M. bovis (BCG) infected epithelial cell model that induced 
production of IL-8 (Andersson et al., 2012). The high levels of IL-8 induced by the 
F15/LAM4/KZN and F28 suggest that they may be more efficient at attracting large numbers 
of leukocytes in vivo compared to the Beijing and Unique clinical strains.  
 
The recruitment of T-cells, monocytes and macrophages to the site of infection is crucial as 
they play a major role in granuloma formation and effective immune response. G-CSF and 
GM-CSF stimulate production of macrophages and granulocytes and their migration to the 
site of infection for granuloma formation (Nambiar et al., 2010; Szeliga et al., 2008; Thomas 
et al., 2002). Nambiar et al. (2010) showed that mice infected with the M. bovis (BCG) strain 
induced moderate GM-CSF production necessary to prevent immunopathology of the lung 
tissue (Nambiar et al., 2010). However, over-production of this chemokine has been 
associated with severe immunopathology (Lang et al., 1987). In our study, a time dependent 
increase in both chemokines was observed for the F15/LAM4/KZN strain which peaked with 
high concentrations at 72hr. In contrast, the F28 peaked at 48 hr and rapidly declined to 




Unique strains at all intervals, except for the former at 48 hr. The differences in the quantity 
and time of production of these chemokines might be related to the time required for 
granuloma formation by the host. The low quantities of G-CSF and GM-CSF by the Beijing 
and Unique strains suggest delays in this process or ineffectual granuloma production, 
resulting in the lack of containment of the bacilli. Paradoxically, the high amounts of both G-
CSF and GM-CSF by the F15/LAM4/KZN and F28 strains may be responsible for extensive 
lung damage, leading to increased infectivity and dissemination of the pathogen in the lungs.   
 
Monocytes and alveolar macrophages are the main producers of MCP-1 and play an 
important role in granuloma formation (Silva Miranda et al., 2012). In vivo studies have 
shown that increased production of MCP-1 were accompanied by a corresponding increase in 
the numbers of monocytes in the pleural fluid of the infected patients (Antony et al., 1993) as 
well as in the BAL of TB infected individuals (Kurashima et al., 1997). Although 
demonstrating an inability to effectively recruit monocytes to M. tuberculosis infected lungs, 
clearance of the pathogen by MCP-1 deficient mice remained unaffected (Lu et al., 1998). M. 
tuberculosis infected epithelial cells can also produce MCP-1. Lin et al. (1998) showed a 
time and inoculum dose dependent increase in MCP-1 concentrations up to 6 days post 
infection. As observed by Lin et al. (1998), in our study, epithelial cells also spontaneously 
produced MCP-1. Levels of this chemokine increased up to 48 hr after infection and 
decreased at 72 hr in epithelial cells infected by all strains with the exception of the F11 
strain which peaked at 72 hr. Increased amounts were induced by all clinical strains, with the 
highest by the F15/LAM4/KZN and F11 strains. Similar amounts were induced by the 
Beijing and Unique strains at both 48 and 72 hr, supporting the finding by Lin et al. (1998) 
that MCP-1 production is independent of strain virulence. The differences in MCP-1 




the time  taken for the involvement of other immune cells to further produce other protective 
cytokines.  
 
As a result of its multiple receptor binding capacity (Proudfoot et al., 2000), Rantes has the 
potential to activate numerous signaling pathways leading to a wide spectrum of cellular 
responses (Wong et al., 2001). Skwor (2005) elucidated the regulatory role of Rantes in the 
cytokine/chemokine network. Whilst expression of the pro-inflammatory cytokines IL-8, 
TNF-α and IL-1β and chemokine MCP-1 was induced by recombinant Rantes in guinea pig 
macrophages, LPS exposure of Rantes pre-treated cells led to decreased expression of these 
genes at either 2 and/or 6 hr (Skwor, 2005). Similarly, TNF-α protein secretion by Rantes 
pre-treated macrophages was decreased following LPS exposure after 6 hr. Inconsistent 
findings with respect to IL-1β protein secretion have been reported (Locati et al., 2002; 
Schindler et al., 1990). In the present study, maximum production of Rantes was induced at 
48 hr in epithelial cells by all clinical strains except the F11 strain at 72 hr. The Beijing and 
the Unique strains produced the lowest amount of Rantes at any time point. Failure to 
produce Rantes could be detrimental to the host as was observed in individuals with 
polymorphisms in the Rantes gene that rendered them more susceptible to TB infection 
compared to healthy controls (Ben-Selma et al., 2011). Rantes production by epithelial cells 
could be important in activating the surrounding T-cells to favour a TH1 phenotype that 
could lead to bacterial clearance. This was observed with T-cells activated by dendritic cells 
that produced Rantes resulting in a TH1 phenotype of T-cells (Salam et al., 2008). Rantes 
production by epithelial cells was stimulated by IL-1β production by monocytes 
(Wickremasinghe et al., 2004). In contrast, in our study, M. tuberculosis stimulated epithelial 
cells were able to produce Rantes, despite the lack of induction of IL-1β production. This 




(Akdis et al., 2011). Unlike our study, Lin et al. (1998) demonstrated that A549 cells were 
incapable of Rantes expression following infection with M. tuberculosis. 
 
Similar to other cytokines/chemokines detected in this study, a host-specific response was 
observed by epithelial cells infected by different strains to produce IP-10. The highest 
concentrations were produced by the F15/LAM4/KZN and F11 strains at 72 hr and F28 strain 
at 48 hr. The Beijing and Unique strains again induced the lowest production of this 
chemokine. As with Rantes, IP-10 has been shown to activate T-cells to favour a TH1 
phenotype and intracellular mycobacterial clearance (Salam et al., 2008). In addition, both 
Rantes and IP-10 have been reported to be important for chemotaxis of other immune cells 
(Alam et al., 1993) to the site of infection.  
 
Production of IL-2, -12p70, -17, Eotaxin, β-chemokines (MIP-1α and MIP-1β), PDGF-bb and 
VEGF was also strain specific as observed with other analytes detected in this study, with 
peak production at either 48 or 72 hr after infection by each strain. Lowest production of all 
these analytes at 48 hr was induced by the F11 strain but increased at 72 hr, while Beijing and 
Unique strains induced lower concentration compared to other clinical strains. Our study 
demonstrated for the first time, that pulmonary epithelial cells produce these chemokines 
(Eotaxin, IL-2, PDGF-bb, MIP-1α and MIP-1β) in response to infection by clinical strains of 
M. tuberculosis in variable concentrations and peaking at different times. We hypothesize 
that the functional significance of epithelial MIP-1α and MIP-1β may play a supportive role 
in macrophage inhibition of M. tuberculosis replication at the site of infection. IL-17 is one of 
the important pro-inflammatory cytokine that act together with TNF and IL-1 and destroy 
cellular components of the pathogens (Chiricozzi et al., 2010; Miossec et al., 2009). IL-2 is 




2011), while IL-12 is required for differentiation of T-cells to TH1 cells (Hsieh et al., 1993). 
Production of these analytes detected in pulmonary epithelial cells indicates a crucial role of 
pulmonary epithelial cells to contribute to both local and adaptive immunity in a strain 
specific manner.   
 
The diverse patterns of cytokine production shown by hierarchical clustering and PCA 
indicate distinct strain-specific patterns induced in pulmonary epithelial cells at an earlier 
time of infection. These differences can be attributed to differences in virulence factors that 
are yet to be identified in these clinical strains. Among the obvious differences in these 
patterns were cytokines induced by the F15/LAM4/KZN (48 and 72 hr) and F28 (48 hr) 
strains within the PCA plots. Both these clinical strains induce specific patterns that differed 
from those of other clinical strains. Generally, peak concentrations for most analytes were 
induced by the F28 strain at 48 hr and F15/LAM4/KZN strain at 72 hr post-infection. This 
might cause differences in cytokines/chemokines patterns as shown by the PCA plot. High 
concentrations of cytokines/chemokines by both these strains at an earlier time of infection 
might indicate an early response by the host compared to other clinical strains. Since 
pulmonary alveolar epithelial cells are present at the site of infection, these differences in 
cytokine levels induced by diverse clinical strains can influence down-stream changes and 
outcome of infection. The dominant South African F15/LAM4/KZN, F11 and F28 strains 
induced higher concentrations compared to the global prevalent Beijing strain and non-
clustering Unique strain. This demonstrates a protective response induced by the 
F15/LAM4/KZN and F28 strain compared to the Beijing and Unique strain at an earlier time 
of infection.  Moreover, the  strain-specific immunological markers observed in this study 




innate receptors, such as toll-like receptors, expressed in pulmonary epithelial cells (Li et al., 
2012). 
 
There was no correlation between the intracellular growth and cytokine production as shown 
by the multi-regression analysis. These findings suggest that intracellular bacillary load did 
not influence production of most cytokines/chemokines tested at all-time intervals and that 
differential cytokine production might be due to diverse virulence factors rather than 
differences in the intracellular growth of clinical strains in pulmonary epithelial cells. 
Sampling intervals was the only significant factor to influence analytes production shown by 
multi-regression analysis. This might be due to peak production of all cytokines at 48 or 72 hr 
by the clinical strains, therefore supporting positive correlation between time of incubation 
and higher cytokine production.  
Virulent strains, particularly of the Beijing family, evoked lower protective cytokine 
responses compared to less virulent ones in in vivo and in vitro studies (Chen et al., 2014; 
Manca et al., 2004; Manca et al., 1999; Manca et al., 2001; Portevin et al., 2011; Tanveer et 
al., 2009). The current data, with lower cytokine/chemokine production induced by the 
Beijing compared to the F15/LAM4/KZN, F11 and F28 strains concurs with those findings, 
suggesting that the Beijing strain may be the most virulent among clinical strains globally. 
The similar, consistently lower levels observed for the Unique compared to the Beijing strain, 
suggest that while the former was not detected in more than 1 patient in the study population, 
it nevertheless, may potentially share certain virulent factors as the latter, resulting in low 
cytokine induction by this strain. Virulent strains belonging to the F15/LAM4/KZN and 
Beijing family were reported to induce higher cytotoxicity of epithelial cells compared to the 




lower cytokine/chemokine production by Beijing and Unique-infected epithelial cells, 
however this does not explain higher cytokines/chemokines induced by the F15/LAM4/KZN 
strain. Further studies are warranted to test different hypothesis generated from our findings. 
The higher cytokine/chemokine responses of the F15/LAM4/KZN and other 2 clinical strains 
suggest that their transmissibility may be related to the failure of the TB control program as a 
result of profound delays in the detection and initiation of timeous and appropriate 
treatment/management of drug resistant cases rather than hyper-virulence. The strain specific 
response of these 3 genotypes probably reflects diversity in specific virulence traits that 
should be elucidated in future studies.  
Several limitations may be observed in the study. The use of an in vitro system means that the 
findings emanating from this cannot be directly correlated to what happens in vivo in humans. 
Due to financial constraints, cytokine/chemokine analysis was performed in duplicate and not 
triplicate. Epithelial cells were not examined at sampling times for confluence and adherence. 
Another limitation was that it was not possible to rank these strains for their level of virulence 
in order to understand the different cytokine signatures that were obtained in this study 
despite molecular epidemiology studies being available. No data has been reported on the 
virulence characteristics of these strains apart from the Beijing strain, and only recently, 
limited information on the F15/LAM4/KZN strain (Smith et al., 2014) without details on in 
vitro and in vivo pathogenesis studies. Despite these shortcomings, valuable, novel 
information on the host response to epithelial cell infection has been generated. 
In conclusion, our study demonstrates a strain-specific induction of a wide repertoire of 
cytokine/chemokine production by pulmonary alveolar epithelial cells at different times post-
infection by virulent strains of M. tuberculosis. We therefore hypothesize that the diversity 
observed in the cytokine/chemokine production may reflect the presence of determinants that 




complex interaction between the host and pathogen and outcomes of infection. Furthermore, 
the F15/LAM4/KZN strain is unlikely to be a hypervirulent strain due to induction of high 
concentrations of protective cytokines in epithelial cells, and its association with the 
development of the XDR-TB epidemic in the Tugela Ferry region, South Africa, was 
probably related to programmatic shortcomings such as delays in diagnosis, control and 
treatment programs for tuberculosis.  
We further confirm and extend the findings of other studies that, epithelial cells via their 
extensive repertoire of cytokine/chemokine production, play a significant role in the host 
immune response, most likely by recruitment of other immune cells and in granuloma 
formation in vivo. Future pathogenesis studies on the in vitro host response to M. tuberculosis 
infection should include the use of epithelial cells due to their abundance in the human lung 
alveolar space compared to macrophages, as well as inclusion of different virulent M. 

















CHAPTER 3: Mycobacterium tuberculosis CLINICAL STRAINS EXHIBIT 






Novel approaches to biomarker identification are urgently required in the design and 
development of effective new therapeutic strategies that take cognisance of host response, 
especially to genetically diverse, dominant strains of M. tuberculosis in specific geographic 
regions. Given the importance of pulmonary epithelial cells in host immune response to M. 
tuberculosis infection, few studies have focussed on global transcriptomics in this infection 
model with different strains of M. tuberculosis.    
Therefore, this study was undertaken to elucidate differential gene expression and strain-
specific molecular signatures in pulmonary epithelial cells during infection by clinical M. 
tuberculosis strains of varying pathogenicity. Transcriptomics was used to investigate 
changes in gene expression by directly sequencing RNA transcripts from pulmonary 
epithelial cells infected with strains belonging to four different genotypes and a Unique strain 
of M. tuberculosis, associated with drug resistance in KwaZulu-Natal. The Illumina HiSeq 
2000 platform generated 50 bp reads that were mapped to the human genome (hg19) using 
Tophat (2.0.10). Differential expression between the uninfected and infected cells, as well as 
among the different strains, was quantified using Cufflinks (2.1.0) with a significant Q-value 
and a fold-change cut-off of 2. Gene expression varied among the strains with the total 
number of genes up-regulated and down-regulated shown in parentheses: F15/LAM4/KZN 
(1187), Beijing (1252), F11 (1639), F28 (870), Unique (886) and H37Rv (1179). A subset of 




regulated and 240 were up-regulated. Down-regulation was associated with signal 
transduction, membrane associated functions, endopeptidase activity and steroid biosynthesis 
while up-regulation was associated with proteins found in the extracellular space, immune 
response genes, plasma membrane and cell receptors. The number of strain-specific genes 
activated by each strain were as follows: F15/LAM4/KZN (138), Beijing (52), F11 (255), 
F28 (55), Unique (185) and H37Rv (125). Strain specific molecular signatures associated 
with functional pathways were observed only in the F15/LAM4/KZN, Unique and H37Rv 
strains. These findings demonstrate that in addition to other cellular functions, pulmonary 
epithelial cells infected by M. tuberculosis, are involved in both innate and adaptive immune 
responses. Strain-specific molecular signatures identified in this study have the potential to be 
exploited for novel biomarker applications that could impact on host directed treatment 
strategies including immunotherapy. 
 
Introduction 
Despite the availability of effective drugs and advances in the development of rapid 
diagnostic techniques (Hillemann et al., 2009; Ling et al., 2008; Ulrich et al., 2006), global 
burdens of TB, have not decreased significantly, with prevalence, incidence and mortality 
rates of approximately 2 billion, 9 million, and  1.5 million per year, respectively (WHO, 
2014). These high burdens resulted largely from the emergence of drug resistant, including 
MDR and XDR strains (Abebe and Bjune, 2006; Klopper et al., 2013; Shah et al., 2007; 
Singh et al., 2007; Velayati et al., 2009) of M. tuberculosis, which are virtually untreatable 
(Klopper et al., 2013). High HIV-co-infection rates (WHO, 2014), especially in poorly 
resourced countries, as well as the slow replication rate of this pathogen and the associated 




significantly to high TB incidence rates (WHO, 2014). Moreover, the only effective available 
vaccine, BCG, is incapable of protecting individuals beyond childhood (Abebe and Bjune, 
2006), and recent strategies to develop new vaccines have been either unsuccessful (Martin et 
al., 2006; Waters et al., 2009) or still under clinical investigation (Kaufmann, 2014). Upon 
testing of the latest and promising MVA85A TB vaccine, low tolerance with modest 
immunogenic and insignificant protection against M. tuberculosis in infant clinical trials was 
observed (Tameris et al., 2013). Thus, pathogenesis studies that will enable the identification 
of novel pathogen and host specific biomarkers are urgently required for the development of 
rapid point of care diagnostic tools, and efficacious vaccines and therapeutics, especially 
against MDR and XDR-TB.  
 
Genotyping has identified numerous strain families (de Viedma et al., 2005; Glynn et al., 
2002; Streicher et al., 2012; Valway et al., 1998) that may elicit specific host responses based 
upon their unique virulence attributes (Koo et al., 2012; Manca et al., 2004; Manca et al., 
1999; Manca et al., 2001; Subbian et al., 2013). Different M. tuberculosis strains induce 
strain-specific host responses to infections in macrophages at different times post-infection 
(Koo et al., 2012). Higher levels of certain cytokine/chemokine mRNA expression were 
observed in pulmonary epithelial cells infected with the less virulent M. avium compared to 
M. tuberculosis (Sato et al., 2002). These studies elucidated the possible diversity of 
antigenic properties found in different mycobacterial species (Sato et al., 2002), and 
expression patterns among M. tuberculosis strains (Dheenadhayalan et al., 2006). A phenolic 
glycolipid was shown to be produced by hyper-virulent M. tuberculosis Beijing strains, 
resulting in lower host inflammatory responses and suppressed innate immune response 
(Reed et al., 2004). Furthermore, genetic and phenotypic diversity among M. tuberculosis 




response which can have implications on disease outcome (Kato-Maeda et al., 2001; Malik 
and Godfrey-Faussett, 2005; Nicol and Wilkinson, 2008) and prevalence of that strain within 
the population. Thus, strain diversity is an important characteristic in the design and 
development of intervention strategies. 
 
The host response to M. tuberculosis infection has been extensively studied by screening 
changes in gene expression using microarray analysis in mice (Jang et al., 2008) and 
macrophages (Giacomini et al., 2001; Koo et al., 2012; Volpe et al., 2006) as well as 
quantifying mRNA in epithelial cells using quantitative real time PCR (qRT-PCR) (Lee et 
al., 2009; Lin et al., 1998; Sato et al., 2002). Transcriptomic studies in macrophages and 
dendritic cells using microarray analysis revealed changes in numerous immune related genes 
at different times of infection by M. tuberculosis (Tailleux et al., 2008; Volpe et al., 2006).  
Studies on gene expression in epithelial cells (Lee et al., 2009; Lin et al., 1998; Sato et al., 
2002; Wickremasinghe et al., 1999; Wickremasinghe et al., 2004) have  focused only on  a  
limited number of genes, whilst understanding of host-pathogen interactions using whole 
genome transcriptomics remains largely unexplored especially in epithelial cells  infected 
with different clinical strains of M. tuberculosis. The importance of epithelial cells in 
pathogenesis has already been documented (Chuquimia et al., 2013; Chuquimia et al., 2012; 
Lee et al., 2009; Lin et al., 1998; Sato et al., 2002; Sharma et al., 2007), since they may be 
the first point of contact with the pathogen because of their abundance in the lung relative to 
macrophages (Dobbs et al., 2009; Williams, 2003). 
 
In this study, transcriptomics was used to investigate gene expression changes by using RNA-
Seq of pulmonary epithelial cells infected with strains belonging to a Unique genotype, as 




expression and strain-specific molecular signatures would be differentially induced in 
pulmonary epithelial cells infected with the different clinical strains of M. tuberculosis.   
 
Materials and methods 
 
Details of selection of bacterial strains and infection of epithelial cells methods are provided 




Clinical strains of M. tuberculosis F15/LAM4/KZN, Beijing , F11 , F28  and a Unique  strain  
used in the study  were isolated from  sputum specimens of patients in KwaZulu-Natal and 
characterized in Medical Microbiology and Infection Control, University of KwaZulu-Natal. 
The laboratory strain M. tuberculosis H37Rv was included as a virulent control. M. 
tuberculosis isolates were cultured in 10 ml Middlebrook 7H9 broth supplemented with  50% 
glycerol, 20% Tween-80 and 10% OADC at 37 ºC aerobically to a mid-log phase. Glycerol 
stocks of an actively growing culture at mid-log phase were stored at -70 ºC to avoid multiple 
passages and loss of virulence. For each infection assay, cultures were revived in 7H9 broth 
and grown to an OD600nm of 0.8-1, where an OD600nm of 1 = ~1X10
8
 Colony forming units 
(cfu)/mL (Larsen et al., 2007).  
 
Infection of epithelial cells 
 
Stock cultures of A549 type II pulmonary epithelial cells (ATCC CCL 185) were grown in 25 
cm
2
 TCFs containing EMEM (Lonza, South Africa) supplemented with 10% heat inactivated 




determine optimal MOI, level of infection at each time intervals to be tested and confluent 
cells after infection. After optimizing the methodology in the pilot study, confluent cells were 
infected in two separate biological replicates with each strain of M. tuberculosis at an MOI of 
~10:1 in 25 cm
2
 TCFs and incubated at 37
o
C in 5% CO
2
 for 48 hr. Infected pulmonary 
epithelial cells were washed with PBS three time to remove extracellular adherent cells prior 
to cell lysis. Thereafter, cells were lysed with tritonX-100, washed twice with PBS, serially 
diluted and plated in triplicate on 7H11 Middlebrook agar plates.  The cfu/ml was calculated 
after incubation at 37
o
C in 5% CO
2
 for 3-4 weeks.  
 
RNA isolation from epithelial cells 
 
RNA was isolated from uninfected as well as infected A549 epithelial cells using the RNeasy 
kit (Qiagen, South Africa) according to the manufacturer‟s instructions. Briefly, cells were 
lysed with RLT buffer together with 10µl β-mercaptoethanol to inhibit RNase activity and 
transferred to a column. This was washed with 700 µl of RW1 buffer followed by washing 
twice with 500 µl of RPE buffer. RNA was eluted twice with 40 µl of RNase-free water, 
quantified using a Nanodrop 2000c Spectrophotometer (ThermoScientific, South Africa) and 
stored in 10µl aliquots at -70ºC to prevent freeze-thaw cycles and retain RNA quality. The 
integrity of the RNA was assessed by RNA curves in the Spectrophotometer and RNA gel 
electrophoresis by estimating the sizes of 18S and 28S eukaryotic RNA subunits (Appendix 
B, Supplementary Fig. 2). 
 
Library preparation and RNA sequencing 
 
The RNA-Seq library for Illumina HiSeq 2000 sequencing for two biological replicates was 




procedure. Briefly, 200 ng of total RNA in a volume of 50 µl was mixed with 50 µl RNA 
purification magnetic beads. The fragmented mRNA was converted to double stranded cDNA 
that was repaired, tailed, and ligated with indexed adaptors. The adaptor linked cDNA library 
was then PCR amplified. The PCR products were purified using Agencourt RNAClean XP 
magnetic beads and electrophoresed on an Agilent high sensitivity DNA chip for quality 
control. Each of four samples used per lane for 50 bp sequencing were pooled in equimolar 
concentration and sequenced for single reads of 50 cycles.   
 
Mapping and transcript assembly 
 
Mapping, transcripts assembly and differential gene expressed was carried out within the 
South African National Bioinformatics Institute server, operating within the linux command 
line. Each job was executed using scripts described in the publicly available “Tuxedo Suite” 
from Trapnell et al. (2012) The details of reads processing and analysis were as follows: The 
sequencing reads were processed and mapped to the UCSC (Homo sapiens) reference 
genome (hg19) using Bowtie operating under TopHat (v. 2.0.9) as a mapping manager with 
the following command line: tophat -p 4 -o tophat_samplename -G references/genes.gtf --
transcriptome-index references/hg19.mRNA references/Bowtie2Index/genome 
data/samplename.fastq. The alignment statistics for all reads was greater than 95% for all 
samples. All short reads were then assembled using Cufflinks (v. 2.0.2) that utilized the 
method of upper quartile normalization to increase the accuracy of differential analysis for 
different genes using the following command: cufflinks -p 4 –o fileoutput 
Condition_1_Replicate_1/accepted_hits.bam. Cuffdiff was used to calculate differential 
expression between the uninfected and infected epithelial cells and calculate a significant 




using the following command line: cuffdiff -o A549vsBeijing -L A549,Beijing -p 4 -N --
compatible-hits-norm -b references/Bowtie2Index/genome.fa -M references/humanmask.gtf -
u references/genes.gtf tophat_sample1/accepted_hits.bam,tophat_sample2/accepted_hits.bam 
tophat_sample13/accepted_hits.bam, tophat_sample14/accepted_hits.bam. CummeRbund (v. 
2.0) was used for pairwise comparison and to visualize the Cuffdiff output generating scatter 
plots as well as volcano plots that shows differential expression and significantly regulated 
genes induced by the different strains in epithelial cells (Goff et al., 2012).  
 
Enrichment and functional analysis 
 
The Molecular Signature Database (MSigDB) (http://www.broadinstitute.org/gsea/index.jsp) 
was used to enrich and functionally classify differentially expressed genes with a significant 
Q-value and a fold change of greater than two induced by different clinical strains of M. 
tuberculosis. Sets of genes that are co-regulated to induce a particular biological function or 
pathway were identified by MSigDB. Statistical cut-off FDR for the analysis was set at P < 
0.05, in which C5 curated was selected to elucidate biological functions associated with 
differentially expressed genes, while C2 curated was selected to understand Kyoto 
Encyclopedia of Genes and Genomes (KEGG) and Reactome pathways associated with 
mRNA genes of interest. Heat maps were generated to indicate the level of fold changes 
between uninfected and infected epithelial cells. Clustering of gene expression profiles 
among M. tuberculosis strains was performed by MeV (4.0.9) (Saeed et al., 2003).  
 
Identification of strain-specific molecular signatures 
 
The total number of differentially expressed genes with a significant Q-value and a fold 




Evolutionary Genomics database (http://bioinformatics.psb.ugent.be/webtools/Venn/). Both 
up-regulated and down-regulated genes were compared at a combination of six datasets, and 
the output for each strain combination and strain specific gene signatures was obtained. 
Expression levels of each comparison of enriched genes (MSigDB) were created using MeV 
(4.0.9) and compared for all strains, different strain comparisons and strain specific genes, 
respectively.  
 
Quantitative real time PCR 
 
In order to validate and confirm RNA-Seq results, six cytokine and chemokine genes were 
randomly selected for qRT-PCR analysis. Primers (Invitrogen, Life Technologies, South 
Africa) for these genes are shown in Table 1. The PCR conditions for each run were modified 
from original references and used accordingly. Denaturing temperature for all selected genes 
was 95 ºC, while annealing and extension temperatures were between 55-65 ºC and 55 to 72 
ºC, respectively. The 2
-∆∆Ct
 method was used to calculate relative gene expression where ∆Ct 
= Ct (gene of interest) – Ct (normalizer_GAPDH). The fold change was calculated as ∆Ct 
(sample)/∆Ct (calibrator_uninfected A549) and graphs were plotted using Graph pad prism 














Table 1: Cytokine/chemokine primers used for quantifying mRNA by real time PCR 
 












(Lin et al., 
1998) 
MCP-1 CAAACTGAAGCTCGCACTCTCGCC ATTCTTGGGTTGTGGAGTGAGTGTTCA (Lin et al., 
1998) 
GM-CSF TGGCTGCAGAGCCTGCTGCTC TCACTCCTGGACTGGCTCCC (Sato et al., 
2002) 




GATGCTCTTCGACCTTGAAACAGCAT (Sato et al., 
2002) 







Differentially expressed genes with a significant Q-value and a fold change of ≥2 varied 
among the strains. There were common genes induced by all clinical and laboratory strains 
used while other genes were only shared by different strain combinations. Strain-specific 
molecular signatures were also obtained and these signatures affected different Kegg and 






Differential gene expression in epithelial cells infected with clinical strains of M. tuberculosis 
 
Differential genes expression obtained from Cuffdiff varied among the clinical and laboratory 
strains of M. tuberculosis compared to the uninfected epithelial cells. The number of 
differentially expressed genes induced in epithelial cells by the different strains are shown in 
parenthesis: F15/LAM4/KZN (1187), F11 (1639), F28 (870), Beijing (1252), Unique (886) 
and H37Rv (1179). Scatter plots of pairwise comparison of differentially expressed genes 
induced by all strains relative to the uninfected epithelial cells showed variation in some gene 
expression patterns, whilst others were common among the strains. According to the patterns 
of gene expression, the strains could be categorized into 2 groups with similar profiles, viz, 
(i) F28, Unique, H37Rv strains and (ii) F15/LAM4/KZN, F11, Beijing strains (Fig. 1). 
Volcano plots showed significantly up- (red) and down (green)-regulated genes compared to 
all genes within the transcriptomics data of infected pulmonary epithelial cells compared to 









Fig. 1.  Scatter plots showing pairwise comparison of differentially expressed genes in epithelial cells induced by different clinical and laboratory strains of M. tuberculosis in 
infected relative to un-infected A549 pulmonary epithelial cells. Differentially expressed genes varied among the strains: F15/LAM4/KZN, F11, F28, H37Rv, Unique and 




















































M. tuberculosis F15/LAM4/KZN strain 
 
M. tuberculosis Beijing strain
 
M. tuberculosis F11 strain 
 





M. tuberculosis Unique strain 
 
M. tuberculosis H37Rv strain 
 
Fig. 2.  Volcano plots showing significantly up- (red) and down 
(green)-regulated genes against all genes (black) in the 
transcriptomic data of infected pulmonary epithelial cells compared 
to uninfected A549 controls. Significantly regulated genes varied 
among clinical strains. Volcano plots were created by using the 




The top 10 most up-regulated and down-regulated genes are shown in Table 2.  Among these, 
OASL, P13 and RSAD2 were commonly up-regulated by all strains. CSF3, IF127, PI3, OAS2 
and CLEC4E were up-regulated by all clustering strains and H37Rv but not the Unique 
strain. IF16 was induced only by the Beijing and Unique strains in the top 10 up-regulated 
genes. Among the top 10 down-regulated genes, similar to the up-regulated ones, several 
genes were uniquely induced by the different strains, whilst none was commonly induced by 
all. Eight and 3 different genes were down-regulated in combination by 2 and 3 strains, 
respectively. Of these, DYSF and CNTD2 were induced by the Beijing and the Unique strains 




















Table 2: The total number and the 10 most up- and down-regulated genes induced by 
different M. tuberculosis strains in A549 pulmonary epithelial cells 
 
 
 F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
       



































































































































Expression pattern of common genes induced by all M. tuberculosis strains in pulmonary 
epithelial cells 
 
Differentially expressed genes between uninfected and infected pulmonary epithelial cells 
were compared with RNA-Seq Tuxedo tools. The Bioinformatics & Evolutionary Genomics 
database (http://bioinformatics.psb.ugent.be/webtools/Venn/) was used to identify genes that 
were induced by all strains in pulmonary epithelial cells as well as genes shared by different 
strain comparisons. A total of 292 genes were induced by all strains and the expression 
profile of 152 of these is illustrated in Fig. 2. HLA genes (HLA-B, HLA-C, HLA-F and HLA-
H) were significantly up-regulated together with surface markers (CD38, CD68 and CD274) 
and other receptors (TLR5 and NOD2). Additionally, these clinical strains induced an 
increase in MMP (MMP1 and MMP10) genes. Moreover, expression of MMP7 was induced 
only by the Beijing and F11 strains, while down-regulation of MMP14 was induced by these 
2 strains and the Unique strain. Down-regulation of the MMP2 gene was induced only by the 
F28 strain compared to other strains (data not shown). Among the up-regulated genes, 
increased expression of cytokines/chemokine (IL1A, IL1B, IL8, IL23A, CCL2, CCL5, CCL20, 
CXCL1, CXCL5) together with other transcriptional factors (STAT1, STAT2, IRF7) was 
observed with differences in the level of expression among clinical strains (Fig. 3). 
 
Fig. 3 shows hierarchical clustering of the 100 most up-regulated and all (52) down-regulated 
genes in epithelial cells among the strains. Down- and up- regulated genes cluster together 
with a few exceptions (MMP10, CA9, LBP, GDA, SLC1A2, GPR1). The lowest fold changes 
of these commonly shared genes was induced by the Unique strain followed by the laboratory 
H37Rv strain compared to the much higher changes by the clinical strains. Among the 




Beijing and F11 strains, compared to the F28 strain (Fig. 3; Appendix B, Supplementary 





Fig. 3. Fold changes showing gene 
expression profiles of top 100 (out of 240) 
up-regulated, and all (52) down-regulated 
genes in A549 pulmonary epithelial cells 
at 48 hr post-infection. Hierarchal 
clustering indicates that highly virulent M. 
tuberculosis strains cluster together and 
induce a similar behaviour in epithelial 
cells compared to less virulent Unique 
strain. The Tuxedo RNA-Seq pipeline was 
used to identify differentially expressed 
genes between uninfected and infected 
epithelial cells by F15/LAM4/KZN, 
Beijing, F11, F28, Unique clinical strains 
and a laboratory H37Rv strain of M. 
tuberculosis. The fold changes were 
compared among the strains and a heat 
map was created using MeV. The 
F15/LAM4/KZN, F11 and Beijing strains 
induced higher fold changes compared to 







Gene Ontology analysis 
 
Gene ontology enrichment analysis (MSigDB: C5) was performed on 292 genes to clarify the 
biological, molecular and cellular functions associated with both up (n = 240) - and down-
regulated (n = 52) genes. These functions ranged from signal transduction, membrane 
associated functions, endopeptidase activity, and steroid biosynthesis of down-regulated 
genes, to extracellular space, immune system processes, defense response, response to 
external stimuli, plasma membrane and receptor binding functions of the up-regulated genes 
(Table 3). 
 
Table 3: Biological functions associated with up- and down-regulated genes in A549 
pulmonary epithelial cells 
 Gene ontology 
functions 
Genes 
   
Down-regulated genes Signal transduction APOE, CARD9, ADRB1, RHBDL1, GPR1, KCNIP3, CAPN5, 
BCL2L10, NR4A3, CDKL2 
   
 Membrane associated 
functions 
AOC3, BCL2, CDH24, SLC4A11, DYSF, CTGF, GPNMB, HDAC10 
   









Up-regulated genes Extracellular space CCL20, IL8, INHBA, EBI3, SECTM1, CCL2, CXCL1, IL1A, LBP, 
LGALS3BP, CSF3, IL1B, FGFBP1, GPX3, CP, PRSS3, MMP10, 
LOXL2, APOL1, CHI3L2, SERPINA1, FBLN5, ADAMTS9, PI3, 
CDA, SPINT1 
 Immune system 
processes 
 
CCL20, IL8, INHBA, EBI3, SECTM1, CCL2, CXCL1, CXCR4, 
CCL5, RSAD2, BST2, IFITM3, IFI6, CD274, TRIM22, CTSS, DPP4, 
GBP2, PF4 
 Defense response  
CCL20, IL8, INHBA, CXCL1, IL1A, LBP, LGALS3BP, CXCR4, 
CCL5, RSAD2, TNFAIP6, AHSG, MX1, HLA-B, MX2, HCP5 
   
 Response to external 
stimulus 
CCL20, IL8, INHBA, CCL2, CXCL1, IL1A, LBP, CXCR4, CCL5, 




EBI3, CXCR4, BST2, IFITM3, PLAUR, ITGB3, TNFSF10, IFITM1, 
ROBO1, ADAM12, DNER, CD38, OLR1, SLC16A3, PTPRN2, 
ANPEP, EMR1, KCNJ6, ITGA5, ITGB8, SLC22A11, HAS3, 




CCL20, IL8, INHBA, SECTM1, CCL2, CXCL1, CSF3, FBLN5, 
CCL5, PF4, CXCL5, STC1, IGF2, C3, APOL2, OASL 
   
 
Validation by qRT-PCR 
 
Validation of RNA-Seq transcriptomics data of 6 cytokine and chemokine genes showed 
increased expression of IL6, IL8, CCL2, CSF2, TNF-α, IFN-γ mRNA at 48 hr after infection 




changes detected by qRT-PCR ranged from 0.055 to 12.64. A fold change of below 0.4 was 
obtained for IFN-γ mRNA. The validation results were consistent with those of RNA-Seq, 
with the exception for the IFN-γ mRNA that was not detected by the latter. The differences in 
the fold changes between the 2 techniques ranged from 0.117 to 3.71, but these were not 
significant except for IFN-γ (P = 0.0131). There was a positive (r
2 
> 0.5) correlation between 
the RNA-Seq and qRT-PCR for IL6, IL8, CCL2, CSF2, TNF-α validating the expression 
profiles detected by the RNA-Seq. Correlation could not be performed for IFN- γ because it 
















































































































































































































































































































































Fig. 4. The expression and validation of cytokine/chemokine (IL6, 
IL8, CCL2, CSF2, TNF-α, IFN-γ) mRNA levels was performed with 
quantitative real time PCR. RNA was extracted at 48 hr post-
infection from M. tuberculosis infected pulmonary epithelial cells. 
The genes of interest were normalized by using the house keeping 
gene GAPDH and the expression data for two independent 
experiments are presented as fold changes between the infected and 
uninfected epithelial cells for both RNA-Seq and quantitative real 
time PCR. The expression levels shown by quantitative real time 
PCR were comparable with RNA-Seq with the exception of the 
IFN-γ gene that was detected by the real time PCR and was less than 







Kegg and Reactome pathways: Strain-specific signatures in pulmonary epithelial cells  
 
In order to identify strain-specific molecular signatures induced by different strain 
comparisons and strain specific functions in epithelial cells, all differentially expressed genes 
(fold change ≥2) were compared between all strains using the publically available 
Bioinformatics & Evolutionary Genomics database 
(http://bioinformatics.psb.ugent.be/webtools/Venn/). The number of induced genes and 
associated pathways that were activated/down-regulated, varied with different strain 
comparisons as shown by Fig. 5 and Table 4. These pathways were identified by selecting 
KEGG and Reactome pathways in the MSigDB (C2 curated). Changes in genes that activate 
or down-regulate specific KEGG and Reactome pathways were observed for the different 






Fig. 5. A six-way Venn diagram showing molecular signatures shared by different strain 
combinations. Differentially expressed genes were compared among the strains to reveal 
strain-specific signatures in pulmonary epithelial cells at 48 hr post-infection. Intersections 
and the Venn diagram were created using the Vennture software. The number of strain-
specific signatures was as follows: F11 (255), F15/LAM4/KZN (138), F28 (55), Beijing (52), 
Unique (186) and H37Rv (125). 
 
All strains except the Unique strain activated cytokine signalling, IFN-γ signalling, JAK-
STAT pathways, cytokine-cytokine signalling and signalling of interleukins, and down-
regulated the axon guidance pathway. Metabolism of β-alanine and the cholesterol 

















strains only. These strains also down-regulated Terpenoid backbone biosynthesis and 
phenylalanine metabolism. The Beijing, F11, Unique and H37Rv strains activated 
carbohydrate and amino acid metabolism, glycolysis/gluconeogenesis, and transmembrane 
transport pathways, whilst down-regulating genes involved in amino acid synthesis and 
interconversion. Genes specific for F15/LAM4/KZN, Beijing and F11 activated apoptosis 
and RIG-I-like receptor signalling pathway. The TLR 4 signalling, Integrin cell surface 
interactions, Plasma membrane MyD88:Mal cascade and Toll Receptor Cascades pathways 
were activated by the F15/LAM4/KZN, F11 and F28 strain comparison. The 
F15/LAM4/KZN and F11 up-regulated genes involved in the adaptive immune system, Toll-
like and B cell receptor signalling. No significant KEGG and Reactome pathways were 
activated/down-regulated by the molecular signatures specific for the gene comparisons of 
Beijing, F11 and F28 strains. Some of the genes involved in the same pathway were shared in 
different strain comparisons. This was observed with the JAK-STAT signalling and cytokine-
cytokine receptor interaction pathways induced by the genes shared by all but Unique strain, 
while on the other hand, the F15/LAM4/KZN strain specifically activated the same pathway. 
Similarly, the up-regulated genes shared by all but the F28 strain were involved in cholesterol 
biosynthesis, while Beijing and F11 specific genes were also involved in the same pathway.  
 
The highest number of strain-specific molecular signatures in M. tuberculosis infected 
pulmonary epithelial cells were present in the F11 (255), followed by the Unique (187), 
F15/LAM4/KZN (138), H37Rv (125), F28 (55), and Beijing (52) strains, respectively. Each 
strain induced strain specific genes in pulmonary epithelial cells (Table 4), however only the 
F15/LAM4/KZN, Unique and H37Rv gene signatures induced overlapping KEGG and 
Reactome pathways. The F15/LAM4/KZN strain activated the cytokine-cytokine receptor 




the same cytokine-cytokine receptor pathway. The Unique strain specifically down-regulated 
genes that are involved in developmental biology, exon guidance, L1CAM interactions, 
NCAM signalling for neurite out-growth and netrin-1 signalling. Furthermore, the Unique 
strain up-regulated genes involved in sugar metabolism and variety of other pathways as 
shown in Table 4. Genes involved in chronic myeloid leukemia, TGF-beta signalling pathway 
and cell cycle were down-regulated in H37Rv infected epithelial cells (Table 4, Appendix B, 
Supplementary Table 2 and 3).  
 
Table 4: Strain-specific signatures and their respective KEGG and Reactome pathways 


















Cytokine Signalling in immune system, Immune System, Interferon/ interferon gamma signalling, Cytokine-cytokine 







Amino acid synthesis and interconversion (transamination) 
 
Up-regulated 
Metabolism of amino acids and derivatives, Metabolism of carbohydrates, Glucose metabolism, Transmembrane 
transport of small molecules, Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine 
compounds, Glycolysis, Glycine, serine and threonine metabolism, SLC-mediated transmembrane transport, 




























































Immune system, Leishmania infection, Cytokine signalling in immune system 
Adaptive immune system, Toll-like receptor signalling pathway, Signaling by the B cell receptor (BCR), Genes 
involved in interferon signalling, Cytokine-cytokine receptor interaction, Antigen activates B Cell receptor leading to 








Glucuronidation, Ascorbate and aldarate metabolism, Pentose and glucuronate interconversions, Porphyrin and 
chlorophyll metabolism, Drug metabolism - other enzymes, Starch and sucrose metabolism, Steroid hormone 











Common Pathway, Starch and sucrose metabolism, Pentose and glucuronate interconversions, Complement and 
coagulation cascades, Formation of Fibrin Clot (Clotting Cascade), Metabolism of xenobiotics by cytochrome P450, 












Discussion and conclusion 
 
Molecular epidemiological studies have identified genetically diverse strains of M. 
tuberculosis that vary in virulence (Coll et al., 2014; Coscolla and Gagneux, 2010; 
Fleischmann et al., 2002). This diversity has been reported to impact on clinical outcome as 
exhibited by the capacity of several of these strains for increased transmission rates (Brites 
and Gagneux, 2012; Mihret et al., 2012), rapid progression to active disease (Nahid et al., 
2010), and differential host immune response (Koo et al., 2012; Manca et al., 1999; Subbian 
et al., 2013), including subversion of the host response that may be associated with increased 
virulence (Hoal-van Helden et al., 2001; Nicol and Wilkinson, 2008). In an effort to identify 
strain specific molecular signatures that may be associated with virulence, we investigated 
the global transcriptomic profile by RNA-Seq of the epithelial cells infected with the 
F15/LAM4/KZN strain that has been transmitted largely in its drug resistant form (Pillay and 




province of KwaZulu-Natal in the mid 2000‟s (Gandhi et al., 2006). We compared this to the 
transcriptomes of epithelial cells infected with the Beijing, F11, F28 and Unique strains that 
are also widely transmitted in this province as well as the laboratory strain H37Rv infected 
cells. The qRT-PCR assay validated the RNA-Seq data with the exception of IFN-γ, 
suggesting the reliability of the latter technique (Fig 3).  
 
Epithelial cells in immune response 
 
Host infection by M. tuberculosis results in a variety of changes that favour the growth and 
replication of the bacilli within the lungs. Epithelial cells, in addition to their protective 
functions, simultaneously play a significant role  in both the innate and adaptive immune 
response during infection by M. tuberculosis via induction of the cytokines/chemokines 
(Chuquimia et al., 2012; Lee et al., 2009; Lin et al., 1998; Sato et al., 2002; Sharma et al., 
2007; Stadnyk, 1994). The current study revealed differential changes in the transcripts of 
numerous genes of epithelial cells infected with the different clinical strains, similar to 
studies in other infection models such as monocytes and macrophages (Koo et al., 2012; 
Manca et al., 2004) as well as in mice (Manca et al., 1999). Strain specific responses were 
also observed.  
 
The differential gene expression levels and strain specific responses may be due to the 
varying virulence determinants of these clinical strains. In our study, the Unique (non-
clustering) strain exhibited the lowest fold change in the expression of the 100 most up- and 
all 52 down-regulated genes in epithelial cells compared to the clustering strains. This may 
suggest that lower gene expression, including immune related genes may be associated with 




correlate with our findings that the Unique strain behaved similar to the Beijing strain with 
respect to the low cytokine/chemokine production in our previous work (Chapter 2). A 
limitation in our study is that further investigations were not performed to ascertain the 
virulence of the Unique strain. The low cytokine/chemokine induced by the Unique strain in 
our previous work may be associated with low mRNA changes induced by this strain. 
However, similar low cytokine/chemokine production but higher gene expression levels by 
the Beijing strain suggests the involvement of other complex mechanisms that require further 
investigation.   
 
The up-regulation of the CSF3, IF127, PI3, OAS2 and CLEC4E genes amongst the top-10 
up-regulated genes in only clustering strains and H37Rv but not the Unique strain suggest 
that these may represent host factors that may be associated with increased transmissibility of 
the former strains. Functions associated with these up-regulated genes range from stimulating 
stem cells to produce granulocytes (Nambiar et al., 2010; Szeliga et al., 2008; Thomas et al., 
2002), promoting cell death (Rosebeck and Leaman, 2008), antimicrobial peptides 
(Molhuizen et al., 1994; Neto et al., 2014), controlling cellular function (Besse et al., 1998) 
and recognition of cell wall components of Mycobacteria (Schoenen et al., 2010).  
 
Since epithelial cells play a crucial role in initiating an inflammatory response in innate 
immune response (Chuquimia Flores, 2011; Chuquimia et al., 2012), our results suggest that 
less virulent or lower transmissible strains of M. tuberculosis may tend to induce lower 
inflammatory response through involvement of cytokines and chemokines. Our findings 
differ from that reported by Lin et al. (1998) and Sato et al. (2002) where M. tuberculosis 




CSF2 by the latter organism were explained by the use of different receptors by the latter to 
facilitate adhesion to and entry into host cells (Lin et al., 1998; Sato et al., 2002).   
 
Our study indicated that up-regulated genes in epithelial cells are involved in immune and 
defence response, activated crucial immune associated surface markers, cell receptors and 
transcriptional factors during infection. The role of epithelial cells in production of chemo-
attractant proteins and cytokines as a defence mechanism has been well studied (Lee et al., 
2009; Lin et al., 1998; Sato et al., 2002; Sharma et al., 2007; Wickremasinghe et al., 1999). 
In this study, increased expression of cytokines (IL1A, IL1B, IL8, IL23A) and chemokines 
(CCL2, CCL5, CCL20, CXCL1, CXCL5) to inhibit bacterial replication at the site of infection 
was induced by all strains. Additionally, activation of STAT1 (Sharma et al., 2007), STAT2 
(Stockinger and Decker, 2009), IRF7 (Honda et al., 2005) transcriptional factors results in an 
increased protective response in epithelial cells by the production of pro-inflammatory 
cytokines including IFN-γ, that is crucial for the anti-tuberculosis clearance at the site of 
infection (Sharma et al., 2007). The observed changes in pulmonary epithelial cells support 
mounting evidence of the involvement of epithelial cells in both innate and adaptive immune 
response during M. tuberculosis infection. Lower fold changes of immune associated genes 
induced by the Unique strain compared to other clinical strains, is suggestive of a less 
vigorous immune response of epithelial cells during infection by this strain.  
 
Antigen presentation 
The role of epithelial cells as antigen presenting cells (APCs) has been well studied in type II 
pulmonary epithelial cells (Cunningham et al., 1997; Cunningham et al., 1994; Debbabi et 
al., 2005; Fehrenbach, 2001; Harbeck et al., 1988; Lo et al., 2008). The increased fold 




markers (CD38, CD68 and CD274) induced by all clinical and laboratory strains in our study 
lend further support to their findings that alveolar pulmonary epithelial cells most likely play 
a significant role in antigen presentation via the MHC class I molecules (Mack et al., 2013). 
Antigen presentation by epithelial cells was further characterized by the increased expression 
of the TLR5 and NOD2 receptors that are known to play a role in antigen recognition and 
presentation (Cooney et al., 2010; Takeda and Akira, 2005). Epithelial cells may not be 
classified as professional APCs (Kumari and Saxena, 2011), however, their contribution to T-
cell trafficking through antigen presentation indicates their important immunological 
functions during TB infection (Gereke et al., 2009) by linking both the innate and adaptive 
immune response. Inhibition of the antigen presentation phenotype during infection by M. 
tuberculosis has been identified as an intracellular persistence strategy of this pathogen 
(Flores-Batista et al., 2007; Harding and Boom, 2010). This was not the case with our current 
findings, although we observed differences in expression levels among the clinical strains.  
 
Granuloma formation 
Matrix metalloproteinases (MMPs) belong to a family of enzymes that play a significant role 
in various cellular activities (Parks and Shapiro, 2001), promotion of early granuloma 
formation during M. tuberculosis infection, as well as dissemination of the pathogen through 
extracellular matrix destruction (Izzo et al., 2004; Parks and Shapiro, 2001).  In our study, all 
strains induced increased expression of the MMP1 and MMP10 genes in epithelial cells, with 
the highest expression by the H37Rv strain compared to clinical strains. There were 
variations in the expression of other MMP genes (data not shown) shared by different 
comparisons of clinical strains. The diversity in expression of these granuloma associated 
genes induced in pulmonary epithelial cells may influence the time needed for the granuloma 




virulence. MMP1 was the most highly up-regulated of all MMP genes tested, whilst both 
MMP1 and MMP3 protein levels were both increased in primary human monocytes of 
patients with TB, with the former being strongly associated with immunopathology of the 
lungs in patients (Elkington et al., 2011). However, the genotype of the infecting strain was 
not determined, and therefore no associations with differential expression and strain virulence 
could be drawn. The association between strain virulence and MMP gene expression needs to 
be explored in future studies by investigating times taken by different strains to induce 
formation of the granuloma in mice models as well as understanding MMP genes in other cell 
types.  
 
Molecular signatures among strain combinations 
In addition to common genes activated or down-regulated in epithelial cells infected by 
different strains of M. tuberculosis, we further attempted to identify strain specific molecular 
signatures by examining the pathways that are affected by each strain. Several pathways were 
activated or down-regulated in epithelial cells either by the F15/LAM4/KZN, Unique or 
H37Rv alone or by different strain comparisons (Table 4). All strains up-regulated genes of 
the immune system except the Unique strain, reflecting a failure to provoke a more vigorous 
host immune response at 48 hr compared to others. Activation of the immune associated 
pathways by clustering strains, but not  the Unique strain, may be attributed to increased 
expression of the JAK-STAT pathway that has been known to contribute to effective host 
immune response (Stockinger and Decker, 2009). The same JAK-STAT pathway was up-
regulated by the F15/LAM4/KZN specific genes that may perform different functions within 






Genes involved in apoptosis 
Several studies have shown that whilst virulent M. tuberculosis is capable of inducing 
apoptosis in host cells, this process can also be inhibited via the regulation of 3 genes: nuoG, 
SecA2 and pknE (Chaussabel et al., 2003; Danelishvili et al., 2003; Velmurugan et al., 2007). 
Thus, avirulent mycobacteria induce a more vigorous apoptotic response than virulent 
mycobacteria (Briken and Miller, 2008; Keane et al., 2000). Schaible et al. (2003) showed 
that M. tuberculosis infected macrophages undergo apoptosis to overcome the loss of antigen 
presenting capacity by facilitating  antigen cross presentation to T-cells (Schaible et al., 
2003). Contrary to macrophages, H37Rv-infected alveolar epithelial cells inhibited apoptosis 
mediated by the down-regulation of the pro-apoptotic genes bad and bax, and up-regulation 
of the anti-apoptotic genes bcl-2 and Rb (Danelishvili et al., 2014). In addition, the apoptosis 
associated caspase (casp1, casp3 and casp10) genes were also repressed by the up-regulation 
of bcl-2 in A549 epithelial cells (Danelishvili et al., 2003).  
In the present study, activation of the genes (CASP10, TRADD, CFLAR, BID, CASP7, 
TMEM173) involved in the apoptosis pathway was surprisingly induced in epithelial cells by 
only the F15/LAM4/KZN, Beijing and F11 strains, but not the other virulent F28, Unique and 
H37Rv strains. Despite the down-regulation of the BCL2 genes by all strains, only 
F15/LAM4/KZN, Beijing and F11 significantly affected the apoptosis pathway with the up-
regulated CASP10 gene. Up-regulated apoptotic genes may facilitate rapid, earlier 
progression to disease in patients infected with the former clinical strains due to apoptosis of 
the epithelial cells. Alveolar macrophages infected with M. tuberculosis underwent apoptosis 
mediated by TNF-α (Keane et al., 1997). These authors also showed that lower macrophage 
apoptosis induced by virulent M. tuberculosis occurred via inhibition of TNF-α by soluble 
TNFR2 (sTNFR2) that was stimulated by IL-10. In a subsequent study, they reported a lack 




(Keane et al., 2000). Similarly, TNF-α and IL-10 production in epithelial cells infected with 
different virulent strains (Chapter 2) showed no correlation with our contradictory 
transcription profiles, suggestive of diverse virulence determinants among the virulent strains 
tested in the present study.   
 
Genes involved in toll-like receptor signalling 
In the mouse model, TLR 4 signalling was associated with a late chronic protective response, 
M. tuberculosis control at the infection site, dissemination from the lungs, inhibition of 
macrophages and pro-inflammatory cytokines (Abel et al., 2002; Branger et al., 2004).  In the 
current study, TLR 4 signalling and toll receptor cascades pathways were specifically up-
regulated in epithelial cells by the F15/LAM4/KZN, F11 and F28 strains, indicating a 
potential protective role for these pathways in late stages of infection by these strains. These 
findings lend support to those of Carmona et al. (2013), in that different strains of M. 
tuberculosis are preferentially recognised by different TLRs which may impact on the 
immune response through the differential production of cytokines/chemokines (Carmona et 
al., 2013).  
 
Genes involved in cholesterol metabolism 
Host lipids, including cholesterol, play a significant role in TB pathogenesis, as high levels of  
these have been implicated in granuloma development during infection (Kim et al., 2010) as 
well as during persistence of M. tuberculosis within the host (Ouellet et al., 2011). In our 
study, the HMGCS1 and FDPS genes involved in cholesterol biosynthesis were up-regulated 
in all strains except the F28. Additionally, genes specific for the Beijing and F11 strains up-
regulated the cholesterol biosynthesis pathway (CYP51A1, HSD17B7, HMGCR) and 




These findings suggest that the F28 strain, unlike the others, may not be able to sequestrate 
host cholesterol as a source of carbon and energy (Ouellet et al., 2011), and uses alternate 
sources such as sugars and amino acids to survive and replicate within epithelial cells as seen 
with other intracellular pathogens (Eisenreich et al., 2010). The additional cholesterol 
biosynthesis genes may confer an advantage to the Beijing and F11 strains in their ability to 
mobilize host cholesterol, and contribute to increased virulence compared to the other 3 
clinical strains.   
 
Strain-specific molecular signatures 
Significant up-regulation/down-regulation of specific pathways resulted in molecular 
signatures that were specific for the F15/LAM4/KZN, Unique and H37Rv strains. Cytokine-
cytokine receptor and JAK-STAT pathways were specifically regulated by the 
F15/LAM4/KZN strain, which seems capable of significantly provoking an effective host 
immune response at an earlier time in epithelial cells. Despite this capacity, the successful 
spread of the F15/LAM4/KZN strain might be fuelled by XDR and compromised host 
immunity (Gandhi et al., 2006; Pillay and Sturm, 2007) rather than hypervirulent attributes.  
 
The Unique strain specifically down-regulated several pathways, including a netrin-1 
pathway that is known to inhibit leukocyte migration in both in vitro and in vivo models (Ly 
et al., 2005).  This could lead to increased migration of leukocytes to the lungs resulting in 
improved bacterial clearance, and may explain the low prevalence of this strain within the 
population. Up-regulation of the starch and sucrose metabolism might be beneficial to the 
Unique strain as these may be used as carbon and energy sources in addition to host 
cholesterol. Metabolic changes and control of major metabolic pathways such as sugars are 




proteins and other molecules produced by the Unique strain to activate these pathways within 
epithelial cells. Decreased sugar (mainly glucose and glycogen) metabolism within mice 
(Shin et al., 2011) and guinea pigs (Somashekar et al., 2012) was  induced by M. tuberculosis 
infection, in contrast to our findings, where increased expression of different sugar pathways 
including pentose and glucuronate sugars was induced by the Unique strain in epithelial cells. 
These differences might be attributed to different infection models and different strains of M. 
tuberculosis used in the different studies. Metabolomics studies to elucidate sugar profiling 
have not yet been documented in pulmonary epithelial cells infected with different M. 
tuberculosis clinical strains. However, such information would serve to broaden our 
knowledge of the different nutritional requirements of these clinical strains to facilitate 
further understanding of the complex-host pathogen interactions.  
 
Infection with the laboratory adapted H37Rv strain might not necessarily result  in responses 
similar to those elicited by other clinical strains as  was shown in our study by  several down-
regulated pathways that were unaffected by other clinical strains. Mononuclear phagocytes 
have been known to be the main source of TGF-β in the lungs (Aung et al., 2005), however, 
our study revealed that epithelial cells infected with the laboratory strain may reduce the 
production of TGF-β through down-regulation of its pathway. TGF-β has anti-inflammatory 
properties and its inhibition was shown to improve lymphocyte response and M. tuberculosis 
containment by macrophages (Hirsch et al., 1997). Highly virulent and transmissible clinical 
strains did not down-regulate the TGF-β pathway, which highlights differences in using 
laboratory and clinical strains isolated in patients. This data emphasizes the importance of 





Molecular signatures that were specific for the Beijing, F11 and F28 strain combinations did 
not affect changes in KEGG and Reactome pathways, however, they may be involved in 
other host biological functions that can be further explored in future studies. In vivo studies 
utilising global transcriptome analysis of human blood samples have provided evidence that 
molecular signatures show promise as targets for the development of TB diagnostics (Lesho 
et al., 2011), treatment monitoring (Cliff et al., 2012), vaccine and drug therapies (Berry et 
al., 2010). However, the influence of strain identity on host immune response in pulmonary 
epithelial cells has not been considered. Our data shows clearly, that specific host genes and 
signalling pathways are induced in epithelial cells infected with virulent strains of diverse 
genetic background.  
 
The main technical limitation in this study is that epithelial cells were not examined at 
sampling times for confluence and adherence. Another limitation is the lack of prior 
knowledge on virulence determinants in our clinical strains which could have explained 
differential expression patterns in pulmonary epithelial cells. Another limitation is the lack of 
literature on metabolic changes in pulmonary epithelial cells during infection with a wide 
range of clinical strains belonging to either different strain families or lineages. Such 
knowledge may have enabled a deeper understanding of the interaction of certain host factors 
that are crucial during M. tuberculosis infection, as well as an understanding on some of the 
changes observed for the different genes that were expressed.  
 
In conclusion, the current study adds to the growing body of evidence that epithelial cells 
play a significant role in both the innate and adaptive response, and that genetically different 
virulent strains stimulate a strain specific immune host responses with the potential to impact 




specific molecular signatures identified in this study can potentially be exploited in the design 
of efficacious vaccines and adjunctive immunotherapies. These findings warrant further 
exploration and confirmation in future in vivo studies on mice and patients infected with 


























CHAPTER 4: CANONICAL PATHWAYS, NETWORKS AND TRANSCRIPTIONAL 
FACTOR REGULATION BY CLINICAL STRAINS OF Mycobacterium tuberculosis IN 




The high prevalence and spread of M. tuberculosis globally has identified the need for further 
investigation of host associated molecular mechanisms that may affect the outcome of 
infections by different strains. The current study investigated epithelial cell pathways, 
networks and transcriptional factors that are induced upon infection with clinical M. 
tuberculosis strains belonging to 4 genotype families and a Unique strain. Epithelial cells 
were infected at MOI~10:1 and RNA samples were collected at 48 hr post-infection. The 
RNA-Seq Tuxedo pipeline (Bioinformatics) was used to obtain differentially expressed 
genes. Changes in affected pathways, networks and transcriptional factors were identified 
using Ingenuity Pathway Analysis (IPA).  
The top canonical pathways differed among the strains with the interferon signalling and 
hepatic Fibrosis/hepatic stellate cell activation pathways being among the top 5 pathways in 
all the strains. Immune related pathway enrichment was similar in the Beijing and Unique 
strains, whilst the F15/LAM4/KZN showed closer relatedness to the F11 strain, and the F28 
strain clustered closely to the H37Rv strain. The induction of top scoring networks varied 
among the strains. The functions associated with these gene networks involved antimicrobial 
response, developmental disorder, organismal injury, infectious disease and cellular 
development. Among the transcriptional factors, only EHL, IRF7, PML, STAT1, STAT2 and 
VDR were induced by all clinical strains while the induction of other factors, were strain, viz., 




MEIS1, NKX2-5, RELA, RFX5, TFCP2L1), F28 (SOX8), Unique (BHLHE41, EGR1, FOSL1, 
IRF4, KLF2) and H37Rv (EGR2, EN2, MLXIPL, MYC, OLIG1, PPARGC1B). The 
heterogeneity in the molecular mechanisms elucidated in infected epithelial cells in the 
current study may account for the widespread dissemination of certain strains such as the 
Beijing strain, while other strains are easily eradicated within the population. This may be 
mediated through low protective immune associated pathways induced by the Beijing strain 
compared to the F15/LAM4/KZN, F11 and F28 genotypes. However, similarities in the 
behaviour induced by the Beijing and Unique strains require further investigation. Activation 
of the different pathways, networks and transcriptional factors revealed in the current study 
may explain the diversity in the inflammatory response, and may be an underlying 
mechanism that results in differential host response that determines the outcome of infection 




The high global TB burden (WHO, 2014), particularly in resource constrained countries, has 
been fuelled by the high HIV prevalence (Churchyard et al., 2014; Elizabeth et al., 2003), 
and the emergence of MDR, XDR and TDR M. tuberculosis strains (Marahatta, 2010; Pillay 
and Sturm, 2007; Streicher et al., 2012; Udwadia, 2012; Udwadia et al., 2012). The lack of 
effective anti-TB drugs to treat these highly resistant strains, resulting in patients remaining 
infectious for extensive periods, has greatly facilitated escalating TB transmission rates. This 
problem is further heightened by the low protective power of the current BCG vaccine to 




Novel biomarkers are therefore, urgently needed as targets for drug, vaccine and 
immunotherapeutic agents. Much research effort has been directed towards the pathogen 
(Caminero et al., 2010; Dutta et al., 2014; Schoeman and du Preez, 2012; Swanepoel and 
Loots, 2014) and not much towards host targets (Hawn et al., 2013; Maiga et al., 2012; Roca 
and Ramakrishnan, 2013; Tobin et al., 2012). Alternate targets such as host immune 
pathways and/or networks may offer novel options for therapeutic interventions, since 
conventional approaches have realised limited success thus far (Azuma et al., 2013; Quy et 
al., 2003; Sadacharam et al., 2007).  
Computational analysis identified numerous proteins involved in the complex interplay  
between M. tuberculosis and the host following infection (Rapanoel et al., 2013). The clinical 
outcome of infection depends on the presence of different virulence factors by the infecting 
strain (Caws et al., 2008; Manca et al., 1999; Tsenova et al., 2005), host genotype (Caws et 
al., 2008), and host molecular pathway changes (Koo et al., 2012). Host molecular 
mechanisms including pathways and transcriptional factor changes in macrophages (Koo et 
al., 2012; Tailleux et al., 2008), DCs (Tailleux et al., 2008), and mouse models (Kang et al., 
2011) during M. tuberculosis infection have been well described. High immune related 
pathway enrichment in M. tuberculosis H37Rv infected mice were observed for the different 
immune cell signalling pathways and involvement of host receptors in recognition of bacteria 
and viruses (Kang et al., 2011). In vitro studies performed on macrophages and DCs revealed 
common, as well as diverse  host immune associated pathways and metabolic functions that 
were associated with M. tuberculosis infection (Tailleux et al., 2008). Simultaneous 
interrogation of the M. tuberculosis H37Rv transcriptome identified, in addition, host cell 
specific pathogen transcriptional signatures in the same study (Tailleux et al., 2008). An 
immune activation network that included crucial transcriptional factors (STAT3 and STAT5A) 




lipid metabolism network in macrophages (Koo et al., 2012). The importance of strain 
virulence on pathway changes was also observed in macrophages infected with an avirulent 
H37Ra strain that induced a more potent apoptosis compared to the virulent H37Rv strain 
(Behar et al., 2011; Hart et al., 1989). This occurred despite comparable amounts of TNF 
produced by both strains that greatly influence the extrinsic apoptosis pathway (Behar et al., 
2011). 
 A study modelling macrophage response during M. tuberculosis infection revealed that 
cytokine, MAPK and calcium signalling featured among the top regulated of numerous 
signalling pathways involving diverse, activated proteins (Sambarey et al., 2013). Whole 
blood transcriptional studies showed that IFNI signalling holds promise in the development 
of vaccines and therapeutics, whilst a 393-transcript signature could play a role in diagnosis 
of active tuberculosis (Berry et al., 2010). However, the contribution of IFNI signalling to the 
outcome of TB infection remains to be elucidated in future studies (Blankley et al., 2014).  
A wealth of knowledge has been generated in in vivo and in vitro studies demonstrating 
diverse signalling pathways and transcriptional signatures related to host metabolism and 
immune associated response, and with significant potential as biomarkers in novel 
diagnostics as well as host-directed therapy for anti-TB interventions. The heterogeneous host 
immune response to infection with strains of diverse genetic background, and in different 
infection models has been well documented (Manca et al., 2004; Manca et al., 1999; Manca 
et al., 2001; Rakotosamimanana et al., 2010; Subbian et al., 2013). 
Despite this increasing knowledge, few studies have focused on understanding cellular 
response to clinical strains of M. tuberculosis in pulmonary epithelial cells (Lin et al., 1998) 
although there is compelling evidence showing the importance of these cells in TB 




studies to understand pathways, networks and transcriptional factor regulation induced by M. 
tuberculosis, particularly of diverse genotypes, within these cells, have not been elucidated to 
date.  
Recently, we have shown that dominant strains in South Africa, induce differential cytokine 
production and gene expression in epithelial cells (Chapter 2 and 3). In this study, we used 
the IPA software to quantitatively analyse the enrichment of canonical pathways and 
networks as well as transcriptional factor regulation induced by different clinical strains on 
pulmonary epithelial cells.  
 
Materials and methods  
 
Bacterial isolates and infection of pulmonary epithelial cells 
Infection of the A549 pulmonary epithelial cells with one laboratory and 5 clinical strains 
was performed as described in Chapters 2 and 3. M. tuberculosis strains belonging to the 
F15/LAM4/KZN, Beijing, F11, F28 families, and a Unique genotype, were previously 
isolated from patients in the KwaZulu-Natal region of South Africa.  Briefly, the 
F15/LAM4/KZN, Beijing, F11, F28 and Unique strains were grown in Middlebrook 7H9 
broth [supplemented with 50% glycerol, 20% Tween-80 and 10% OADC] until the log phase 
was reached. Glycerol stocks of these cultures were stored at -70 ºC. Prior to infection, these 
stocks were revived and grown until mid-log phase. A549 pulmonary epithelial cells (ATCC 
CCL 185) were infected with each strain at an MOI of ~10:1 in 25 cm
2
tissue culture flasks 
and incubated at 37 ºC in 5% CO2 for 48 hr. 
RNA extraction, sequencing and mapping, and transcript assembly were performed as 




epithelial cells were extracted using the RNeasy kit (Qiagen, South Africa). RNA 
concentrations were quantified using the nanodrop (ThermoScientific, South Africa) and 
stored at -70ºC. The integrity of the RNA was assessed using the Agilent 2100 Bioanalyzer 
(Johns Hopkins Deep Sequencing & Microarray Core Facility, USA). The TruSeq RNA 
Sample Preparation Kit v2 was used to prepare the RNA sequencing library, while the 
Illumina HiSeq platform was used to sequence 50 bp for each sample. The sequencing reads 
were mapped into the UCSC (Homo sapiens) reference genome (Hg19) using TopHat (2.0.9), 
aligned with cufflinks (2.0.2), and differential gene expression between infected and 
uninfected cells were calculated using cuffdiff (Trapnell et al., 2012; Trapnell et al., 2010).  
 
Ingenuity Pathway Analysis 
Differentially expressed genes (Cutoff ≥2) were used to investigate significantly affected 
canonical pathways, gene networks and transcriptional factors induced in pulmonary 
epithelial cells infected with different clinical strains of M. tuberculosis. Changes in 
canonical pathways were investigated with IPA (7.0) (Ingenuity Systems, USA), and an 
enrichment score for each pathway was displayed as a heat map using MeV (4.0.9). The 
networks induced by each of the clinical and laboratory strains were compared by IPA. Genes 
differentially expressed between infected and uninfected pulmonary epithelial cells, and IPA 
hypothetical interacting genes found in the IPA knowledge base system, were used to 
generate networks based on their connectivity with a maximal network size of 35 genes. 
Graphical representation of networks with their scores was computed by IPA. The nodes 
within the networks represent genes and lines indicate biological relationships (direct or 
indirect) with other genes based on published literature within the IPA software. The network 
score is based on hypergeometric distribution and is calculated with the right tailed Fisher‟s 




This did not necessarily reflect the significance of that network but rather an approximation 
of the original focus gene list. IPA listed the top molecular and cellular functions as well as 
physiological system development and function of co-regulated differentially expressed 




Different canonical pathways, networks and transcriptional factors that were activated or 
down-regulated in pulmonary epithelial cells infected with clinical strains of M. tuberculosis 
were identified using IPA. IPA also showed network interrelationships among clinical strains 
and their enrichment scores, based on the involvement of different genes from the input 
dataset. Differential regulation of transcriptional factors was observed with some of these 
being shared among the strains while others were strain specific. 
 
Top 10 canonical pathways 
The top 10 canonical pathways varied among the strains (Table 1). The interferon signalling 
and Hepatic Fibrosis/Hepatic Stellate Cell Activation pathways were among the top 5 
canonical pathways induced by all the strains, while Antigen Presentation was among the top 
10 in all but the Unique strain. The role of pattern recognition receptors for bacteria and 
viruses was induced by the F15/LAM4/KZN, F11, F28 and the H37Rv strains only. The 
super pathway of Cholesterol Biosynthesis was induced by only the Beijing and Unique 
strains, while only the former induced the Cholesterol Biosynthesis I pathway.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   




and beta/retinoid X receptor (LXR/RXR) pathway activation. Communication between innate 
and adaptive cells was induced by the Unique and the H37Rv strains only, whilst granulocyte 
adhesion and diapediesis was induced by all except the F15/LAM4/KZN strain. The 
farnesoid X receptor/ retinoid X receptor (FXR/RXR) activation pathway was induced by 
only the Unique strain. 
 




Table 1:  The top 10 canonical pathways induced by each strain of 















 Genes  
Canonical pathways for the 
F15/LAM4/KZN strain 
Up-regulated  Down-regulated  -log(p-value) 
    
Interferon Signalling 17/36 (47%) 1/36 (3%) 1.30E+01 
Dendritic Cell Maturation 33/179 (18%) 5/179 (3%) 1.20E+01 
Role of Pattern Recognition 








TREM1 Signalling 21/75 (28%) 2/75 (3%) 1.10E+01 








Role of Macrophages, Fibroblasts and 








Atherosclerosis Signalling 26/123 (21%) 2/123 (2%) 9.77E+00 
Antigen Presentation Pathway 15/37 (41%) 0/37 (0%) 9.31E+00 
Acute Phase Response Signalling 30/169 (18%) 2/169 (1%) 8.89E+00 





  Genes  
Canonical 
pathways for the 
Beijing strain  
 
 
Up-regulated Down-regulated -log(p-value) 
    
Hepatic Fibrosis / 
Hepatic Stellate Cell 
Activation 
35/197 (18%) 5/197 (3%) 1.14E+01 




13/29 (45%) 0/29 (0%) 8.58E+00 
Interferon Signalling 13/36 (36%) 1/36 (3%) 8.21E+00 
Atherosclerosis 
Signalling 
24/123 (20%) 2/123 (2%) 8.01E+00 
Granulocyte Adhesion 
and Diapedesis 
29/177 (16%) 3/177 (2%) 7.93E+00 
Acute Phase Response 
Signalling 
27/169 (16%) 4/169 (2%) 7.85E+00 
Antigen Presentation 
Pathway 
13/37 (35%) 0/37 (0%) 7.05E+00 
Agranulocyte Adhesion 
and Diapedesis 
25/189 (13%) 4/189 (2%) 5.70E+00 
Cholesterol 
Biosynthesis I 
7/13 (54%) 0/13 (0%) 5.52E+00 
    
 
 
 Genes  
Canonical 
pathways for the 
F11 strain  
Up-regulated Down-regulated -log(p-value) 
    
Interferon Signalling 20/36 (56%) 1/36 (3%) 1.49E+01 
Hepatic Fibrosis / 
Hepatic Stellate Cell 
Activation 
40/201 (20%) 7/201 (3%) 1.26E+01 
Dendritic Cell 
Maturation 
35/179 (20%) 3/179 (2%) 9.03E+00 
Role of Macrophages, 
Fibroblasts and 








TREM1 Signalling 21/76 (28%) 1/76 (1%) 8.07E+00 
Type I Diabetes 
Mellitus Signalling 
25/111 (23%) 2/111 (2%) 7.93E+00 
Antigen Presentation 
Pathway 
15/37 (41%) 0/37 (0%) 7.92E+00 
Granulocyte Adhesion 
and Diapedesis 
32/179 (18%) 3/179 (2%) 7.41E+00 
Role of Pattern 
Recognition Receptors 
in Recognition of 












  Genes  
Canonical 




Up-regulated Down-regulated -log(p-value) 
    
LXR/RXR Activation 20/121 (17%) 4/121 (3%) 9.80E+00 
Acute Phase Response 
Signalling 
26/169 (15%) 2/169 (1%) 9.40E+00 
Interferon Signalling 12/36 (33%) 1/36 (3%) 9.00E+00 
Granulocyte Adhesion 
and Diapedesis 
23/177 (13%) 1/177 (1%) 6.44E+00 
Hepatic Fibrosis / 
Hepatic Stellate Cell 
Activation 
21/197 (11%) 4/197 (2%) 6.13E+00 
FXR/RXR Activation 18/127 (14%) 1/127 (1%) 5.88E+00 
Super pathway of 
Cholesterol 
Biosynthesis 
9/29 (31%) 0/29 (0%) 5.77E+00 
Role of Tissue Factor in 
Cancer 
12/110 (11%) 5/110 (5%) 5.53E+00 
Atherosclerosis 
Signalling 
15/123 (12%) 2/123 (2%) 4.86E+00 
Communication 
between Innate and 
Adaptive Immune Cells 
11/91 (12%) 3/91 (3%) 4.64E+00 
    
 
 Genes  
Canonical 
pathways for the 
F28 strain  
Up-regulated Down-regulated -log(p-value) 
    
Acute Phase Response 
Signalling 
22/169 (13%) 8/169 (5%) 1.09E+01 
Hepatic Fibrosis / 
Hepatic Stellate Cell 
Activation 
25/197 (13%) 7/197 (4%) 1.06E+01 
LXR/RXR Activation 15/121 (12%) 9/121 (7%) 9.91E+00 
Interferon Signalling 12/36 (33%) 1/36 (3%) 9.07E+00 
Granulocyte Adhesion 
and Diapedesis 
26/177 (15%) 2/177 (1%) 9.05E+00 
Antigen Presentation 
Pathway 
13/37 (35%) 0/37 (0%) 8.90E+00 
Role of Pattern 
Recognition Receptors 
in Recognition of 









23/179 (13%) 3/179 (2%) 7.65E+00 
Role of Macrophages, 
Fibroblasts and 
Endothelial Cells in 
Rheumatoid Arthritis 
28/298 (9%) 6/298 (2%) 7.09E+00 
TREM1 Signalling 14/75 (19%) 1/75 (1%) 6.48E+00 




  Genes  
Canonical pathways for 
the H37Rv strain 
 
 
Up-regulated Down-regulated -log(p-value) 
    
Hepatic Fibrosis / Hepatic Stellate 
Cell Activation 
33/201 (16%) 6/201 (3%) 1.20E+01 
Interferon Signalling 13/36 (36%) 1/36 (3%) 8.87E+00 
Antigen Presentation Pathway 12/37 (32%) 1/37 (3%) 7.65E+00 
Atherosclerosis Signalling 21/124 (17%) 2/124 (2%) 6.99E+00 
Role of Pattern Recognition 
Receptors in Recognition of 







Dendritic Cell Maturation 25/179 (14%) 3/179 (2%) 6.71E+00 
Granulocyte Adhesion and 
Diapedesis 
27/179 (15%) 1/179 (1%) 6.71E+00 
Communication between Innate 
and Adaptive Immune Cells 
18/92 (20%) 1/92 (1%) 6.64E+00 
TREM1 Signalling 16/76 (21%) 1/76 (1%) 6.53E+00 
Role of Macrophages, Fibroblasts 
and Endothelial Cells in 
Rheumatoid Arthritis 




Cholesterol biosynthesis and immune related canonical pathways   
Clinical strains of M. tuberculosis enriched different immune related pathways shown by 
their P-values in the heat map in Fig. 1 and Supplementary Table 2. The Beijing strain 
induced the highest cholesterol biosynthesis via 3 different pathways (I, II and III), followed 
by the Unique and F11 strains while the other 2 clinical strains least affected these pathways. 
The F15/LAM4/KZN and F11 strains induced the highest immune related pathway 
enrichment in epithelial cells compared to other clinical strains. Very little difference was 
observed among the strains in their enrichment scores (P-values) for both the interferon and 
differential regulation of cytokine production in intestinal epithelial cells by IL-17A and IL-
17F.  
The less enriched pathways by all the strains were the inhibition of matrix metalloprotease, 
chemokine signalling, CCR5 signalling in macrophages, STAT3, IL-22 signalling, IL-1 
signalling, CD40 signalling, IL10 signalling and macropinocytosis signalling pathways. A  
higher enrichment for the F15/LAM4/KZN and F11 strains was observed for the TLR, IL-12 
signalling and production in macrophages, IL-6 signalling, iNOS signalling, apoptosis 
signalling, role of JAK1, JAK2 and TYK2 in interferon signalling and IL-15 signalling 
pathways. The highest P-value for the JAK/STAT pathway was induced by the F11 strain 
followed by the F15/LAM4/KZN strain, while the Beijing, Unique and H37Rv strains 
induced least enrichment of this pathway. The different M. tuberculosis strains differentially 
activated epithelial pattern recognition receptors. The F15/LAM4/KZN strain induced the 
highest, while the Unique strain induced the lowest P-values of the epithelial cell pattern 
recognition receptors. Hierarchical clustering for enrichment of immune associated pathways 
revealed similar patterns of pathway enrichment induced by Beijing and Unique strains, 
F15/LAM4/KZN and F11 and F28 and H37Rv strains, respectively (Fig. 1; Appendix C, 





Fig. 1. Heat map showing the P-values of the cholesterol biosynthesis and immune associated 
canonical pathways in pulmonary epithelial cells infected with clinical strains of M. 
tuberculosis at 48 hr post-infection. The highest enrichment was induced by the 
F15/LAM4/KZN and F11 strains in the immune associated pathways while the Beijing and 
Unique strains induced the highest enrichment for the cholesterol biosynthesis pathways 
compared to other strains. Hierarchical clustering indicated similar enrichment profiles 
between the Beijing and Unique strains, the F15/LAM4/KZN and F11 strains and the F28 




Toll-like receptor pathway 
The TLR pathway plays a significant role in the innate immune response in recognition of 
different bacterial cell wall components and nucleic acids in pathogens (Li et al., 2012). In 
the current study, TLR5 and IL-1 were up-regulated by all strains within this pathway. The 
activation of the other TLRs varied among strains (Fig. 2). The H37Rv strain down-regulated 
the expression of TLR1 compared to the clinical strains, whilst the F15/LAM4/KZN, F11 and 
F28 strains up-regulated TLR2. All strains down-regulated the TLR9 which was unaffected by 
the H37Rv strain. The Myeloid differentiation primary response gene (88) (MYD88) that 
facilitates signal transduction in the TLR pathway, was up-regulated by Beijing, F11, 
F15/LAM4/KZN and H37Rv strains. The Interleukin-1 receptor-associated kinase 1 (IRAK) 
gene was up-regulated by all except the Unique strains. Increased IL-12 expression was 
induced by the F11 and F15/LAM4/KZN strains, while the latter and H37Rv strains induced 
an increase in TNF-α gene expression within the pathway. Signal transduction in this 
pathway resulted in activation of transcriptional factors that facilitate transcription of pro-
inflammatory cytokines. The C-Fos transcriptional factor was up-regulated by only the 
Beijing, F11 and Unique strains while NF-κB was only activated by F15/LAM4/KZN and 
F11 strains (Fig. 2).  
 
Interferon signalling pathway  
For all strains, interferon signalling was among the top five enriched pathways that resulted  
in the activation of essential transcriptional factors required for an effective immune response 
in epithelial cells. The F15/LAM4/KZN and F11 strains both activated JAK2 and 
transmembrane receptors (IFNγRα and IFNAR2) together with the IRF1 genes. All strains 




STAT2, TAP1, IFITM3, IFITM1, IFITM2, PSMB8, IFI35, IFIT1, OAS1, MX1 and IFIT3) 
within the pathway. No gene expression changes were observed for the following genes by 
all strains: JAK1, TC-PTP, PIAS1, GIP2, GIP-3, TYK2, IFNR1, BAK, BAX. The SOCS1, 
IFNγRβ, and NF-κB p65 genes were activated only by the F11 strain and not other strains. 
Increased expression of IRF9 was induced by all but Unique strain. No change for the 
IFITM2 gene was observed for the F28 strain while other strains showed an increased 
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Fig. 2. IPA analysis of the toll like receptor and interferon signalling 
pathways induced by the Beijing, F11, F28, H37Rv, 
F15/LAM4/KZN and Unique  strains in pulmonary alveolar 
epithelial cells. Interferon signalling and Hepatic Fibrosis/Hepatic 
Stellate Cell Activation pathways were among the top 5 canonical 
pathways induced by clinical strains. There were differences in some 
of the genes activated/down-regulated by each strain within these 





Top scoring gene networks in pulmonary epithelial cells induced by clinical strains of M. 
tuberculosis 
Gene networks, associated with diverse functions within pulmonary epithelial cells were 
differentially regulated by each strain (Fig. 3). The top scoring networks, with their 
enrichment scores, and their associated molecular functions, induced in pulmonary epithelial 
cells differed among the strains. The highest scoring network (score=33) induced by the 
F15/LAM4/KZN strain, was associated with antimicrobial response. The highest enriched 
network for the Beijing strain was the developmental disorder network (score=47), while the 
organismal injury and abnormality network (score=34) was by the F11 strain. Lipid 
metabolism was the top network (score=40) affected by the genes induced by the F28 strain, 
while the infectious disease network (score=43) was induced by the Unique strain.  Genes 





















































Fig. 3. Top IPA scoring networks induced by the F15/LAM4/KZN, 
Beijing, F11, F28, Unique and H37Rv strains of M. tuberculosis in 
pulmonary epithelial cells at 48 hr post-infection. The top scoring 
networks induced by different strains differed with their associated 
functions and enrichment scores as follows: F15/LAM4/KZN: 
Antimicrobial Response (33), Beijing: Developmental Disorder (47), 
F11: Organismal Injury and Abnormalities (34), F28: Lipid 
Metabolism (40), Unique: Infectious Disease (43), H37Rv: Cellular 





Differential regulation of transcriptional factors by clinical strains of M. tuberculosis  
Transcriptional factors which are located on the upstream region of the genes greatly 
influence gene regulation and pathways within the genome. Some of the changes in pathways 
associated with infection by different strains might be explained by specific regulation of 
each transcriptional factor. In this study, clinical strains of M. tuberculosis differentially 
regulated the expression of diverse transcriptional factors which may be associated with 
complex down-stream molecular changes during infection (Fig. 4; Appendix C, 
Supplementary Table 3). BATF2, EHL, HLF, HLX, IRF7, MSX2, PML, STAT1, STAT2, VDR 
transcriptional factors were induced by all strains, albeit at different fold changes. These 
transcriptional factors were mainly involved in interferon and cytokine signalling pathways. 
Variations in transcriptional factor fold changes were observed for different strain 
combinations.  
Up-regulation of BRCA2, IFI16, IRF9, NLRC5 and STAT5A factors was significantly induced 
by all strains except the Unique strain. The functional categories of these factors include 
immune system processes and cell response to IFN-γ treatment. The F15/LAM4/KZN and 
F11 strain specific transcriptional factors included CYLD, HOXB4, IRF1, IRF8, NFκB1 and 
NFκBIZ that are involved in interferon signalling pathway and other immune system 
processes. The ATF3 and RCAN1 transcriptional factors are involved in repressing gene 
expression including those involved in TLR pathway, while the RCAN1 factor has been 
linked to disease neuropathology. Both ATF3 and RCAN1 were down regulated by the 
H37Rv and Unique strain while the CEBPD factor, associated with immune response, cell 
differentiation, metabolism and cell death, was up-regulated by these strains respectively 





Fig. 4. Fold changes of transcriptional factors induced by clinical strains of M. tuberculosis in 
pulmonary epithelial cells at 48 hr post-infection. Up-stream regulators were identified by the 
IPA software based on published literature and fold changes of transcriptional factors induced 
by each strain are shown as a heat map. Genes are sorted according to their expression fold 
changes: Green-down-regulated, Red-up regulated.  
The TBL1X factor was Beijing specific, and is involved in a variety of functions including 




skeleton assembly. The F11 specific transcriptional factors were ANKRD42, BRCA1, GLI3, 
GLIS2, IRF2, MEIS1, NKX2-5, RELA, RFX5, TFCP2L1 and their functions were NF-κB 
heterodimer formation, transcriptional activator of histone H4 to nuclear translocation and 
activation, normal development, kidney development and neurogenesis. The SOX8 factor was 
specific for the F28 strain and is associated with determination of the cell fate as well as 
regulating the embryonic development. The transcriptional factors EGR2, EN2, MLXIPL, 
MYC, OLIG1 and PPARGC1B that code for proteins required for heterodimeric complex 
formation that activate carbohydrate response elements (ChoRE) motifs and these factors 
were specific for the H37Rv strain.  The transcriptional factor SOX2, crucial for maintaining 
self-renewal, was F15/LAM4/KZN specific. Factors associated with the Unique strain were 
BHLHE41, EGR1, FOSL1, IRF4 and KLF2 which are involved in cell differentiation and 
mitogenesis, cell proliferation, differentiation, and transformation, lung development, 












Table 2: Strain specific transcriptional factors that are regulated by each strain in pulmonary 
epithelial cells 

































Discussion and conclusion  
 
Molecular mechanisms associated with host response to infection by dominant strain families 
of M. tuberculosis in South Africa have been largely unexplored. To our knowledge, this is 
the first in vitro study using RNA-Seq to analyse changes induced in pathways, networks and 
transcriptional factors in pulmonary epithelial cells infected with clinical strains of M. 
tuberculosis. Epithelial cells, because of their increased presence in the alveolar space 




encounter the pathogen, and there is increasing evidence of their involvement in host immune 
response (Lee et al., 2009; Lin et al., 1998; Sato et al., 2002; Sharma et al., 2007).  
The identification of strain specific pathway activation might provide insights into potential 
novel targets that may be useful for the design of host directed immunotherapies or vaccine 
development that take into consideration the genetic heterogeneity of different strain families 
in different geographic settings. Virulent strains may activate certain pathways that will 
beneficiate them, whilst some strains may lack this ability, to the host advantage.    
The present study demonstrated that infection of pulmonary epithelial cells induced changes 
in different canonical pathways, networks and transcriptional factors by different M. 
tuberculosis strains. Enrichment  of  the top 10 immune related canonical pathways was 
differentially induced by each strain in this study. The F15/LAM4/KZN and F11 strain 
activated the most immune related pathways that were highly enriched by these, but not the 
other 4 strains. These pathways included host cell recognition receptors, IL-12 signalling and 
production in macrophages, JAK/STAT signalling, role of JAK1, JAK2 and TYK2 in 
interferon signalling, IL-15 signalling and production pathways, suggestive of some 
similarity in the behaviour between these two strains. These pathway changes differed 
markedly compared to the other 3 clinical strains. The activation of protective immune 
associated pathways alludes to lower virulence of the F15/LAM4/KZN and F11 strains.  
The interferon signalling pathway was among the top 5 activated pathway induced by all 
strains in our study. This may indicate that different types of interferons are induced in 
pulmonary epithelial cells during early infection with M. tuberculosis. This may explain the 
findings of Sharma et al. (2007)   that M. tuberculosis infected epithelial cells are a source of 
IFN-γ (Sharma et al., 2007), mediated by the activation of both types I and II interferon 




clinical strains used in our study. Interferon pathways were shown to differentiate TB 
infection from other infectious diseases (Berry et al., 2010). In contrast, another study 
showed that the interferon pathways were activated by both TB and melioidosis infections 
(Koh et al., 2013) indicating a general host response to both these infections.  These results 
suggest that the interferon signalling pathways are not differentially induced by different 
clinical strains of M. tuberculosis.  
The cholesterol biosynthesis pathways were the most distinguishable canonical pathways 
among the clinical strains. These were highly enriched by the Beijing strain followed by the 
Unique strain compared to the others. These results suggest differences in host metabolism in 
response to different strains of M. tuberculosis, with host lipids preferentially utilized as 
carbon and energy sources during intracellular growth by the Beijing and Unique strains 
compared to others. The need to utilize host cholesterol using the ABC-like transport system 
(Pandey and Sassetti, 2008), as well as the ability of M. tuberculosis to grow and persist 
within cholesterol rich host cells has been well established (Kim et al., 2010; Singh et al., 
2012). Cholesterol  has been shown to be required for M. tuberculosis intracellular adaptation 
and host immune impairment within host cells (Gatfield and Pieters, 2000; Martens et al., 
2008). M. tuberculosis mutants defective in cholesterol utilization and degradation lacked the 
ability to grow in animal models of TB pathogenesis, indicating the importance of cholesterol 
in intracellular persistence and survival within the host (Chang et al., 2009; Pandey and 
Sassetti, 2008; Yam et al., 2009). High cholesterol synthesis induced by the Beijing and 
Unique strains may contribute to higher virulence and persistence within the host cells 
compared to the other strains. This characteristic may be associated with the increased 
virulence of the Beijing strains globally (Glynn et al., 2002), however, this may not 
necessarily be linked to increased transmissibility of the Beijing strain as suggested by the 




Host protective pathways, such as the LXR/RXR pathway, are essential for effective response 
to M. tuberculosis. LXRα and β isoform knockout mice were more susceptible to infection 
with increased bacterial loads, severe lung pathology and decreased TH1 and TH17 functions 
in the lungs (Korf et al., 2009), compared to the wild type mice following treatment  with 
LXR agonists. In our study, this pathway was among the top 10 induced by the F11, F28 and 
Unique strains only. This is suggestive of a potential protective immune response induced by 
these strains within host epithelial cells. This may be the molecular mechanism responsible 
for the low prevalence of the Unique compared to the Beijing strains within the population, 
despite the ability of the former to induce an increase in cholesterol biosynthesis required for 
intracellular survival. It is possible that the prevalence and spread of F11 and F28 strains 
within the South African population (Chihota et al., 2012; Victor et al., 2004) may be due to 
alternative molecular mechanisms despite the induction of the LXR/RXR pathway by these 
strains.  
The LXR activation pathway has been identified as a potential pathway to be explored for 
host directed therapy (Hawn et al., 2013). Thus, the diversity exhibited in this pathway 
among clinical strains should be an important consideration in the design of such therapies. 
LXR influenced the activation of the RXR which forms a complex and modulates gene 
expression (Hawn et al., 2013). In the current study, RXR activation was induced only by the 
Unique strain in the top 10 canonical pathways, indicating a potent gene expression 
heterodimer complex formed between the LXR and RXR to induce an increased protective 
response by this strain.  
The diversity observed in the TLR pathway may not necessarily be due to the interaction of 
strain specific components of the different M. tuberculosis strains. The rationale for this 
thinking is that the RNA was sampled at 48 hr post-infection, while attachment and invasion 




can induce differential gene expression of the TLRs. The least enrichment of TLR pathway 
was induced by the Unique strain compared to other clinical strains. Low enrichment of this 
pathway by the Beijing, F28 and Unique strains  may be the molecular mechanism associated 
with the low production of pro-inflammatory cytokines induced by these strains compared to 
other clinical strains (Chapter 2), since stimulation of TLRs results in the production of pro-
inflammatory cytokines (Mitchell et al., 2010).  
The ATF3 transcriptional factor is known to negatively regulate expression of TLRs 
(Whitmore et al., 2007). This inverse relationship was not observed in the current study, since 
significant down-regulation of ATF3 only by Unique and H37Rv strains did not result in an 
increased enrichment of the TLR in both these strains. However, the diversity in the 
expression of TLRs induced by the different strains may be attributable to the differences 
observed in this transcriptional factor. Interestingly, the NFκB and NFκB1 transcriptional 
factors that positively regulate the TLR pathway was induced by only the F15/LAM4/KZN 
and F11 strains, which maybe suggestive of a protective host immune response as this factor 
is involved in production of pro-inflammatory cytokines (Giacomini et al., 2010). These 
results provide further support for the postulation that the F15/LAM4/KZN and F11 strains 
are associated with lower virulence than the other 3 strains. Whilst the  potential of the TLRs 
for therapeutic purposes is still under investigation (Helbig et al., 2013), TLR antagonists that 
exploit differential TLR activation may represent an effective strategy to fight Mycobacterial 
infections.  
Strain specific networks induced in host cells may serve as novel targets for anti-tuberculosis 
treatment by understanding the functional categories involved in these networks. The 
F15/LAM4/KZN strain showed an increased antimicrobial response network in pulmonary 
epithelial cells compared to other strains. While epithelial cells may not directly possess a 




to produce cytokines and chemokines through activation of crucial transcriptional factors 
such as IRFs might result in reduced bacterial replication at the infection site. These 
transcriptional factors (IRF1, IRF8) were up-regulated within the F15/LAM4/KZN and F11 
infected epithelial cells, which may also explain higher immune related pathway enrichment 
compared to other clinical strains, (Fig. 4, Table 2). They were  also shown to be essential in 
the innate responses to infection (Liu and Ma, 2006; Shin et al., 2011). Gene networks 
induced by the Beijing, F11, F28 and Unique strains were strain specific, with diverse gene 
interaction and regulation by different clinical strains of M. tuberculosis in pulmonary 
epithelial cells.  
Differentially regulated immune related and lipid metabolism networks were identified in 
macrophages infected with the Beijing and CDC1551 strains at an earlier time of infection 
Koo et al. (2012). The CDC1551 strain up-regulated the immune related network while the 
Beijing strain up-regulated the lipid metabolism network at 6 hr post-infection (Koo et al., 
2012). Subbian et al. (2013) reported higher enrichment of the macrophage activation 
network in the Beijing (HN878) strain in infected rabbit lungs compared to the CDC1551 
strain at 3 hr post-infection. Compared to these studies, we observed differential network 
regulation by each clinical strain, accompanied by varying levels of activation in pulmonary 
epithelial cells. Furthermore, the highest scoring network for lipid metabolism was induced 
by the F28 strain and not the Beijing strain as was reported in macrophages by Koo et al. 
(2012). These differences might be attributed to cell specific response and differences 
between pulmonary epithelial cells and macrophages when infected by clinical strains as well 
as differences in sampling time.  
In conclusion, this study demonstrated strain specific molecular pathways, and networks in 
epithelial cells induced by clinical strains representing major strain families in South Africa. 




complex down-stream changes in pathways and networks induced by these strains. This study 
provides further supporting evidence that hypervirulent strains such as the Beijing strain, 
invoke lower protective host responses, as displayed by low enrichment of the immune 
related pathways compared to the F15/LAM4/KZN, F11 and F28 genotypes. An unusual 
discovery was the similarity in the immune related and cholesterol pathways of the non-
clustering Unique genotype to the Beijing strain, which suggests that despite its low 
transmissibility, this strain may be more virulent than expected, and warrants further study. 
The strain components that affect changes in these canonical pathways and networks will be 




















CHAPTER 5: GENERAL DISCUSSION 
The current study evaluated the in vitro response of pulmonary epithelial cells infected by 
various clinical strains of M. tuberculosis by quantifying cytokine production at 24-, 48- and 
72- hr post infection, as well as gene expression and pathway regulation at 48 hr. The clinical 
strains elicited different epithelial cell responses, suggesting the recognition of different 
virulence factors among these strains. The Beijing and Unique strains induced lower 
protective responses as evidenced by lower cytokine production, and least enrichment of 
immune associated pathways compared to other clinical strains. A low gene expression was 
observed for the Unique strain while the Beijing strain induced higher levels of gene 
expression (Chapter 3). Therefore, cytokine/chemokine production did not correlate with 
gene expression by the Beijing strain indicated by lower cytokine production (Chapter 2) and 
high gene expression (Chapter 3), suggesting the involvement of other mechanisms and 
interactions that result in lower cytokine production compared to other clinical strains. 
Furthermore, similarities were also observed between the Beijing and Unique strains to 
induce increased enrichment of the cholesterol pathways that have been associated with 
intracellular persistence of M. tuberculosis within host cells (Gatfield and Pieters, 2000; 
Martens et al., 2008) compared to other clinical strains suggesting a preference for lipids as 
carbon and energy source by both these strains at 48 hr after infection. This hypothesis on 
differences in lipid preferences by clinical strains remains to be tested in future studies 
involving other cell types and in vivo infection models. 
The global prevalence of the Beijing strains (Bifani et al., 2002; Glynn et al., 2002; Nguyen 
et al., 2012; Streicher et al., 2012) may be due to lower protective immune response induced 
within the host compared to other clinical strains (Manca et al., 2004). Surprisingly, a similar 
response was induced by the less prevalent non-clustering Unique strain, which may suggest 




undertaken in order to understand similarities between these strains. Moreover, the in vitro 
(Koo et al., 2012; Manca et al., 2004) and in vivo (Manca et al., 1999; Manca et al., 2001; 
Subbian et al., 2013) studies performed  on the Beijing strains revealed induction of delayed 
TH1 response, low pro-inflammatory cytokines and high anti-inflammatory cytokine 
production in macrophages (Manca et al., 2004). This behaviour by the Beijing strain may be 
attributed to the constitutive expression of the DosR regulon responsible for the synthesis of 
phenolic glycolipid components that have only been identified in the Beijing family (Reed et 
al., 2004; Sinsimer et al., 2008). These lipid fractions in the Beijing genotype resulted in a 
lower protective host response and earlier mortality in Beijing infected mice compared to 
those infected with the CDC1551 and laboratory strains (Manca et al., 1999). This might also 
explain low cytokine production and enrichment of the immune associated pathways 
observed in pulmonary epithelial cells in our study. Collectively, these attributes may be 
responsible for the higher transmissibility of this hypervirulent strain.  
The Beijing, F15/LAM4/KZN, F11 and F28 strains were included in this study due to their 
dominance within the South African population (Chihota et al., 2012; Pillay and Sturm, 2007; 
Streicher et al., 2012). Compared to the Beijing and Unique strains, the F15/LAM4/KZN, 
F11 and F28 strains induced higher cytokine/chemokine production, immune associated gene 
expression and pathway enrichment. These were pro-inflammatory and some of the anti-
inflammatory cytokines as well as chemokines, transcriptional factor activation such as NFκB 
and crucial immune associated pathway enrichment that included JAK-STAT, TLR 
signalling, and cytokine/chemokine signalling pathways required for protective immune 
response (Desvignes and Ernst, 2009; Khader and Gopal, 2010; Korf et al., 2009). This 
suggests that the transmission and persistence of F15/LAM4/KZN, F11 and F28 strains 
within the population may be associated with other factors such as drug resistance, including 




and treatment strategies in South Africa, rather than hypervirulence attributes such as those 
identified in the Beijing strain.   
This study has increased our understanding of the role of epithelial cells in the immune 
response to different clinical strains of M. tuberculosis. The abundance of these cells in the 
lungs ensures first encounter with M. tuberculosis and can orchestrate downstream changes 
within the lungs depending on the infecting strain. Moreover, these findings have the 
potential to identify useful biomarkers as targets for alternative TB therapeutics including 
immuno-modulators that take into consideration strain specific pathways, network regulations 
and strain specific molecular signatures. Several speculations and hypothesis from this study 
remains to be confirmed in future pathogenesis studies to get a different perspective and 
better understanding of our findings.  
 
LIMITATIONS, CHALLENGES AND RECOMMENDATIONS 
A major limitation in the current study was the lack of knowledge of different virulence 
factors harboured by the clinical strains that might explain differential cytokine production, 
gene expression and pathway changes in pulmonary epithelial cells. These virulence factors 
may range from lipid components, cellular appendages and secretory proteins that can 
modulate the immune response in a strain specific manner. Another limitation was the lack of 
literature on previous pathogenesis studies using a wide range of clinical strains that might 
have enabled understanding the epithelial cells cytokine/gene expression and pathway 
patterns observed in the current study. This was an in vitro study focusing only on one cell 
type during early infection. Due to financial and time constraints, further experiments to 
understand the mechanisms underlying the results obtained, could not be performed. Nor 
could in vivo studies be undertaken in order to confirm and support our in vitro findings, 




Another major challenge was the extensive bioinformatics analysis of the vast amount of data 
generated by the RNA-Seq. The current common transcriptomic microarray technique has an 
optimized pipeline for analysis, unlike RNA-Seq, for which numerous tools and software 
packages are required, the application of which poses serious challenges for a laboratory 
based biologist. 
Future recommendations will entail understanding the influence of strain identity in the 
outcome of infection in mice and human models and individuals infected with clinical M. 
tuberculosis strains of varying pathogenicity that are dominant within the South African 
population. This will enable a better understanding of tissue pathology, in vivo immune cell 
trafficking and granuloma formation induced in a strain specific manner. Moreover, strain-
specific virulence factors that are expressed and required for pathogenesis within different 
infection models  should be identified and characterized. This will provide better 
understanding of the differential and specific immune responses induced clinical strains of M. 
tuberculosis in pulmonary epithelial cells. Studies to determine differential 
cytokine/chemokine responses induced by these strains in humans will require well 
characterized biorepositories. Furthermore, the current RNA-Seq database will be analysed in 
greater depth to elucidate differential isoform switching and splicing events induced by these 
clinical strains which might have implications on the functioning of the immune system 
proteins.   
 
CONCLUSION 
This study provides further support that pulmonary epithelial cells are not just a passive 
protective barrier against M. tuberculosis but significantly contribute to the innate immune 




differentially induced by different clinical strains of M. tuberculosis and can influence 
downstream changes due to infection by these strains. This study also reveals the in depth 
transcriptome analysis of pulmonary epithelial cells that had not been previously investigated 
despite the abundance of these cells in the alveolar space.  
Differences in cytokine/chemokine production, global gene expression and pathway specific 
changes identified in the current study has opened doors for further investigation of 
associated virulence factors within these clinical strain. Furthermore, identification of strain 
specific molecular signatures, pathways and transcriptional factors can be explored for 
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LIST OF APPENDICES 
APPENDIX A 
Supplementary Table 1: The mean ± SEM of the cytokine/chemokine concentrations induced by clinical strains of M. tuberculosis at 0, 24, 48 
and 72 hr post-infection 
Cytokine Time Uninfected  F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
IL1ra 0 hr 22.24±0.5 23.97±4 19.69±0.75 19.69±0.25 0.31±0.25 31.97±5.75 3.72±0.5 
 24 hr 27.48 ±  2 29.26 ± 1.5 10.07±1.25 29.26 ± 2 10.07 ± 0.25 15.56±0.5 14.76 ± 0.25 
 48 hr 23.10 ± 2.75 99.94 ± 2 33.80 ± 3.75 53.87 ± 4 15.56 ± 2.5 137.16±4.75 65.96 ± 2 
 72 hr 42.22 ± 2 253.58 ± 32.5 117.74±3.5 47.99 ± 3.5 115.49 ± 5.5 91.23 ± 0 116.61 ± 1.25 
IL-2 0 hr 3.52±3.5 4.52±3.5 3.52±3.5 3.52±3.5 3.52±3.5 3.52±3.5 3.52±3.5 
 24 hr 3.50 ± 3.5 3.50 ± 0.75 3.50 ± 1.25 3.50 ± 0.5 3.50 ± 3.75 3.50 ± 0.5 3.50 ± 2.75 
 48 hr 3.50 ± 2.5 15.11 ± 4.75 3.50 ± 0.5 3.52 ± 0.5 3.50 ± 2 23.43 ± 14.75 4.44 ± 4 
 72 hr 3.52 ± 3.5 42.48 ± 3.5 8.34 ± 7 3.50 ± 3.25 14.64 ± 7.75 4.73 ± 4.5 9.25 ± 3.25 
IL-4 0 hr 1.70±1.25 1.34±0.5 1.49±0.5 1.05±1 0.89±0.5 2.12±2 0.74±1 
 24 hr 1.19 ± 0 2.05 ± 0.5 1.41 ± 0.25 1.41 ± 1.75 1.34 ± 0 2.05 ± 0.5 2.25 ± 1.75 
 48 hr 1.70 ± 0.25 5.51 ± 2 3.12 ± 1.5 2.19 ± 0 1.63 ± 1 8.64 ± 5.75 6.35 ± 1.5 
 72 hr 1.98 ± 0.25 12.24 ± 2.75 5.20 ± 0.25 3.89 ± 0.5 8.12 ± 1 6.95 ± 1 7.83 ± 0.25 
IL-6 0 hr 1.15±0.5 1.15±1 1.15±0.5 1.15±0.5 1.15±0.5 4±1.5 1.15±0.5 
 24 hr 1.15 ± 0.25 161.4 ± 22.5 627.26 ± 20.5 107.58 ± 21 530.04 ± 77 1531.01 ± 173.25 2292.69 ± 79.75 





Cytokine Time Uninfected  F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
IL-7 0 hr 2.77±0 9.93±0.5 2.77±0.25 2.77±1.5 2.77±0.5 2.77±0.75 2.77±0.5 
 24 hr 14.45 ± 2.5 12.2 ± 0.5 4.19 ± 1 3.02 ± 2.5 5.35 ± 0.5 12.76 ± 1.25 17.81 ± 3 
 48 hr 55.61 ± 2.25 53.99 ± 1.5 25.59 ± 2.5 23.93 ± 3.75 3.02 ± 1.5 132.38 ± 20.75 60.47 ± 1.5 
 72 hr 131.33 ± 8.25 113.35 ± 12.75 49.11 ± 14.25 45.31 ± 11 143.45 ± 25.5 66.4 ± 0.25 99.55 ± 5.75 
IL-8 0 hr 1.95±0.25 1.95±0.5 1.95±0.5 1.95±0.5 1.95±0.25 1.95±0.5 1.95±1.5 
 24 hr 11.30 ± 2.25 97.70 ± 35.75 199.58 ± 30.5 90.06 ± 43.75 282.97 ± 147 990.44 ± 160.25 510.29 ± 66.5 
 48 hr 32.63 ± 2 38972.00 ± 182.25 28854.37 ± 110.75 30717.73 ± 569.25 1.95 ± 0.5 24298.97 ± 3083.25 26667.46 ± 2684 
 72 hr 77.64 ± 29.25 48804.12 ± 507.5 3100.87 ± 1120.5 29926.60 ± 642.25 32025.49 ± 2983 28469.73 ± 225.5 7500.41 ± 484.5 
IL-9 0 hr 5.93±0.25 23.73±2 2.96±2.5 2.70±2 2.96±3.5 8.03±5.75 2.96±1.25 
 24 hr 23.13 ± 2 39.78 ± 4 32.26 ± 1 28.58 ± 2 27.35 ± 1 36.00 ± 3 24.93 ± 5 
 48 hr 31.64 ± 0.5 79.45 ± 6 44.25 ± 5 59.24 ± 2 9.38 ± 0.5 83.22 ± 20.25 46.18 ± 0 
 72 hr 47.47 ± 7 162.49 ± 50 71.29 ± 0 47.79 ± 3.25 76.72 ± 9 48.44 ± 2.25 56.27 ± 5.25 
IL-10 0 hr 1.5±0.5 1.5±0.25 1.5±1.25 1.5±0.25 1.5±0.25 1.5±0.25 1.5±0.5 
 24 hr 3.79 ± 1.25 1.5 ± 0.5 1.5 ± 0.25 1.5 ± 0.5 1.5 ± 0.5 1.5 ± 1.01 1.5 ± 0.5 
 48 hr 45.13 ± 12.25 43.27 ± 13.75 10.44 ± 5 16.63 ± 10 1.5 ± 1.25 79.1 ± 26 48.02 ± 6.5 
 72 hr 86.74 ± 21.5 79.23 ± 21.5 34.74 ± 11 30.4 ± 12.25 84.9 ± 24.25 52.85 ± 20 64.81 ± 4.25 
IL-12p70 0 hr 9.31±2.5 42.12±2.5 9.56±2.75 9.43±5 9.18±2.5 9.18±0.5 9.18±1.5 
 24 hr 80.86 ± 17.5 64.73 ± 12.5 28.73 ± 1.25 29.76 ± 10 39.95 ± 16 72.26 ± 14.5 44.31 ± 8 
 48 hr 428.69 ± 39.5 348.43 ± 27.75 116.63 ± 4.5 152.88 ± 42.75 39.95 ± 10 890.63 ± 322.5 431.22 ± 68.5 
 72 hr 1090.97 ± 215 779.62 ± 165.75 295.89 ± 23 298.26 ± 107 956.58 ± 229.75 498.38 ± 28 651.17 ± 19 





Cytokine Time Uninfected  F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
 48 hr 39.02 ± 7.42 38.09 ± 18.38 11.71 ± 5.55 11.71 ± 4.4 1.96 ± 1.6 62.83 ± 21.77 37.92 ± 5.66 
 72 hr 70.33 ± 28.24 65.09 ± 35.15 26.34 ± 11.42 33.22 ± 13.54 64.22 ± 20.51 43.98 ± 20.15 47.75 ± 19.09 
IL-17 0 hr 43.09±1 42.3±1.5 46.25±2 24.81±0.5 23.21±7.5 67.52±28.5 6.25±5 
 24 hr 39.52 ± 3.75 48.62 ± 4.5 39.92 ± 0.5 41.11 ± 15.25 6.66 ± 4.25 12.35 ± 3.75 12.76 ± 3 
 48 hr 30.39 ± 5.5 61.23 ± 8.5 35.96 ± 3.5 48.23 ± 17.75 31.58 ± 2.75 37.15 ± 0.75 6.25 ± 5 
 72 hr 35.16 ± 3 116.34 ± 33.75 109.73 ± 19 56.51 ± 21.5 47.83 ± 4 36.75 ± 1 37.15 ± 5.75 
Eotaxin 0 hr 10.74±6.75 9.79±5 10.45±4.75 10±0.5 9.79±1.5 9.88±5.75 9.78±4 
 24 hr 8.79 ± 1.5 40.52 ± 2.25 8.79 ± 4 26.68 ± 4.5 8.79 ± 5.75 8.79 ± 2.5 8.79 ± 6 
 48 hr 8.79 ± 3.75 162.46 ± 5.25 8.79 ± 4.5 84.07 ± 3.25 8.79 ± 1.25 167.76 ± 13.75 8.79 ± 3.25 
 72 hr 68.74 ± 5 256.40 ± 36 160.55 ± 1.25 8.79 ± 1.5 117.2 ± 11.5 8.79 ± 0.5 48.75 ± 5.5 
G-CSF 0 hr 8.8±1.5 8.8±0.25 8.8±1.5 8.8±1 8.8±0.75 8.8±2 8.8±0.75 
 24 hr 3.54 ± 0.5 221.42 ± 0 421.54 ± 0 121.54 ± 0 289.54 ± 1.5 1107.01 ± 12 2090.42 ± 0.5 
 48 hr 7.54 ± 1 4454.84 ± 27 6900.56 ± 0 547.71 ± 11.75 5.54 ± 1.5 32735.56 ± 1660.5 17522.52 ± 651.75 
 72 hr 23.54 ± 3 21460 ± 279 250.64 ± 131.5 860.92 ± 17.25 10963.86 ± 460 1527.8 ± 92.5 1309.98 ± 160.75 
GM-CSF 0 hr 13.68±3.5 27.40±6 8.31±2.5 14.85±4 7.29±3.5 8.64±4 7.29±5.5 
 24 hr 2.45 ± 2.25 4.07 ± 4 5.19 ± 4 2.62 ± 2.30 9.98 ± 7.25 20.99 ± 5.5 36.78 ± 10 
 48 hr 3.30 ± 2.00 180.40 ± 30.75 27.90 ± 12 22.22 ± 12.5 134.97 ± 6.5 735.16 ± 10.75 190.98 ± 34.75 
 72 hr 42.19 ± 15.25 818.17 ± 230.5 69.70 ± 26.5 7.29 ± 2 219.36 ± 26.5 0.98 ± 1.25 397.07 ± 0 
IFN-γ 0 hr 0.03±0 28.08±0.5 30.96±0.75 1.25±0.15 2.5±1.5 3±0.5 8.69±1.5 
 24 hr 3.63 ± 0.5 48.35 ± 0.25 62.96 ± 0.5 33.84 ± 0.5 11.00 ± 2 80.60 ± 0.5 54.18 ± 1.75 






Cytokine Time Uninfected  F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
IP-10 0 hr 10.13±0.5 19.37±0.5 10.13±0.5 10.13±1.5 10.13±2 9.91±2.25 10.13±0.25 
 24 hr 4.11 ± 1 95.85 ± 2 62.94 ± 0.75 8.90 ± 0.5 279.08 ± 1.75 795.9 ± 3.25 386.16 ± 0.5 
 48 hr 8.90 ± 0.25 9487.01 ± 191.5 2275.50 ± 25 235.62 ± 4 8.90 ± 0.75 9464.02 ± 601.75 4998.51 ± 56.5 
 72 hr 28.44 ± 3 29159.77 ± 580.5 2610.58 ± 212 871.72 ± 31.25 24233.67 ± 238.25 3495.49 ± 87.5 10973.59 ± 152.25 
MCP-1 0 hr 16.16±2.5 76.77±20.75 1.40±1.25 1.42±0.25 1.42±0.25 1.42±0.5 1.42±0.25 
 24 hr 100.48 ± 2.5 661.86 ± 279 472.12 ± 5 327.81 ± 191 1125.35 ± 220.75 3380.68 ± 904 1493.60 ± 167.25 
 48 hr 180.77 ± 58 19816.96 ± 209.25 12363.67 ± 477 11294.67 ± 2133.25 14.16 ± 3 8802.30 ± 1593.75 14353.83 ± 903.75 
 72 hr 243.12 ± 68 4929.45 ± 131.75 11943.59 ± 382.5 10205.41 ± 239.5 14688.81 ± 166.5 7747.75 ± 186.5 5014.35 ± 379.75 
MIP-1α 0 hr 1.34±1 1.34±0.5 1.34±0.25 1.34±0.5 1.34±1 1.34±1.25 1.34±0.5 
 24 hr 3.33 ± 1.75 3.33 ± 1 8.44 ± 1.5 3.33 ± 1.5 3.33 ± 2 10.21 ± 0.5 45.88 ± 2.5 
 48 hr 7.33 ± 0.5 76.48 ± 6.5 70.22 ± 11.75 12.88 ± 0.75 45.56 ± 0 189.12 ± 21.1 288.75 ± 39 
 72 hr 9.33 ± 2.5 511.88 ± 109.5 14.33 ± 2.5 13.33 ± 0.75 141.46 ± 61.5 238.12 ± 64.5 390.56 ± 40.5 
PDGF-bb 0 hr 1.15±0.5 6.80±1 1.15±1.25 1.15±0.5 1.15±0.25 1.15±1 1.15±0.25 
 24 hr 0.14 ± 1 6.80 ± 0 4.94 ± 0.5 0.14 ± 1 0.14 ± 0.5 7.72 ± 1.25 0.14 ± 0 
 48 hr 0.14 ± 1.75 55.15 ± 0.75 19.43 ± 0.5 30.90 ± 0.75 19.43 ± 1.5 106.87 ± 11 45.68 ± 0 
 72 hr 31.77 ± 2 101.83 ± 12.5 153.59 ± 16 26.51 ± 4.5 83.27 ± 8 95.10 ± 2.5 81.58 ± 2.5 
MIP-1β 0 hr 1.67±0.75 1.67±0.5 1.67±0.75 1.67±0.25 1.67±1 1.67±1.25 1.67±0.5 
 24 hr 6.50 ± 0.25 6.50 ± 3.5 10.98 ± 1.5 3.11 ± 3 18.34 ± 2 32.15 ± 3 77.81 ± 2.75 
 48 hr 6.44 ± 3 78.02 ± 1.75 64.19 ± 1 10.54 ± 3.25 5.88 ± 2.5 55.11 ± 12.5 96.77 ± 24 
 72 hr 6.50 ± 6 125.45 ± 24.5 6.50 ± 6 6.50 ± 2.25 13.96 ± 7.25 6.50 ± 2.5 10.13 ± 1.75 





Cytokine Time Uninfected  F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
 48 hr 8.83 ± 0.5 739.56 ± 1.5 425.05 ± 0.25 40.40 ± 0 6.86 ± 0.75 2415.47 ± 557 1236.08 ± 392.5 
 72 hr 22.93 ± 2.5 347.27 ± 35.75 29.61 ± 6 23.59 ± 2.25 507.54 ± 92.25 148.19 ± 34 287.24 ± 66.5 
TNF-α 0 hr 4.22±0.75 4.60±1.5 10.76±2.5 1.96±0.25 1.59±0.5 1.59±1.25 1.59±0.25 
 24 hr 2.71 ± 1.25 4.60 ± 0.75 5.36 ± 3 4.60 ± 4.5 4.60 ± 0.5 19.59 ± 0.5 36.84 ± 2 
 48 hr 1.33 ± 1.5 201.11 ± 5.5 30.87 ± 0.5 4.84 ± 2 2.60 ± 1.5 456.28 ± 10.75 98.65 ± 0.5 
 72 hr 6.90 ± 1 520.77 ± 31.5 42.45 ± 9.5 13.09 ± 3 258.58 ± 6.5 353.73 ± 0.5 45.67 ± 0.5 
VEGF 0 hr 50.75±6.75 252.83±21.5 8.23±5.5 8.23±1.5 8.23±6.5 36.38±5.31 8.23±4 
 24 hr 645.08 ± 31.5 494.67 ± 59 256.21 ± 1.25 231.98 ± 77.75 343.74 ± 19.5 447.18 ± 45.75 368.47 ± 26.25 
 48 hr 4891.7 ± 85.75 3508.1 ± 22.75 1067.04 ± 59.5 1116.48 ± 286.25 447.48 ± 33.5 10559.76 ± 746 3944.56 ± 2 




Supplementary Table 2: Fold changes of 23 analytes detected by Bio-plex system 
 
M. tuberculosis F15/LAM4/KZN strain M. tuberculosis Beijing strain M. tuberculosis F11 strain M. tuberculosis F28 strain M. tuberculosis Unique strain M. tuberculosis H37Rv strain  
 
24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 
IL1ra 1.06 4.33 3 0.37 1.46 2.79 0.37 0.67 2.74 0.57 5.94 2.16 1.06 2.33 1.14 0.54 2.86 2.76 
IL-2 1 4.31 12.07 1 1 2.37 1 1 4.16 1 6.69 0.57 1 1 1 1 1.27 2.63 
IL-4 1.72 3.24 6.18 1.18 1.84 2.23 1.13 0.96 4.1 1.72 5.08 3.51 1.18 1.29 1.96 1.89 3.74 3.95 
IL-6 140.34 42688.69 3038.5 545.44 9715.22 537.56 460.9 27.01 2623.14 1331.31 51113.73 3702.14 93.55 1196.62 215.29 1993.64 31389.85 3462.91 
IL-7 0.84 0.97 0.86 0.29 0.46 0.37 0.37 0.05 1.09 0.88 2.38 0.51 0.21 0.43 0.35 1.23 1.09 0.76 
IL-8 8.64 1194.36 628.6 17.66 884.29 39.94 25.04 0.06 412.49 87.65 744.68 366.69 7.97 941.4 385.45 45.16 817.27 96.6 
IL-9 1.72 2.51 3.42 1.39 1.4 1.5 1.18 0.3 1.62 1.56 2.63 1.02 1.24 1.87 1.01 1.08 1.46 1.19 
IL-10 0.4 0.96 0.91 0.4 0.23 0.4 0.4 0.03 0.98 0.4 1.75 0.61 0.4 0.37 0.35 0.4 1.06 0.75 
IL-12p70 0.8 0.81 0.71 0.36 0.27 0.27 0.49 0.09 0.88 0.89 2.08 0.46 0.37 0.36 0.27 0.55 1.01 0.6 
IL-13 1 0.98 0.93 1 0.3 0.37 1 0.05 0.91 1 1.61 0.63 1 0.3 0.47 1 0.97 0.68 
IL-17 1.23 2.01 3.31 1.01 1.18 3.12 0.17 1.03 1.36 0.31 1.22 1.04 1.04 1.59 1.61 0.32 0.21 1.06 
Eotaxin 4.61 18.48 3.73 1 1 2.33 1 1 1.7 1 1 0.12 3.03 9.56 0.13 1 1 0.71 
G-CSF 62.54 590.83 911.64 119.08 915.19 10.65 81.79 0.73 465.75 312.71 4341.59 64.9 34.33 72.64 36.57 590.51 2323.94 55.65 
GM-CSF 1.66 54.67 19.39 2.12 8.45 1.65 4.07 40.9 5.2 8.57 222.78 0.02 1.07 6.73 0.17 15.01 57.87 9.41 
IFN-γ 13.32 6.49 10.84 17.34 2.41 4.65 3.03 0.29 0.83 22.2 12.89 5.34 9.32 2.11 2.78 14.93 7.6 6.8 
IP-10 23.32 1065.96 1025.31 15.31 255.67 91.79 67.9 1 852.1 193.65 1063.37 122.91 2.17 26.47 30.65 93.96 561.63 385.85 
MCP-1 6.59 109.63 20.28 4.7 68.39 49.13 11.2 0.08 60.42 33.65 48.69 31.87 3.26 62.48 41.98 14.86 79.4 20.63 
MIP-1α 1 10.43 54.86 2.53 9.58 1.54 1 6.22 15.16 3.06 25.8 25.52 1 1.76 1.43 13.78 39.39 41.86 
PDGF-
bb 48.57 393.93 3.2 35.29 138.79 4.83 1 138.79 2.62 55.14 763.21 2.99 1 220.71 0.83 1 326.29 2.57 
MIP-1β 1 12.11 19.3 1.7 9.97 1 2.82 0.91 2.15 4.94 8.56 1 0.48 1.64 1 11.97 15.03 1.56 
Rantes 3.5 83.76 15.14 6.45 48.14 1.29 3.27 0.78 22.13 7.15 273.55 6.46 3.5 4.58 1.03 21.81 139.99 12.53 
TNF-α 1.7 151.21 75.47 1.98 23.21 6.15 1.7 1.95 37.48 7.23 343.07 51.27 1.7 3.64 1.9 13.59 74.17 6.62 




Supplementary Table 3: Statistical analysis between uninfected and infected epithelial cells and among clinical strains for 23 analytes 
IL-1ra 
IL-1ra: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected 1 0.5499 0.0179 0.5931 0.0131 0.0286 0.0242 
F15/LAM4/KZN  1 0.0102 1.0000 0.0062 0.0131 0.0108 
Beijing   1 0.0148 1.0000 0.0552 0.0668 
Unique    1 0.0109 0.0219 0.0188 
F11     1 0.0102 0.0057 
F28      1 0.2844 
H37Rv       1 
 
IL-1ra: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0020 0.1481 0.0240 0.1796 0.0023 0.0062 
F15/LAM4/KZN   0.0041 0.0093 0.0014 0.0186 0.0069 
Beijing    0.0672 0.0560 0.0034 0.0170 
Unique     0.0148 0.0055 0.1139 
F11      0.0019 0.0040 
F28       0.0052 
H37Rv        
 
IL-1ra: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0229 0.0028 0.2886 0.0063 0.0018 0.0010 
F15/LAM4/KZN   0.0533 0.0244 0.0525 0.0378 0.0520 
Beijing    0.0050 0.7629 0.0173 0.7898 
Unique     0.0092 0.0066 0.0029 
F11      0.0481 0.8610 
F28       0.0028 





IL-2: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected 1 1 1 1 1 1 1 
F15/LAM4/KZN  1 1 1 1 1 1 
Beijing   1 1 1 1 1 
Unique    1 1 1 1 
F11     1 1 1 
F28      1 1 
H37Rv       1 
 
IL-2: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.1630 0.7327 0.9945 1.0000 0.3143 0.8605 
F15/LAM4/KZN   0.1185 0.1360 0.1531 0.6451 0.2279 
Beijing    0.2859 0.6756 0.2919 0.6778 
Unique     0.9931 0.3098 0.8407 
F11      0.3125 0.8530 
F28       0.3400 
H37Rv        
 
IL-2: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0158 0.6007 0.9970 0.3211 0.8516 0.3531 
F15/LAM4/KZN   0.0487 0.0147 0.0820 0.0221 0.0200 
Beijing    0.5946 0.6076 0.7067 0.9169 
Unique     0.3161 0.8452 0.3374 
F11      0.3840 0.5870 
F28       0.5010 






IL-4: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.3480 0.7319 0.9148 0.8517 0.3480 0.6192 
F15/LAM4/KZN   0.3708 0.7587 0.4211 1.0000 0.9225 
Beijing    1.0000 0.9118 0.3708 0.6815 
Unique     0.9728 0.7587 0.7666 
F11      0.4211 0.6667 
F28       0.9225 
H37Rv        
 
IL-4: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.1993 0.4490 0.4732 0.9520 0.3512 0.0924 
F15/LAM4/KZN   0.4400 0.2486 0.2248 0.6583 0.7688 
Beijing    0.6160 0.4954 0.4510 0.2673 
Unique     0.6661 0.3800 0.1192 
F11      0.3527 0.1201 
F28       0.7371 
H37Rv        
 
IL-4: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0654 0.0118 0.0760 0.0270 0.0404 0.0036 
F15/LAM4/KZN   0.1255 0.0962 0.2945 0.2124 0.2513 
Beijing    0.1438 0.1053 0.2317 0.0176 
Unique     0.0633 0.1116 0.0195 
F11      0.4951 0.8049 
F28       0.4832 






IL-6: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0192 0.0011 0.0368 0.0205 0.0126 0.0012 
F15/LAM4/KZN   0.0042 0.2225 0.0442 0.0159 0.0015 
Beijing    0.0032 0.3468 0.0353 0.0024 
Unique     0.0339 0.0147 0.0014 
F11      0.0341 0.0039 
F28       0.0574 
H37Rv        
 
IL-6: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0001 0.0013 0.1665 0.0931 0.0001 0.0001 
F15/LAM4/KZN   0.0003 0.0003 0.0001 0.0077 0.0028 
Beijing    0.0060 0.0013 0.0003 0.0006 
Unique     0.1722 0.0003 0.0005 
F11      0.0001 0.0001 
F28       0.0013 
H37Rv        
 
IL-6: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0042 0.0006 0.0220 0.0001 P<0.0001 P<0.0001 
F15/LAM4/KZN   0.0062 0.0050 0.1737 0.0803 0.1654 
Beijing    0.0116 0.0002 0.0001 P<0.0001 
Unique     0.0003 0.0002 P<0.0001 
F11      0.0015 0.0012 
F28       0.0155 






IL-7: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.4706 0.0625 0.0838 0.0703 0.6069 0.4802 
F15/LAM4/KZN   0.0189 0.0692 0.0105 0.7178 0.2064 
Beijing    0.7063 0.4085 0.0332 0.0499 
Unique     0.4572 0.0734 0.0632 
F11      0.0315 0.0547 
F28       0.2604 
H37Rv        
 
IL-7: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.6099 0.0123 0.0185 0.0026 0.0666 0.2141 
F15/LAM4/KZN   0.0104 0.0176 0.0017 0.0638 0.0925 
Beijing    0.7480 0.0163 0.0362 0.0069 
Unique     0.0353 0.0358 0.0120 
F11      0.0249 0.0014 
F28       0.0745 
H37Rv        
 
IL-7: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.3581 0.0378 0.0246 0.6954 0.0158 0.0872 
F15/LAM4/KZN   0.0783 0.0561 0.4018 0.0665 0.4278 
Beijing    0.8524 0.0840 0.3489 0.0816 
Unique     0.0716 0.1953 0.0486 
F11      0.0943 0.2351 
F28       0.0288 






IL-8: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0323 0.0254 0.2140 0.2059 0.0258 0.0173 
F15/LAM4/KZN   0.0972 0.8846 0.3368 0.0310 0.0264 
Beijing    0.1764 0.6344 0.0400 0.0512 
Unique     0.3354 0.0324 0.0341 
F11      0.0829 0.2942 
F28       0.1095 
H37Rv        
 
IL-8: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  P<0.0001 P<0.0001 0.0003 0.0045 0.0158 0.0100 
F15/LAM4/KZN   0.0004 0.0052 P<0.0001 0.0416 0.0446 
Beijing    0.0847 P<0.0001 0.2778 0.5011 
Unique     0.0003 0.1772 0.2779 
F11      0.0157 0.0100 
F28       0.6209 
H37Rv        
 
IL-8: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0001 0.1144 0.0005 0.0086 P<0.0001 0.0042 
F15/LAM4/KZN   0.0007 0.0019 0.0310 0.0007 0.0003 
Beijing    0.0023 0.0119 0.0020 0.0691 
Unique     0.5626 0.1657 0.0013 
F11      0.3566 0.0148 
F28       0.0006 






IL-9: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0652 0.0551 0.1938 0.1998 0.0703 0.7700 
F15/LAM4/KZN   0.2097 0.1292 0.0947 0.5286 0.1462 
Beijing    0.2416 0.0739 0.3585 0.2871 
Unique     0.6375 0.1758 0.5678 
F11      0.1117 0.6818 
F28       0.1980 
H37Rv        
 
IL-9: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0155 0.1288 0.0055 0.0010 0.1258 0.0024 
F15/LAM4/KZN   0.0459 0.0856 0.0073 0.8748 0.0312 
Beijing    0.1085 0.0201 0.2027 0.7379 
Unique     0.0017 0.3598 0.0240 
F11      0.0677 0.0004 
F28       0.2090 
H37Rv        
 
IL-9: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.1504 0.0769 0.9707 0.1243 0.9071 0.4205 
F15/LAM4/KZN   0.2097 0.1493 0.2334 0.1503 0.1690 
Beijing    0.0190 0.6081 0.0100 0.1043 
Unique     0.0942 0.8845 0.3033 
F11      0.0929 0.1887 
F28       0.3040 






IL-10: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.2311 0.2143 0.2311 0.2311 0.2902 0.2311 
F15/LAM4/KZN   1 1 1 1 1 
Beijing    1 1 1 1 
Unique     1 1 1 
F11      1 1 
F28       1 
H37Rv        
 
IL-10: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.9288 0.1199 0.2133 0.0712 0.3587 0.8542 
F15/LAM4/KZN   0.1540 0.2577 0.0941 0.3473 0.7844 
Beijing    0.6355 0.2249 0.1221 0.0445 
Unique     0.2721 0.1541 0.1191 
F11      0.0965 0.0197 
F28       0.3659 
H37Rv        
 
IL-10: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.8280 0.1642 0.1505 0.9599 0.3677 0.4224 
F15/LAM4/KZN   0.2068 0.1872 0.8772 0.4638 0.5782 
Beijing    0.8168 0.2003 0.5107 0.1255 
Unique     0.1827 0.4395 0.1175 
F11      0.4152 0.5002 
F28       0.6178 






IL-12p70-24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.5315 0.0971 0.1267 0.2266 0.7415 0.1979 
F15/LAM4/KZN   0.1033 0.1605 0.3467 0.7320 0.3027 
Beijing    0.9279 0.5568 0.0960 0.1942 
Unique     0.6432 0.1373 0.3737 
F11      0.2732 0.8302 
F28       0.2335 
H37Rv        
 
IL-12p70: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.2383 0.0158 0.0418 0.0108 0.2910 0.9774 
F15/LAM4/KZN   0.0144 0.0617 0.0090 0.2359 0.3791 
Beijing    0.4878 0.0198 0.1385 0.0445 
Unique     0.1237 0.1515 0.0748 
F11      0.1188 0.0299 
F28       0.2981 
H37Rv        
 
IL-12p70: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.3701 0.0667 0.0808 0.7109 0.1119 0.1785 
F15/LAM4/KZN   0.1017 0.1348 0.5960 0.2363 0.5219 
Beijing    0.9847 0.1035 0.0306 0.0070 
Unique     0.1217 0.2121 0.0832 
F11      0.1863 0.3163 
F28       0.0457 






IL-13: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  1 1 1 1 1 1 
F15/LAM4/KZN   1 1 1 1 1 
Beijing    1 1 1 1 
Unique     1 1 1 
F11      1 1 
F28       1 
H37Rv        
 
IL-13: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.9413 0.0800 0.0870 0.0395 0.4093 0.9169 
F15/LAM4/KZN   0.1013 0.1082 0.0515 0.4000 0.9881 
Beijing    1.0000 0.1293 0.1464 0.0593 
Unique     0.1727 0.1480 0.0673 
F11      0.1081 0.0257 
F28       0.3835 
H37Rv        
 
IL-13: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.9181 0.2855 0.3578 0.8772 0.5268 0.5758 
F15/LAM4/KZN   0.4044 0.4866 0.9849 0.6543 0.7069 
Beijing    0.7352 0.2480 0.5258 0.4374 
Unique     0.3344 0.7009 0.5980 
F11      0.5544 0.6162 
F28       0.9044 






IL-17: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.2605 0.9254 0.9286 0.0285 0.0361 0.0307 
F15/LAM4/KZN   0.1946 0.6832 0.0211 0.0251 0.0220 
Beijing    0.9449 0.0162 0.0183 0.0123 
Unique     0.1615 0.2085 0.2097 
F11      0.4212 0.3617 
F28       0.9397 
H37Rv        
 
IL-17: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0930 0.4829 0.4383 0.8644 0.3475 0.0832 
F15/LAM4/KZN   0.1108 0.5768 0.0800 0.1060 0.0307 
Beijing    0.5676 0.4288 0.7712 0.0397 
Unique     0.4518 0.5965 0.1506 
F11      0.1899 0.0472 
F28       0.0257 
H37Rv        
 
IL-17: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.1388 0.0606 0.4291 0.1268 0.6650 0.7880 
F15/LAM4/KZN   0.8802 0.2735 0.1814 0.1425 0.1468 
Beijing    0.2048 0.0859 0.0617 0.0673 
Unique     0.7298 0.4555 0.4761 
F11      0.1151 0.2668 
F28       0.9516 






Eotaxin-24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0072 1.0000 0.0637 1.0000 1.0000 1.0000 
F15/LAM4/KZN   0.0203 0.1106 0.0358 0.0111 0.0384 
Beijing    0.0971 1.0000 1.0000 1.0000 
Unique     0.1339 0.0738 0.1398 
F11      1.0000 1.0000 
F28       1.0000 
H37Rv        
 
Eotaxin: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0018 1.0000 0.0043 1.0000 0.0079 1.0000 
F15/LAM4/KZN   0.0020 0.0061 0.0012 0.7532 0.0016 
Beijing    0.0054 1.0000 0.0082 1.0000 
Unique     0.0021 0.0273 0.0037 
F11      0.0075 1.0000 
F28       0.0078 
H37Rv        
 
Eotaxin: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0355 0.0031 0.0075 0.0070 0.0609 0.1149 
F15/LAM4/KZN   0.1170 0.0205 0.0664 0.0205 0.0294 
Beijing    0.0002 0.0644 P<0.0001 0.0025 
Unique     0.0113 1.0000 0.0198 
F11      0.0111 0.0330 
F28       0.0186 






G-CSF: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  P<0.0001 P<0.0001 P<0.0001 P<0.0001 0.0001 P<0.0001 
F15/LAM4/KZN   P<0.0001 P<0.0001 0.0005 0.0002 P<0.0001 
Beijing    P<0.0001 0.0001 0.0003 P<0.0001 
Unique     P<0.0001 0.0001 P<0.0001 
F11      0.0002 P<0.0001 
F28       0.0001 
H37Rv        
 
G-CSF: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  P<0.0001 P<0.0001 0.0005 0.3828 0.0026 0.0014 
F15/LAM4/KZN   0.0001 P<0.0001 P<0.0001 0.0034 0.0025 
Beijing    P<0.0001 P<0.0001 0.0041 0.0037 
Unique     0.0005 0.0027 0.0015 
F11      0.0026 0.0014 
F28       0.0135 
H37Rv        
 
G-CSF: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0002 0.2264 0.0004 0.0018 0.0038 0.0153 
F15/LAM4/KZN   0.0002 0.0002 0.0026 0.0002 0.0003 
Beijing    0.0441 0.0020 0.0155 0.0364 
Unique     0.0021 0.0193 0.1089 
F11      0.0025 0.0025 
F28       0.3611 






GM-CSF: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.7578 0.6111 0.9627 0.4258 0.0892 0.0788 
F15/LAM4/KZN   0.8614 0.7831 0.5494 0.1306 0.0935 
Beijing    0.6335 0.6214 0.1458 0.0992 
Unique     0.4353 0.0911 0.0796 
F11      0.3499 0.1622 
F28       0.3007 
H37Rv        
 
GM-CSF: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0290 0.1805 0.2736 0.0027 0.0002 0.0327 
F15/LAM4/KZN   0.0438 0.0413 0.2852 0.0034 0.8408 
Beijing    0.7742 0.0159 0.0005 0.0472 
Unique     0.0153 0.0005 0.0447 
F11      0.0004 0.2540 
F28       0.0044 
H37Rv        
 
GM-CSF: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0275 0.4632 0.1513 0.0285 0.1146 0.0018 
F15/LAM4/KZN   0.0302 0.0249 0.0461 0.0246 0.0841 
Beijing    0.1433 0.0574 0.1223 0.0065 
Unique     0.0153 0.1159 P<0.0001 
F11      0.0144 0.0215 
F28       P<0.0001 






IFN-γ: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0002 0.0001 0.0005 0.0701 P<0.0001 0.0013 
F15/LAM4/KZN   0.0015 0.0015 0.0029 0.0003 0.0809 
Beijing    0.0006 0.0016 0.0016 0.0404 
Unique     0.0080 0.0002 0.0079 
F11      0.0009 0.0038 
F28       0.0047 
H37Rv        
 
IFN-γ: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  P<0.0001 0.0004 0.0006 0.0015 0.0011 0.0002 
F15/LAM4/KZN   P<0.0001 P<0.0001 P<0.0001 0.0037 0.0079 
Beijing    0.0016 P<0.0001 0.0014 0.0004 
Unique     P<0.0001 0.0013 0.0003 
F11      0.0009 0.0002 
F28       0.0057 
H37Rv        
 
IFN-γ: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0008 0.0012 0.0063 0.4852 0.0005 0.0005 
F15/LAM4/KZN   0.0020 0.0012 0.0010 0.0023 0.0047 
Beijing    0.0044 0.0025 0.0107 0.0026 
Unique     0.0109 0.0015 0.0010 
F11      0.0016 0.0011 
F28       0.0031 






Uninfected Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
F15/LAM4/KZN  0.0006 0.0005 0.0504 P<0.0001 P<0.0001 P<0.0001 
Beijing   0.0042 0.0006 0.0002 P<0.0001 P<0.0001 
Unique    0.0003 P<0.0001 P<0.0001 P<0.0001 
F11     P<0.0001 P<0.0001 P<0.0001 
F28      P<0.0001 0.0003 
H37Rv       P<0.0001 
Uninfected        
 
IP-10: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0004 0.0001 0.0003 1.0000 0.0040 0.0001 
F15/LAM4/KZN   0.0007 0.0004 0.0004 0.9743 0.0020 
Beijing    0.0002 0.0001 0.0069 0.0005 
Unique     0.0003 0.0042 0.0001 
F11      0.0040 0.0001 
F28       0.0178 
H37Rv        
 
IP-10: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0004 0.0067 0.0014 P<0.0001 0.0006 0.0002 
F15/LAM4/KZN   0.0005 0.0004 0.0158 0.0005 0.0011 
Beijing    0.0148 0.0002 0.0611 0.0010 
Unique     0.0001 0.0013 0.0002 
F11      0.0001 0.0005 
F28        






MCP-1: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.1819 0.0002 0.3561 0.0434 0.0683 0.0141 
F15/LAM4/KZN   0.5667 0.4273 0.3225 0.1028 0.1249 
Beijing    0.5289 0.0978 0.0845 0.0258 
Unique     0.1119 0.0807 0.0443 
F11      0.1363 0.3150 
F28       0.1765 
H37Rv        
 
MCP-1: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0001 0.0016 0.0349 0.1031 0.0326 0.0041 
F15/LAM4/KZN   0.0048 0.0578 0.0001 0.0206 0.0276 
Beijing    0.6732 0.0015 0.1656 0.1908 
Unique     0.0340 0.4481 0.3175 
F11      0.0314 0.0039 
F28       0.0938 
H37Rv        
 
MCP-1: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0010 0.0011 0.0006 0.0002 0.0007 0.0065 
F15/LAM4/KZN   0.0033 0.0027 0.0005 0.0065 0.8523 
Beijing    0.0613 0.0223 0.0101 0.0060 
Unique     0.0042 0.0149 0.0074 
F11      0.0013 0.0018 
F28       0.0231 






MIP-1α: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  1.0000 0.1569 1.0000 1.0000 0.0634 0.0051 
F15/LAM4/KZN   0.1052 1.0000 1.0000 0.0254 0.0040 
Beijing    0.1376 0.1776 0.3793 0.0060 
Unique     1.0000 0.0490 0.0047 
F11      0.0793 0.0056 
F28       0.0051 
H37Rv        
 
MIP-1α: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0088 0.0332 0.0254 0.0003 0.0132 0.0187 
F15/LAM4/KZN   0.6869 0.0104 0.0417 0.0363 0.0330 
Beijing    0.0397 0.1709 0.0389 0.0330 
Unique     0.0008 0.0140 0.0194 
F11      0.0209 0.0248 
F28       0.1537 
H37Rv        
 
MIP-1α: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0444 0.2929 0.2651 0.1649 0.0712 0.0111 
F15/LAM4/KZN   0.0452 0.0450 0.0983 0.1640 0.4079 
Beijing    0.7385 0.1749 0.0741 0.0114 
Unique     0.1726 0.0734 0.0113 
F11      0.3914 0.0774 
F28       0.1833 






PDGF-bb: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0270 0.0502 1.0000 1.0000 0.0418 1.0000 
F15/LAM4/KZN   0.1192 0.0270 0.0111 0.5649 0.0111 
Beijing    0.0502 0.0210 0.1749 0.0210 
Unique     1.0000 0.0418 1.0000 
F11      0.0301 1.0000 
F28       0.0301 
H37Rv        
 
PDGF-bb: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0012 0.0088 0.0038 0.0140 0.0107 0.0016 
F15/LAM4/KZN   0.0006 0.0019 0.0022 0.0426 0.0089 
Beijing    0.0061 1.0000 0.0155 0.0007 
Unique     0.0207 0.0204 0.0037 
F11      0.0157 0.0036 
F28       0.0309 
H37Rv        
 
PDGF-bb: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0311 0.0171 0.3973 0.0247 0.0025 0.0041 
F15/LAM4/KZN   0.1255 0.0297 0.3376 0.6503 0.2531 
Beijing    0.0167 0.0590 0.0688 0.0470 
Unique     0.0252 0.0056 0.0086 
F11      0.2936 0.8589 
F28       0.0621 






MIP-1β: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  1.0000 0.0985 0.3771 0.0278 0.0135 0.0015 
F15/LAM4/KZN   0.3605 0.5386 0.0990 0.0308 0.0039 
Beijing    0.1435 0.0986 0.0242 0.0022 
Unique     0.0517 0.0207 0.0030 
F11      0.0619 0.0033 
F28       0.0079 
H37Rv        
 
MIP-1β: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0023 0.0030 0.4518 0.8991 0.0632 0.0648 
F15/LAM4/KZN   0.0206 0.0030 0.0018 0.2112 0.5174 
Beijing    0.0040 0.0021 0.5443 0.3078 
Unique     0.3736 0.0747 0.0706 
F11      0.0610 0.0638 
F28       0.2636 
H37Rv        
 
MIP-1β: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0421 1.0000 1.0000 0.5110 1.0000 0.6201 
F15/LAM4/KZN   0.0421 0.0402 0.0487 0.0403 0.0425 
Beijing    1.0000 0.5110 1.0000 0.6201 
Unique     0.4294 1.0000 0.3308 
F11      0.4333 0.6587 
F28       0.3563 






Rantes: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0256 0.0062 0.0564 0.0263 0.0070 0.0005 
F15/LAM4/KZN   0.0096 1.0000 0.3829 0.0123 0.0003 
Beijing    0.0331 0.0059 0.2467 0.0005 
Unique     0.7007 0.0277 0.0010 
F11      0.0093 0.0002 
F28       0.0010 
H37Rv        
 
Rantes: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  P<0.0001 P<0.0001 0.0005 0.1604 0.0496 0.0237 
F15/LAM4/KZN   P<0.0001 P<0.0001 P<0.0001 0.0950 0.1232 
Beijing    P<0.0001 P<0.0001 0.0702 0.0520 
Unique     0.0007 0.0508 0.0250 
F11      0.0495 0.0237 
F28       0.1833 
H37Rv        
 
Rantes: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0033 0.4121 0.8626 0.0215 0.0352 0.0297 
F15/LAM4/KZN   0.0034 0.0033 0.2252 0.0074 0.0255 
Beijing    0.4467 0.0222 0.0409 0.0316 
Unique     0.0216 0.0354 0.0298 
F11      0.0421 0.1244 
F28       0.1172 






TNF-α: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.3242 0.5005 0.7249 0.2955 0.0063 0.0047 
F15/LAM4/KZN   0.8288 1.0000 1.0000 0.0036 0.0044 
Beijing    0.9011 0.8260 0.0428 0.0129 
Unique     1.0000 0.0804 0.0225 
F11      0.0022 0.0041 
F28       0.0140 
H37Rv        
 
TNF-α: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0008 0.0029 0.2955 0.6102 0.0006 0.0003 
F15/LAM4/KZN   0.0011 0.0009 0.0008 0.0022 0.0029 
Beijing    0.0062 0.0031 0.0006 0.0001 
Unique     0.4648 0.0006 0.0005 
F11      0.0006 0.0003 
F28       0.0009 
H37Rv        
 
TNF-α: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0037 0.0652 0.1894 0.0007 P<0.0001 0.0008 
F15/LAM4/KZN   0.0047 0.0039 0.0147 0.0338 0.0044 
Beijing    0.0984 0.0028 0.0009 0.7672 
Unique     0.0008 P<0.0001 0.0086 
F11      0.0047 0.0009 
F28       P<0.0001 






VEGF: 24 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.1535 0.0065 0.0389 0.0148 0.0705 0.0213 
F15/LAM4/KZN   0.0561 0.1148 0.1358 0.5898 0.1899 
Beijing    0.7848 0.0465 0.0529 0.0507 
Unique     0.2979 0.1398 0.2382 
F11      0.1730 0.5284 
F28       0.2742 
H37Rv        
 
VEGF: 48 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0041 0.0007 0.0062 0.0004 0.0171 0.0081 
F15/LAM4/KZN   0.0007 0.0141 0.0002 0.0110 0.0027 
Beijing    0.8813 0.0119 0.0062 0.0004 
Unique     0.1460 0.0071 0.0101 
F11      0.0054 P<0.0001 
F28       0.0125 
H37Rv        
 
VEGF: 72 hr Uninfected F15/LAM4/KZN Beijing Unique F11 F28 H37Rv 
Uninfected  0.0075 0.0064 0.0038 0.0030 0.0024 0.0027 
F15/LAM4/KZN   0.0220 0.0119 0.0184 0.0096 0.0141 
Beijing    0.9449 0.0484 0.0763 0.0528 
Unique     0.0242 0.0384 0.0261 
F11      0.0260 0.2112 
F28       0.0223 





Supplementary Table 4: Colony forming units obtained from infected pulmonary epithelial cells by clinical strains of M. tuberculosis. 
 
  24 hr (x10
6
)  48 hr (x10
6
)  72 hr (x10
6
) 
F15/LAM4/KZN  1.56 1.66 1.58  2.64 2.77 2.65  2.44 2.37 2.55 
F11  0.3 0.3 0.3  16 13 14  0.24 0.27 0.23 
F28  0.7 0.4 0.2  13 10 9.4  10 13 9.9 
Beijing  3.7 3.7 4.6  2.7 2.6 3.6  0.03 0.026 0.042 
Unique  0.98 0.8 1.1  5.6 5.3 4.8  2.2 2 1.9 
H37Rv  0.2 0.2 0.4  1.7 1.6 1.9  0.2 0.1 0.3 











Supplementary table 5: Statistical analysis of the cfu/ml for clinical strains of M. tuberculosis at 24, 48 and 72 hr post-infection 
24 hr F15/LAM4/KZN Beijing F11 F28 Unique H37Rv 
F15/LAM4/KZN 1 0.0164 0.0017 0.0177 0.0302 0.0038 
Beijing  1 0.0052 0.0139 0.0060 0.0039 
F11   1 0.6220 0.0101 0.1835 
F28    1 0.1091 0.4975 
Unique     1 0.0056 
H37Rv      1 
 
48 hr F15/LAM4/KZN Beijing F11 F28 Unique H37Rv 
F15/LAM4/KZN 1 0.4985 0.0061 0.0189 0.0083 0.0158 
Beijing  1 0.0072 0.0271 0.0517 0.0340 
F11   1 0.0220 0.0073 0.0048 
F28    1 0.0261 0.0156 
Unique     1 0.0075 
H37Rv      1 
 
72 hr F15/LAM4/KZN Beijing F11 F28 Unique H37Rv 
F15/LAM4/KZN 1 0.0004 0.0007 0.0152 0.0739 P<0.0001 
Beijing  1 0.0045 0.0086 0.0020 0.0888 
F11   1 0.0089 0.0018 0.5286 
F28    1 0.0132 0.0097 
Unique     1 0.0043 








MOP gels and nanodrop readings of the RNA samples 
 
Integrity of the A549 uninfected controls (t=0-12 h) 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=0 (a) 1041.2 2.07 
3-T=0 (b) 1040.2 2.06 
4-T=0 (c) 807.1 2.05 
5-T=1 (a) 865.4 2.08 
6-T=1 (b) 1216.4 2.07 
7-T=1 (c) 841.8 2.05 
8-T=2 (a) 439.6 2.05 
9-T=2 (b) 639.5 2.02 
10-T=2 (c) 849.6 2.06 
11-T=4 (a) 1040.7 2.07 

















13-T=4 (c) 779.3 2.05 
14-T=8 (a) 936 2.06 
15-T= 8 (b) 1491.5 2.07 
16-T=8 (c) 1688 2.08 
17-T=12 (a) 1167.3 2.07 
18-T=12 (b) 1040.3 2.07 















RNA integrity of the A549 uninfected controls (t=24-72 h) 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=24 (a) 1033.9 2.08 
3-T=24 (b) 1109.2 2.07 
4-T=24 (c) 947.8 2.07 
5-T=48 (a) 626.6 2.08 
6-T=48 (b) 594.3 2.06 
7-T=48 (c) 403.6 2.07 
8-T=72 (a) 525.4 2.07 
9-T=72 (b) 544.9 2.07 
10-T=72 (c) 578.8 2.06 
 





RNA integrity of the A549 cells infected with the F15/LAM4/KZN (t=0-12 h) strain 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=0 (a) 752.7 2.05 
3-T=0 (b) 881.8 2.06 
4-T=0 (c) 1065.3 2.08 
5-T=1 (a) 970.2 2.07 
6-T=1 (b) 993.3 2.06 
7-T=1 (c) 684.3 2.07 
8-T=2 (a) 826.1 2.08 
9-T=2 (b) 965.1 2.06 
10-T=2 (c) 930.1 2.06 
11-T=4 (a) 957.1 2.08 
12-T=4 (b) 889.2 2.07 
13-T=4 (c) 899.4 2.06 
14-T=8 (a) 1091.7 2.07 




15-T= 8 (b) 850 1.99 
16-T=8 (c) 658.1 2.06 
17-T=12 (a) 1011.9 2.08 
18-T=12 (b) 1067.7 2.08 















RNA integrity of the A549 cells infected with the F15/LAM4/KZN (t=24-72 h) and F11 (t=0-
48 h) strains 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=24 (a) 868 2.08 
3-T=24 (b) 664.7 2.06 
4-T=24 (c) 972.4 2.06 
5-T=48 (a) 573.6 2.07 
6-T=48 (b) 528.2 2.07 
7-T=48 (c) 454.8 2.05 
8-T=72 (a) 315.2 2.08 
9-T=72 (b) 257.2 2.09 
 10-T=72 (c) 307.3 2.1 
11-T=0 (a) 1159.6 2.07 
12-T=0 (b) 1374.0 2.07 
13-T=0 (c) 1087 2.05 




  14-T=24 (a) 653 2.02 
  15-T=24 (b) 927 2.06 
 16-T=24 (c) 597.8 2.04 
 17-T=48 (a) 311.8 2.12 
 18-T=48 (b) 268.3 2.12 















RNA integrity of the A549 cells infected with the F11 (t=72 h), F28 (t=0-72 h) and H37Rv 
(t=0) strains 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=72 (a) 169.8 2.05 
3-T=72 (b) 152.3 2.06 
4-T=72 (c) 144.0 2.13 
5-T=0 (a) 1191.9 2.05 
6-T=0 (b) 1026.9 2.06 
7-T=0 (c) 940.1 2.05 
8-T=24 (a) 478.8 2.07 
9-T=24 (b) 626.7 2.05 
10-T=24 (c) 630.4 2.04 
11-T=48 (a) 310.8 2.11 
12-T=48 (b) 341.6 2.11 
13-T=48 (c) 337.7 2.13 
14-T=72 (a) 173.4 2.06 




15-T=72 (b) 231.7 2.06 
16-T=72 (c) 154.6 2.04 
17-T=0 (a) 872.4 2.05 
18-T=0 (b) 951.5 2.06 















RNA integrity of the A549 cells infected with the H37Rv (t=24-72) strain 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=24 (a) 461.6 2.07 
3-T=24 (b) 797.5 2.06 
4-T=24 (c) 764.9 2.07 
5-T=48 (a) 484.5 2.06 
6-T=48 (b) 472.2 2.06 
7-T=48 (c) 536.3 2.06 
8-T=72 (a) 237.0 2.35 
9-T=72 (b) 190.2 2.44 
10-T=72 (c) 174.6 2.49 
 





RNA integrity of the A549 cells infected with the Beijing (t=0-72 h) and Unique (t=0-24 h) 
strains 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=0 (a) 872.6 2.05 
3-T=0 (b) 1032.3 2.05 
4-T=0 (c) 1053.2 2.05 
5-T=24 (a) 683.5 2.08 
6-T=24 (b) 592.9 2.07 
7-T=24 (c) 658.5 2.07 
8-T=48 (a) 349.3 2.1 
9-T=48 (b) 250.5 2.13 
10-T=48 (c) 516 2.07 
11-T=72 (a) 239.2 2.09 
12-T=72 (b) 250 2.11 
13-T=72 (c) 101 2.09 
14-T=0 (a) 952.1 2.05 




15-T=0 (b) 1191.1 2.06 
16-T=0 (c) 1222.6 2.08 
17-T=24 (a) 614.2 2.06 
18-T=24 (b) 754.6 2.08 

















RNA integrity of the A549 cells infected with the Unique (t=48-72) strain 
Well Concentration (ng/µl) Purity (260/280) 
1-Marker   
2-T=48 (a) 418.8 2.07 
3-T=48 (b) 621.9 2.06 
4-T=48 (c) 445.1 2.06 
5-T=72 (a) 225.8 2.09 
6-T=72 (b) 195.1 2.1 
7-T=72 (c) 192.7 2.1 
 
Supplementary Fig. 1. RNA integrity of uninfected and infected A549 pulmonary epithelial 











Supplementary Table 1: Fold changes of 292 genes that are shared by all clinical and 
laboratory strains of M. tuberculosis 
Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
ACSL4 3.95838 4.6745 3.64264 4.38683 2.69558 4.10799 
ACSL5 4.58701 5.21155 4.30048 4.20811 3.12627 4.19116 
ADAM12 2.42838 4.13885 3.04329 4.04269 3.11493 4.66463 
ADAMTS9 6.22784 7.02038 5.32867 6.83322 4.97676 6.79308 
ADRB1 -2.2721 -2.29451 -2.24894 -2.56921 -2.28405 -2.89337 
AHSG 4.02042 6.53805 2.69623 5.56956 8.53399 4.0639 
ANGPTL6 3.14373 3.3847 2.09323 3.11962 2.03544 2.69788 
ANPEP 3.73722 3.17803 2.90657 4.09735 2.94155 5.11184 
ANXA8L2 2.25175 2.45336 2.42793 2.55801 2.04274 2.69691 
AOC3 -2.94626 -3.24766 -2.12678 -2.8296 -3.4655 -3.00166 
APOE -3.19 -4.07381 -4.19631 -4.38964 -3.32049 -3.35683 
APOL1 5.45298 6.42466 4.56305 5.86027 3.80488 5.57883 
APOL2 4.07432 4.96193 2.93634 4.60532 3.1803 4.23785 
ASS1 4.27331 4.34895 3.93794 4.10729 3.04284 3.70079 
ATP8B5P 3.9557 4.74668 3.00928 4.47799 3.62639 3.65453 
BATF2 6.11848 6.78011 4.74164 6.26566 4.47917 5.39188 
BCL11B 2.51099 4.31509 2.94439 4.55339 3.5058 4.65524 
BCL2 -2.83312 -3.91041 -3.41378 -3.80404 -3.60599 -3.93982 
BCL2A1 8.06049 8.22911 6.55853 6.49439 3.13755 6.63116 
BCL2L10 -3.55142 -3.28198 -2.14562 -4.22732 -2.51236 -2.44587 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
BST2 9.7693 9.43184 8.23892 8.88134 6.25715 7.55367 
C11orf86 4.29992 5.6979 4.0394 4.59557 3.72714 4.55155 
C11orf96 5.66344 7.04047 4.82876 6.44274 3.70353 5.27796 
C15orf48 8.08707 8.48302 7.94532 7.37778 4.01893 7.25585 
C15orf59 -2.55366 -3.05516 -2.18932 -2.87253 -2.80165 -2.69079 
C19orf66 3.28763 3.59127 2.33067 3.2656 2.21606 2.97096 
C1orf116 3.03719 3.57772 3.01244 3.55947 3.59936 2.8864 
C1R 6.48452 6.78924 5.84026 6.59977 4.76978 6.03363 
C1RL 3.23041 3.45233 2.96796 3.3705 2.85479 2.79296 
C1S 5.12931 5.47894 4.41702 5.50867 4.02233 4.71449 
C3 4.74323 5.07983 4.34649 5.41176 4.21993 4.6084 
C4orf33 3.29961 3.37358 2.01048 3.15943 2.5044 2.81636 
C6orf223 2.4958 3.05224 2.29333 3.25658 2.27782 2.98117 
CA9 5.39769 8.07752 5.4973 8.34871 9.41324 7.54376 
CABLES1 -3.80536 -3.5787 -2.12735 -3.16049 -2.67859 -2.38645 
CAPN5 -3.65628 -4.49155 -2.55737 -3.70291 -2.50324 -3.73097 
CARD9 -2.4034 -3.69586 -2.27297 -3.82755 -4.01661 -2.76954 
CATSPERB 4.45359 3.84058 3.88304 4.281 2.13068 2.87125 
CCL2 5.62672 5.40018 3.4407 3.78896 2.73086 2.2771 
CCL20 6.57196 6.98019 5.33902 6.16308 3.3272 5.60776 
CCL5 7.39263 9.01358 7.74906 6.05803 2.61885 7.06112 
CD274 6.50107 6.80733 3.77581 5.41016 2.45992 3.99845 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
CD68 4.13386 4.72129 3.01219 4.24285 2.03879 3.79736 
CDA 2.84561 4.0074 3.86327 3.99375 2.92631 4.39304 
CDCP1 3.44433 4.28639 4.15668 4.13 2.56783 4.96767 
CDH24 -2.51608 -3.62037 -2.82694 -2.92197 -2.14061 -3.48186 
CDKL2 -2.47484 -4.22421 -2.33364 -4.83609 -2.2792 -2.75572 
CEACAM5 3.29609 4.72502 4.6511 4.7551 2.31839 2.66775 
CEACAM7 4.09309 4.13843 4.49313 5.60659 3.35412 3.80277 
CFB 8.94072 9.51435 8.17166 8.94312 6.70465 7.80353 
CHI3L2 3.97803 5.55162 3.09243 4.70855 2.85864 3.0718 
CLEC4E 10.0401 10.866 10.4537 9.69265 6.62845 9.63749 
CLMP 4.54489 5.3177 5.39004 4.67276 2.08349 6.51259 
CMPK2 9.82841 9.57136 8.73052 9.07116 7.84263 8.74077 
CNTD2 -3.58449 -3.61801 -3.31387 -4.81994 -4.39259 -2.99902 
COL11A2 -4.02084 -3.53354 -3.19964 -3.69393 -4.10295 -2.17089 
COL22A1 5.8534 6.80898 7.39715 6.52053 3.77623 7.53007 
CP 3.87704 5.27025 3.18158 4.82398 5.03523 3.86226 
CPNE7 -2.3358 -3.41343 -2.84403 -3.09551 -3.07814 -2.48979 
CREB3L1 -3.62588 -4.46191 -3.91431 -3.89378 -2.84576 -3.50759 
CSF3 11.6252 11.5005 10.7491 10.7267 6.223 10.3787 
CST1 2.36079 4.69368 2.64546 6.3706 5.35331 3.43419 
CTGF -3.29598 -3.91388 -2.72646 -3.63402 -2.63318 -3.04932 
CTSS 4.94386 5.29067 4.17324 4.82297 2.17639 4.51767 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
CXCL5 5.4222 5.74236 4.4797 5.2362 3.29586 4.56433 
CXCR4 3.29595 4.45584 2.52922 4.18055 2.26864 4.24144 
CYBA 2.61896 2.99482 2.55259 2.86666 2.05341 2.08381 
CYP1B1 2.85337 3.49937 4.64684 2.4258 2.69928 2.34892 
DBP -4.25491 -3.64113 -2.6304 -4.42328 -2.3311 -3.36198 
DDX58 6.1742 6.39318 4.4398 5.92034 4.49532 5.34728 
DDX60 4.62992 4.46514 3.92795 4.27028 3.80854 4.0533 
DDX60L 4.17384 4.1082 3.00028 3.70346 2.4309 3.57489 
DNAJC15 2.84201 4.80114 2.51798 4.36118 3.55543 2.67835 
DNER 4.0336 5.10917 4.6895 4.24017 2.34449 4.91705 
DPP4 2.60868 3.87621 2.20501 3.09557 2.04599 3.93235 
DTX3L 3.27252 3.34869 2.60117 2.8231 2.17672 2.69634 
DYSF -3.41077 -4.71238 -3.41209 -5.35588 -4.98365 -3.2417 
EBI3 7.2643 8.20801 7.42441 7.78099 4.89773 7.09824 
EHF 3.47197 3.10815 3.44949 4.45457 3.69705 2.99713 
ELOVL3 5.2203 6.10314 3.51523 5.86063 4.12786 4.77186 
EMR1 4.23579 4.45266 3.41657 4.45263 2.51453 3.71563 
F3 4.65366 5.82124 2.54297 5.28425 2.52108 5.26718 
FAM101B -3.91432 -4.42917 -2.42466 -4.54447 -2.83428 -3.18192 
FAM160A1 4.87014 5.83471 3.79878 3.98482 3.03275 4.03869 
FAM83A 4.69329 5.7548 2.62541 4.13835 2.95639 3.55805 
FBLN5 3.96781 4.26232 3.40902 3.4345 3.21781 2.10597 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
FGFBP1 2.98948 5.2104 3.65701 5.90129 5.53592 3.80621 
FOXL1 3.36561 3.89136 3.17679 3.3449 2.93956 3.46313 
FST 4.00848 5.0379 3.12299 4.04571 2.76038 3.97895 
G0S2 5.4731 5.16002 3.64206 3.56304 2.00487 4.22193 
GALNT4 3.06363 4.17459 2.08393 3.46603 2.85739 2.71115 
GALNT9 2.33978 2.24432 2.13532 3.47305 2.20072 2.44807 
GBP1 7.79806 7.99964 5.7317 6.58797 3.81045 5.90878 
GBP2 5.37777 5.82931 4.07202 4.44165 2.9621 3.65578 
GBP3 6.02686 6.33353 4.34802 4.88946 2.54602 3.89551 
GBP4 8.48438 9.1585 5.53233 6.44988 3.63379 5.59099 
GDA 5.20339 5.03012 4.03444 4.9995 4.41428 3.0221 
GFRA2 2.97677 3.924 3.71281 3.51862 2.64529 4.21138 
GJB2 4.71124 4.47995 3.46376 2.43904 2.37774 2.31164 
GPNMB -3.23619 -4.90539 -3.63404 -4.33854 -3.58118 -2.94994 
GPR1 -2.74016 -3.28379 -3.30808 -2.87969 -4.03549 -3.1584 
GPX3 2.66362 3.29866 3.13502 3.05631 2.18772 2.74042 
GREB1 -2.71908 -3.37242 -2.56534 -3.17313 -2.42593 -2.98821 
GRHL1 -2.67305 -2.66404 -2.33282 -2.15781 -2.25819 -3.00657 
GZMM -4.12809 -2.99939 -3.01936 -3.29688 -3.41642 -2.30903 
HAS3 4.46629 5.41776 3.68094 3.98851 2.73254 3.81616 
HCAR2 6.01071 5.73337 4.14437 4.74861 3.20962 5.80178 
HCP5 6.57748 7.06735 6.1255 6.7487 3.1811 5.72478 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
HELZ2 4.84988 5.2415 3.73662 4.88688 3.62689 4.37329 
HERC6 4.90654 4.96638 4.33971 4.83021 3.92532 4.55885 
HGFAC -4.23882 -3.68373 -2.75778 -3.51273 -3.17106 -2.98804 
HIST2H2BE 3.9838 4.90726 3.66976 4.69264 2.46978 4.99846 
HLA-B 5.69857 6.36506 5.32149 5.91625 2.80449 5.19389 
HLA-C 4.35218 4.90315 3.83143 4.54592 2.21421 3.73218 
HLA-F 7.39195 8.12363 6.96022 7.59064 4.68399 6.89822 
HLA-H 4.01722 4.89657 3.61834 4.25391 2.17088 3.49238 
HLF -2.62511 -4.82672 -2.45427 -4.22021 -2.23561 -5.40838 
HS3ST1 2.84156 2.96885 2.45339 3.23348 2.19021 2.13925 
HSH2D 5.89837 6.00122 3.93275 5.61431 3.6541 4.82221 
IFI27 10.3865 10.788 9.54881 10.252 6.52275 9.22465 
IFI35 5.20574 5.10196 4.09265 4.77546 3.42489 4.16494 
IFI44 7.81452 7.86926 6.9094 7.49244 6.42383 7.21887 
IFI44L 9.02034 8.3579 8.71222 7.71998 6.22354 8.10954 
IFI6 8.55478 9.21346 7.65467 9.08478 7.30238 8.372 
IFIH1 6.195 6.40279 4.68331 5.56606 3.91455 4.97993 
IFIT1 8.85533 9.42574 7.37901 8.80019 7.43871 8.04116 
IFIT2 9.01452 10.0375 6.42742 8.54799 6.27028 7.65086 
IFIT3 7.42127 7.82087 5.82482 7.05397 5.21392 6.28102 
IFITM1 9.37177 9.40937 8.0916 8.66969 7.52286 8.16817 
IFITM3 5.47643 5.21115 3.78776 4.32528 3.52157 3.60785 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
IGFBPL1 -3.09333 -4.43148 -3.64504 -2.99524 -2.04306 -3.96548 
IKBKE 4.86609 4.56715 3.45225 3.9339 2.16923 2.7732 
IL1A 9.23967 8.63389 6.82572 5.36213 2.23801 5.29544 
IL1B 9.2956 9.59165 7.36795 7.1204 3.19683 6.80114 
IL22RA1 5.4566 6.60646 4.0923 6.01573 3.94251 5.62374 
IL23A 9.95342 9.56809 8.25134 7.35562 3.95109 6.62714 
IL8 5.13022 5.25733 3.87253 4.56741 2.55849 3.7053 
INHBA 6.35451 7.30686 5.3559 5.74011 3.20622 6.63873 
IRF7 4.87605 5.18348 4.39423 4.97046 3.78262 4.32491 
ISG15 7.90817 8.15541 6.97261 7.49978 6.09678 7.01933 
ISG20 4.67573 4.75929 3.1819 4.12862 2.05592 3.17168 
ITGA5 2.90524 5.07577 3.74963 4.78114 3.13682 5.28682 
ITGB3 3.56899 5.26593 3.44729 4.00458 2.2963 5.39828 
ITGB8 5.79489 6.76607 5.74623 5.40711 3.58073 5.23746 
ITIH5 2.72264 3.88437 2.59621 3.70665 3.22892 2.55354 
KCND1 -2.90584 -3.50748 -2.93052 -4.23238 -4.12142 -3.12429 
KCNIP3 -4.40677 -3.09004 -2.09744 -3.2623 -2.36122 -2.69373 
KCNJ16 3.93341 4.01218 3.07509 5.15361 4.28359 2.88018 
KCNJ6 3.24962 4.9136 3.05164 4.80389 4.86519 5.50016 
KCP -2.10554 -4.48721 -2.74145 -3.81267 -4.14168 -3.36816 
KIAA1199 4.75096 7.71954 5.67979 7.86358 6.08633 7.37219 
KIF17 -4.89504 -4.38012 -3.72602 -4.79125 -3.73343 -3.19792 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
KRT20 -3.65138 -3.22803 -3.55445 -2.64182 -2.03963 -4.35341 
LAD1 5.17918 5.39188 4.75306 4.55621 3.41456 4.31402 
LAMB3 5.94448 5.7955 6.20149 4.99123 2.34816 4.97517 
LAP3 4.60272 4.73553 2.55847 4.03179 2.5731 3.27638 
LAPTM5 3.46269 4.67746 3.76505 5.79801 2.93662 5.81553 
LBP 4.95256 4.88496 3.12187 6.8939 5.81088 4.93017 
LGALS3BP 3.3034 3.57698 2.41664 3.51965 2.05865 2.76856 
LGALS9 6.33747 6.54596 4.04213 5.76936 2.11638 3.27212 
LMO2 5.02772 5.69118 2.44776 3.95305 2.20771 2.99131 
LOC100127888 2.69196 4.74959 3.24361 4.86277 2.91223 4.47163 
LOC100130705 -2.28312 -4.00003 -2.66338 -3.13196 -2.98372 -2.55071 
LOC100134229 2.77111 4.70208 2.49144 3.92562 2.32665 4.29658 
LOC100505817 2.12855 2.99098 2.15203 3.13219 2.38807 2.72792 
LOXL2 2.87602 4.40313 3.44112 4.68655 3.68669 4.95803 
LTB 9.08195 9.46265 8.10109 8.40743 5.96664 7.72957 
LYPD3 5.37693 6.44069 4.51979 5.18442 2.15538 5.20106 
MAN1A1 3.26566 4.38479 3.11572 3.83792 3.23198 3.56518 
MASP2 -2.52544 -3.82112 -3.24622 -3.1606 -2.94336 -2.61716 
MAST4 2.7503 3.2324 2.2235 2.95793 2.39689 2.16773 
MCIN -2.73153 -2.53638 -2.10915 -3.20787 -2.0693 -2.4163 
MED12L -2.08553 -2.85095 -2.87357 -3.68062 -2.7363 -2.8543 
MEGF6 2.45881 3.99371 2.56233 4.07927 4.03509 3.75223 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
MMP10 5.32139 7.36226 7.83428 7.03721 5.66926 9.46858 
MSX2 3.64794 4.36058 3.45555 4.0038 2.28927 4.01506 
MTMR11 2.71358 3.82276 2.4903 3.11409 2.36356 3.11075 
MUC1 4.45334 5.6208 2.83129 5.15506 4.67253 3.57716 
MVD 2.75434 3.43576 2.10178 3.68272 2.59111 2.49792 
MX1 7.68353 7.08719 6.45521 6.65092 5.68558 6.43515 
MX2 9.34028 8.51022 7.11293 7.83319 5.71701 7.19506 
NDNF 4.4388 6.13985 4.14258 6.3387 5.49958 6.097 
NOD2 9.58624 9.80697 8.63226 8.15133 5.4466 8.4917 
NOS1 4.78184 5.92403 4.66469 5.40357 4.23546 5.30479 
NPC1L1 -3.48476 -3.80918 -4.19626 -3.35785 -3.56751 -3.85185 
NR0B1 -2.79938 -4.1633 -2.80838 -4.23988 -3.15353 -4.64247 
NR4A3 -2.91418 -2.20468 -4.13023 -2.07687 -3.5548 -2.26189 
OAS1 6.12865 6.92308 5.27503 6.19615 4.69339 5.52235 
OAS2 10.9123 10.2406 8.93686 9.4609 6.94032 8.75582 
OAS3 6.33779 6.15345 5.07524 5.86842 4.66839 5.35202 
OASL 10.7421 11.1366 8.88389 10.2211 7.82173 9.58162 
ODF3B 4.00589 3.75389 3.10406 3.40191 2.01543 3.17271 
OLR1 8.97527 8.75587 7.3439 5.88324 2.87619 6.67438 
PABPC1L -2.49703 -4.99357 -2.78382 -4.2822 -3.56145 -4.00903 
PARP10 5.90146 6.20511 4.84748 5.81507 4.07613 5.18009 
PARP9 4.62089 4.6175 3.7039 4.33843 3.53262 4.11935 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
PDGFRL 3.61365 3.55376 2.10143 3.0103 2.71981 2.19449 
PDZK1IP1 5.20316 5.37374 5.53676 5.9479 2.72668 5.09096 
PF4 2.21911 3.19934 2.09094 3.12071 2.46706 2.52283 
PI3 9.92374 10.4957 9.447 10.4082 7.01702 9.95645 
PID1 4.84739 6.00216 5.40363 5.09751 3.9071 6.16937 
PLAUR 3.69387 4.35606 2.6762 3.79767 2.29634 3.37603 
PLEKHA4 8.47011 9.1429 6.17247 7.86261 4.82129 6.93525 
PLSCR1 3.41937 3.48019 2.76303 3.10407 2.29793 2.77892 
PML 4.0045 4.1959 3.05432 3.73515 2.00893 3.1177 
PNLIPRP3 3.64847 3.02385 4.33425 3.52344 2.56971 4.21838 
PPM1K 4.01785 4.35561 2.73201 3.4401 2.31575 3.11198 
PROZ -2.2045 -2.88009 -2.05253 -3.40155 -2.07588 -2.00306 
PRSS3 2.58847 4.75953 3.34354 4.52275 4.35995 4.37955 
PSD4 3.44412 4.32119 3.00318 4.18979 2.95147 3.66443 
PSMB8 3.40469 3.67144 2.72607 3.37408 2.15453 2.73788 
PSMB9 5.65754 6.01987 4.39809 5.50179 3.44069 4.55202 
PTPRN2 2.04938 3.65125 3.38862 3.36962 2.44837 3.16936 
PYGM -3.48238 -2.93891 -2.15924 -4.26245 -3.04283 -2.43552 
QRICH2 -2.6286 -3.36814 -2.30108 -3.24858 -3.45188 -2.61254 
RAB39B -2.22736 -4.74665 -2.35238 -4.85479 -3.92696 -4.18238 
RARRES3 4.24749 3.46259 2.62548 3.93967 2.26687 2.11832 
RHBDL1 -4.6976 -4.76263 -3.25809 -3.22808 -2.99206 -3.49055 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
RSAD2 11.1901 11.6607 9.8543 10.1216 7.10421 9.73009 
SAA2 8.55086 8.87495 7.89733 8.6781 4.49714 8.04398 
SAMD9 5.91556 6.45489 4.63149 5.75945 3.54918 5.03136 
SAMD9L 7.05924 7.02816 5.11301 6.16611 4.07701 5.43095 
SAMHD1 5.32759 5.11483 3.4612 4.56117 3.30225 4.26762 
SECTM1 4.81208 5.06717 2.20077 4.78264 3.12673 3.65927 
SERINC2 2.27512 3.67037 2.88228 3.35095 2.50355 3.54926 
SERPINA1 3.22736 3.90795 2.39457 3.54201 4.44399 2.89534 
SGPP2 4.86111 5.64548 4.533 3.94557 2.24975 4.14024 
SLC16A3 3.05087 4.08247 2.71857 4.12848 3.49948 3.7335 
SLC1A2 5.25174 6.70661 5.32342 6.47058 5.56499 6.60215 
SLC22A11 4.00707 5.10318 3.20308 5.74807 3.28977 2.88308 
SLC26A9 4.70519 5.29209 3.6237 5.46949 4.33358 3.27505 
SLC2A6 5.34331 5.01116 4.38117 4.4887 2.83803 3.56571 
SLC39A8 4.41603 5.15255 4.11708 4.68785 2.27823 3.99856 
SLC4A11 -2.77382 -3.21029 -2.87533 -3.00901 -2.92562 -3.227 
SLCO4A1 2.47349 4.73001 3.2094 4.94501 2.87813 4.32945 
SLCO5A1 3.44765 5.09583 2.88891 3.42782 2.95191 2.76025 
SLPI 5.30593 6.44015 5.1329 6.17823 4.3658 5.13369 
SOD2 3.86058 4.04596 3.69789 3.71891 2.2209 3.64458 
SORCS2 2.79196 3.50012 2.86832 4.30532 4.00705 4.44218 
SP110 4.13537 4.27048 3.02163 3.87085 2.51426 3.56094 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
SQRDL 3.10575 3.359 2.78348 3.095 2.49467 2.91096 
SRD5A3 2.18603 3.3449 2.38658 3.43629 2.44136 3.40295 
ST6GALNAC3 -3.75664 -5.45571 -2.71177 -4.56078 -3.22363 -3.43285 
STARD4 3.2311 3.48251 2.04145 3.10602 2.0322 2.40559 
STAT1 3.94012 3.91864 3.2584 3.85935 3.22591 3.59764 
STAT2 3.46345 3.59953 2.02872 3.25538 2.15336 2.95356 
STC1 3.88451 5.94009 4.02361 5.65436 4.94857 6.34535 
TAP1 4.0578 4.83575 3.15572 4.2529 2.35929 3.42186 
TAP2 4.34592 4.58011 3.2974 4.10521 2.19446 3.37296 
TESC 2.19799 3.57709 2.01924 3.68038 3.63826 3.27149 
TFF1 3.60969 5.49969 3.36021 5.24948 3.76317 3.39083 
TGM2 4.22632 5.15263 3.16398 4.90842 3.94929 4.48574 
THBS1 -3.05487 -4.16676 -2.82488 -3.90581 -2.72181 -2.92188 
THEMIS2 5.31021 5.86529 3.69702 5.33357 3.87973 5.47124 
TLR5 2.51243 3.89953 2.35796 3.99378 3.02013 4.71785 
TMEM132A 4.4022 4.88249 4.27709 5.0482 2.71305 4.5048 
TMEM154 3.06033 3.49541 4.89545 4.14589 3.00949 4.95251 
TMEM163 3.33567 3.80447 3.10925 3.50336 2.8534 2.32414 
TMEM37 2.73084 4.80121 2.35987 5.66043 6.44741 4.90926 
TMPRSS3 6.08766 7.25866 6.2309 6.90952 4.37527 6.11699 
TNFAIP6 10.3053 11.3011 8.28298 8.52132 6.04027 7.726 
TNFAIP8L3 2.81186 3.19418 2.23478 2.93351 2.4988 3.49422 




Gene F15/LAM4/KZN F11 F28 Beijing Unique H37Rv 
TNFSF10 8.07049 9.10647 4.46502 7.74642 5.54602 5.70674 
TNS1 3.55131 5.75804 3.76863 5.63436 5.30416 6.55993 
TNS4 2.55351 3.8976 2.08444 4.46035 3.69519 4.11298 
TRANK1 6.08728 6.40029 4.63777 5.64694 3.61973 4.96546 
TREX1 3.84333 4.20731 2.96098 3.65333 2.2723 3.1416 
TRIB2 5.46671 7.96902 5.16906 6.82896 5.0678 5.34207 
TRIM14 4.02516 3.87513 2.77427 3.70408 3.0826 3.60997 
TRIM22 8.45266 8.41371 6.43282 7.76301 4.94956 6.97281 
TRIM34 2.60088 3.28127 2.43023 3.60657 2.9045 3.29488 
TRIM67 -2.54104 -4.86817 -2.74583 -3.67823 -3.5388 -3.48696 
UBA7 4.84925 5.03407 3.15953 5.14431 3.13935 4.0566 
UBE2L6 4.25121 4.08085 2.92867 3.65172 2.1498 3.08569 
USP18 6.35555 6.15658 4.59405 5.72925 4.3954 5.20125 
VDR 3.26064 3.81633 2.97066 3.67467 2.44194 3.39074 
WIPF3 -2.20796 -3.39175 -2.0669 -3.77636 -2.23013 -3.79753 
XAF1 9.0612 8.48864 7.45917 7.92858 4.46922 7.12313 
XDH 6.27968 5.4469 5.57217 5.04422 2.46414 4.72157 








Supplementary Table 2: Gene combination for different M. tuberculosis strain families and 
strain specific genes  








292 CLMP CREB3L1 ITGA5 XDH APOL2 CXCR4 ADAM12 C1RL GZMM C15orf48 SOD2 GDA 
KIAA1199 CMPK2 DYSF DNAJC15 CLEC4E CD38 HS3ST1 APOE PF4 BCL2L10 C3 
RARRES3 PPM1K BCL2 ASS1 ANXA8L2 UBE2L6 HLF C15orf59 NDNF KRT15 CDH24 EMR1 
SORCS2 IFI27 LAMB3 KCNJ6 TNFAIP6 ADRB1 CARD9 FOXL1 OAS1 IL23A GRHL1 IL1A 
FST TNFAIP8L3 IL8 IRF7 HERC6 XAF1 CA9 HCAR2 SECTM1 XKRX OLR1 LYPD3 TLR5 
GALNT9 LOC100505817 USP18 MVD GPR1 ITGB8 TRANK1 PSMB8 TRIM14 APOL1 MAST4 
NR4A3 BCL11B TMEM132A PI3 THEMIS2 GBP4 GFRA2 RHBDL1 MMP1 ST6GALNAC3 
STAT1 PDE6G MEGF6 CD68 BCL2A1 FGFBP1 FAM83A PDZK1IP1 DBP HAS3 C1S MAN1A1 
EBI3 BATF2 COL11A2 SP110 TRIM34 SAMHD1 TAP2 KIF17 CHI3L2 CEACAM5 TMPRSS3 
SLC2A6 MASP2 GBP1 QRICH2 PSD4 KRT20 OAS2 PLSCR1 LAD1 STARD4 THBS1 PID1 
SRD5A3 MCIN CATSPERB MED12L SLC39A8 CCL5 MX1 PNLIPRP3 LOC100130705 LAP3 
IFIH1 AHSG HDAC10 IL1B SLCO5A1 C11orf96 NOD2 ATP8B5P HLA-C ODF3B IFITM1 
KCNJ16 HGFAC PARP9 MMP10 CDA TFF1 PLAUR FAM101B FBXO2 CPNE7 TMEM37 
ACSL4 HIST2H2BE CYP1B1 KCP IFIT3 CNTD2 CYBA EHF C1R COL22A1 ITIH5 PROZ 
HCP5 SQRDL C6orf223 LOC100127888 TRIM22 GPNMB KCNIP3 TGM2 NOS1 HLA-H 
KCND1 ELOVL3 DPP4 GREB1 UBA7 TNFSF10 DTX3L MUC1 LBP ADAMTS9 NR0B1 TAP1 
CST1 SERPINA1 WIPF3 MSX2 IFIT2 C11orf86 SERINC2 AOC3 OAS3 SLC22A11 CTSS STC1 
01-Mar SLC1A2 LTB LGALS3BP SAMD9L CSF3 LMO2 DDX60 HELZ2 CCL20 ROBO1 SLPI 
GBP2 TNS1 ACSL5 C4orf33 PRSS3 G0S2 CDKL2 OASL BMPER CCL2 GALNT4 CTGF 
TMEM154 ISG15 MX2 RAB39B VDR SLCO4A1 HLA-F SGPP2 PDGFRL C19orf66 PML 
IFITM3 TRIM67 PTPRN2 BST2 INHBA IFI6 LOXL2 IGF2 NPC1L1 PABPC1L IFI44L IFIT1 
GJB2 PARP10 TNFRSF1B LGALS9 TNS4 SPINT1 SLC16A3 ISG20 IL22RA1 CXCL1 IKBKE 
HSH2D SLC26A9 ANPEP ANGPTL6 CEACAM7 CAPN5 IFI35 LOC100134229 TMEM163 
GBP3 STAT2 RSAD2 DDX60L HLA-B CXCL5 LAPTM5 CFB DDX58 PLEKHA4 CDCP1 GPX3 
ITGB3 CABLES1 SAMD9 SAA2 F3 PYGM DNER TESC IGFBPL1 C1orf116 TREX1 SLC4A11 







217 FSTL1 PLCE1 TNIP3 MEFV STOX1 GGT3P CXCL3 HOXA13 CCL22 FAM129C EFNB1 03-Sep 
COL1A1 GPR37L1 NEIL1 GBP7 GMPR BTN3A1 CD82 STARD13 IL24 NPR1 ADRA2A HLA-J 
HHLA2 RASSF5 PTGES MFAP5 HIST1H2BJ NPHS1 STAT5A MTSS1L IFI16 FHDC1 MUC2 
NGFR CACNA1H EPS8L3 DSE LRRC16B CASP1 WNT5A PTGS2 B2M HAS2 SLC16A2 CILP2 
PLCXD3 CHST2 HIST1H2AG AMPD3 LOC100288432 CARD16 RPH3A FHOD3 COL5A3 IDO1 
ERAP2 LOC100287314 BRCA2 PARP12 CYP4F22 HS3ST3B1 IRAK2 FLJ16779 DHRS12 
KIRREL2 LIPG FEZ1 SCARA3 AKR1B1 HLA-G HRH1 TNFRSF14 TNIP1 SMTN NT5C3 CA8 
HERC5 IL32 LAMC2 KCNJ2-AS1 MLKL SSTR5-AS1 C12orf70 KIAA1462 GBP5 SEMA6B 
CACNG6 IRF9 MT2A CYFIP2 PASK TYMP INSIG1 KCNE4 TRIM5 SAT1 ROS1 C1QTNF1 
SPINK1 ZSCAN18 KLK14 GK BIK RGS16 ACVRL1 PDLIM7 HRK MOB3C MAML2 CREB3L3 
CYP2U1 CD55 LOC339666 RERG GGT8P LOC728392 HLA-E FLT3LG BTN3A2 TRIM31 
OSMR SEMA3E RAP1GAP ADORA2A KCNH2 ADCY5 HIST1H2BC OVGP1 AIM1L PRRG4 
RAB26 HCAR3 SNX10 PARP14 MSI1 PIK3R3 CDCA7L RCOR2 SLC43A3 CARD6 KIAA1217 
FA2H NCCRP1 NALCN CERS1 HLA-A MPP1 STX11 DPYSL5 IRAK3 GARNL3 TBX1 TRIM69 
DPY19L2 KCNE1L TMEM106A RHCG SLC6A14 FAM92A1 DFNA5 IL6 TLR3 ZMAT3 
RNF213 L1CAM GIMAP2 HIST1H3H 03-Mar SEPP1 RASGRP1 SLC16A6 NLRC5 VNN1 
SLC16A13 IFIT5 OSR1 RALA RNF144B AMH NTN1 MDK TNFAIP8 ICAM1 FLJ35282 CA2 
TTYH2 BCAS1 PAPL CNTNAP2 PAX8 BTN3A3 SEMA3D ZEB2 SERPINE1 HLA-L PTAFR 
SMTNL1 DNAJB5 MATN2 GLIPR1 KLK10 P2RX4 LRP4 GPR156 PTPLAD2 IL11 LCN2 






21 HSD17B2 MIR17HG WNK4 RHOV KCNMB3 ITGA2 LRP1 SLAMF7 DOC2B IGFBP3 GJA1 















52 ARRB2 KCNG1 SIDT1 MREG SUSD2 CPNE4 NKD1 NAT8L ISM1 DPYD SH3PXD2A 
BCL2L15 FXYD2 PHF21B EEPD1 PCSK9 FAM83B HOXA2 PI4K2B TOX2 MSMO1 P4HA1 
ALDH1A3 NEURL AIFM3 DDO HMGCS1 CEACAM1 GGT5 AOC2 SEC16B SYPL2 NTNG2 
RET IFITM2 WDR17 C2CD4B NXPH4 C17orf104 HK2 SNAI3-AS1 IL33 TLL1 EXOC3L1 


















34 C11orf93 F7 04-Mar AGTRAP KLRC1 SH3BGRL2 RRAS GPR160 LSAMP EFEMP1 STARD8 
NID2 MAF MROH6 EPHB2 PDE3B C14orf182 ST3GAL1 SLC47A1 GJB3 OXCT1 SLC16A9 







34 STYK1 OTUD3 ECE1 CEBPD IL15RA PARP8 LOC728431 EXOC3L4 TTC39B UXS1 CMTM4 
SLC43A2 ST3GAL4 IL10RA FFAR2 ATRNL1 STOML1 STAT4 GRIK4 OLFM1 LINC00525 
KCNK1 KLHL4 SCEL SERPINF2 SLITRK6 LSS PDIA5 LOC645638 SHROOM3 FLJ22184 











50 ANKRD13B PNPT1 GFPT2 A4GALT TMEM117 NEBL RTN4RL1 IL17D SGK1 PRDM13 PIFO 
CDK18 FAM171B GNAZ NKX3-1 RASGRP3 PDZD2 TMEM229B GATA2 HAPLN3 CD47 
PLEKHF1 BLZF1 TDRD7 SYNM PRTG CARD11 TAPBPL STRIP2 MASTL MYPN GSTO2 
EFNA1 LCA5 DENND5A MYD88 HDX SERPINE2 TCP10L BTC LGMN TRIM21 TNFSF13B 






91 WISP2 GYS1 C4orf3 ALDOC P4HA3 ADAMTS16 PLD6 BACE2 AKNA GALNT18 PSORS1C3 
CSTA S100A3 BEX2 PHGDH CBS TNFRSF19 ITGB2 ULBP1 PLOD2 FIGN LOC728228 
SLC11A1 MAGI2-AS3 SLC2A1 UBE2QL1 EBP FAM13A NDRG1 DCBLD1 MCOLN3 PLAC1 
CYTIP SUSD4 MAFB LOX SLC39A10 BNIP3L HILPDA CD22 TMIE INHA PFKFB4 KCNMB4 
ESR2 MIR210HG LOC154761 PGK1 IQGAP2 LGR6 FAM115C SYNE2 PTPDC1 FAM129A 
ITGB4 LGALS1 ATP1B1 MBOAT1 SLC2A3 RASGRP2 PDE9A TMEM47 LDHA PLD5 
ACVR1C MT1X SEMA4B SPAG4 EFCAB3 C16orf74 ABCG2 LOC100422737 CDH16 AK4 
ARRDC3 PSAT1 PRODH SLC43A1 ASNS WWC2-AS2 FAM189A2 GLT25D2 PDK1 ZMAT4 





30 CECR2 TMEM92 FCGBP KCNQ5 GC MUC5B WNT6 NNMT VASH2 KRT80 C19orf26 PREX1 
TCN2 CYR61 DTNA CFH PKD1L2 AIM1 PLA2G4A RIMKLB SLC7A9 ACAT2 ITIH2 FLRT2 

























21 ACSM3 AGPHD1 ACADL PHACTR1 CDSN AKAP2 GYG2 CNTN1 HIST1H2BK KIF1A 




























63 FIBIN XK CDK20 TLR8-AS1 SYT12 SLC10A4 PGM2L1 CCDC113 PECR EMR2 BMP2 
SLCO1B1 GPD1L IRAK1BP1 MDGA1 TMEM178B HOXD8 FOXP2 NKAIN4 OSGIN1 
SLC25A27 SLC6A8 IFNLR1 IL4R KLHL23,PHOSPHO2-KLHL23 CYB5D1 SP8 NSUN7 SOBP 
CPT1A ROR1 XYLT1 BEAN1 SLC5A11 KIF7 ZBED3 JAM3 MUC16 CLEC2B ZMYND8 
NOTUM SLCO1B7 GATSL3 CNRIP1 ZGLP1 SGTB TMEM169 SEMA7A RBPMS2 DYNC2H1 
ARRDC4 HOXA7 AMIGO1 SEMA6A CAMKMT P4HA2 PLK2 TBC1D30 KCNAB2 





78 TMEM139 LAMP3 FNDC8 PIK3AP1 DAPP1 HABP4 APOBEC3B TJP3 TMEM140 CYP3A5 
MEIS1 LDLR SYDE2 AQP11 C5orf56 EDA2R ABHD16B SLC37A1 APOBEC3F TMEM62 
NRTN NAMPT CXCL2 DANCR PRKD2 NFE2L3 KLF5 LOC728743 BCAT2 UNC13A PDE4B 
ASIC4 KIAA1211 CFLAR FTSJD2 CTSO TRADD BID TGFB2 ALOX5 ZNF704 APOL6 
CYP21A1P CASP10 CSF1 CKB TAPBP ZC3H12A RIMS3 SDC4 CYB561D2 LIPA CDC42EP2 
SLC52A3 RRBP1 SRGN CASP7 PELI1 ZBP1 ISYNA1 MST1R MOV10 KIF26A DSC3 SOCS7 
TMEM173 NR5A2 SNX30 NMNAT3 NMI NOX1 TNFAIP2 ARHGEF17 TCTN2 PARP3 





55 C9orf152 PON3 CCDC64 SPTSSA ID1 CST3 SLC9A3 PFKL CDHR1 IGFLR1 FUOM SQLE 
ENTPD2 TPPP3 GPX2 LFNG IGFBP5 MMP14 ADAM28 LINC00304 LINC00087 LOXL1-AS1 
HCN4 BCRP3 ZNF503-AS2 RGL4 CFD NRXN2 FRMD3 CLGN VEPH1 GRB7 TNFSF15 
FAM215A FSTL4 EDN3 VTN IL15 BEX4 KCNJ14 ACSS2 B3GNT3 TCN1 ID4 FOS IDI1 PRR15 





















15 ANLN RIPK4 FGF17 CCL26 ADAMTSL4 CDCA2 GPR63 CRYAB ITPR1 ABLIM2 COL13A1 









15 LINC00520 CCDC34 DSCC1 QPRT SAPCD2 ARHGEF26 CD302 RUNX2 FOSB HIST1H2BD 




35 KLRG2 ZBTB20 TREML3P L3MBTL4 DOCK4 KCNH3 RASGEF1B CD74 CCDC136 NAV3 
TLR2 GAS6 ETV1 ADAMTS7 CERS4 NBN TNFRSF11B EFHD1 ACP2 RIPK2 MAP2K2 RGL3 







































53 ZNF799 EPB41L4B MMP7 ITM2B LINC00261 ARHGAP39 ROR2 LRRC48 LONRF2 SNHG9 
IER3 C1GALT1C1 FOXN2 HSD17B7 TBC1D10A HSD17B7P2 SLC25A15 HMGCR LMO7 
RCOR1 PGF RGS11 ZNF853 SPTBN4 SULT2B1 HSD17B14 TTC26 LOC151009 RNF122 TC2N 
ZYG11A INTU RNF180 CELF6 TMEM165 FAM169A ABTB2 NAT6 SPATA6 MATN3 CASC2 








26 COL7A1 MYCBPAP UCN2 DMGDH DDIT4L PDGFA KCTD11 CDR1 ARSG SHB GLI2 LINC-
ROR CMIP TBX2 ECM1 KLRC2 ANK2 RORA SORBS1 GUCY1A2 KLRC3 PORCN MYO1F 
FSTL3 NPTX1 LOC100289137 
Beijing  
F15/LAM4/KZN  




34 KCNK3 ELANE TM4SF4 KIAA1161 LINC00239 LINC00324 GAL3ST1 C22orf23 BPIFB1 
SLC29A4 SEC14L2 ALB NGF CLDN2 NUDT18 FADS2 EMID1 P2RY1 CIDEC ANGPT1 
ALDH3A1 SLC1A1 C14orf1 RAB3IL1 TMCC1 NHLRC4 SEMA4G NPR2 HHIP ATP6V0D2 
KLF15 SEC14L4 ADH6 TMEM141 
F11 
F28  
21 MIR4461 LRRC6 FRAS1 SYTL1 KIF4A GAL DACT2 LOC643401 BAAT NEK2 PLK1 SEC31B 




40 NFIA PCDHAC1 SMO LOC645249 GSTM4 TSPAN7 CXCR7 ADCY3 NECAB2 TPD52L1 
ALDH5A1 G6PD PLEKHG5 SPTBN2 CYP27C1 PCYOX1L DAGLA LINC00312 ZNF697 
ADAT2 PAX9 PTPRB MERTK SLC1A5 MPC1 FGFR2 RTN4RL2 FAM212B ALDH1B1 RNFT2 




107 SH3BP4 SPECC1L KNDC1 GTPBP1 SERPINB9 TNFRSF9 INPP5J RGS14 IL18BP SPDYE5 
MIA2 CLDN9 ZFPM2 DIXDC1 TRIM45 SNCAIP NFKBIZ JAK2 USP43 GCH1 PTP4A3 NYAP1 
TNFAIP3 CSAG1 PTGER4 CGNL1 FOXN3 TMEM38A ADORA2A-AS1 HOXB4 C1RL-AS1 
EHD4 RNF24 CCDC85C STK32B LRRC20 NCK1 DLC1 COL26A1 FNDC3B NFKB1 HLA-DOB 
CDRT15P1 PSMA6 IFNAR2 FBXO6 NCOA7 SLC30A3 PSME2 IL18R1 TRAFD1 FAM222A 
PHF11 FAM171A2 DCHS2 IRF1 TTLL6 HAGHL B4GALT1 CD40 MPV17L KHK ELOVL7 
KLF6 MAP3K8 SH3KBP1 RNF112 NPM2 PDK2 EBF1 EREG ADRB2 SLC17A7 IL12A ACTN2 
PBX3 PSTPIP2 OPTN LYN BRIP1 PION ADORA1 GDPD3 HADH ZNF367 TRIM38 CASZ1 
PPAP2B LOC100506714 VSX1 CYLD PPAPDC2 CBLN3 IFNGR1 FAM122C PLEKHS1 
SLC25A28 PDZK1 FDXR IRF8 RNF157 HES4 SYTL3 DENND2D VAV3 LINC00410 BTG3 
F11  
Unique  




20 DNAH17 VWA5A PSG4 FAIM3 C5 ESPNL THSD7A RAPGEF5 DEPDC7 BTNL9 AKR1B10 




31 SORL1 PCOLCE HSD11B2 SLCO2B1 LINC00605 BCAM ATG7 NEFL FGF12 SULF2 C2orf72 
HTRA1 INHBE CYB5R2 RFTN1 MRAP2 CACNG4 HDAC9 STK32A AVPR2 BHLHA15 PTPRD 









15 TMEM52 EN1 TNF PPP1R14D MGC39372 DHX58 LINC00173 SIX3 PLA1A PTK7 GREM1 
ATP8A1 HOXA4 CXCL6 ZFP57 
H37Rv  
Unique 
16 UGT2B7 SYT13 RCAN1 PRIMA1 UGT1A7 SH3D21 SLCO1B3 ATF3 CACNA1B TUBB3 NAGS 








7 LOC653712 CYP2F1 C7orf61 TRIML2 ST6GALNAC1 KLHDC7B PDE2A 
Beijing  
 
52 SERPINF1 PAQR8 CPEB1 TM6SF1 IGSF8 CATSPER1 SLC51B PAWR UPK3B SPDL1 MCM10 
IL21R FAM129B DHCR7 CA12 CITED2 ZNF114 TNPO1 CDC45 COL16A1 ESCO2 BREA2 
FAM111B GLP2R ZC3H12B C3orf72 RCBTB1 TEX19 WTIP MAPT MGAT5B MFSD2A TTLL7 
SEMA3B INO80C TBL1X CLDN15 BCMO1 MEIG1 STIL DMBT1 C2CD2 TSPAN1 FLOT1 
EDN2 GKAP1 IGFBP4 TTC9 SYT9 KIF3C NUSAP1 DHRS2 
F11  
 
255 KCNJ2 GCSH TMSB10 NKX2-5 FAM91A2 CCNB1 CYTH1 CCDC28B SLC12A8 MNS1 
C20orf27 DHRS11 BRCA1 CDC25B IPW BIRC5 STK17A B3GNT7 NPW FAXC CLCN4 EFHC1 
GLIS2 BBS1 VASH1 KIF14 ATP10A PPM1H ARFRP1 TTC13 SYTL4 EDAR KCND3 POLR3G 
WFIKKN1 TEX9 GPATCH11 APOBEC3A HOXA5 CLIP2 CHTF18 RABAC1 PCDHA12 
TNFRSF10C FLYWCH2 GTSE1 NUF2 RAB4B FAM228B USP51 FKTN FBXO15 FN3K 
DEPDC1 ANKRD65 CAPN8 MYBL1 IQGAP3 DIAPH3 EIF2AK2 GPC4 PKIG MRAS FAM8A1 
IFT172 STK36 CES3 CALCB ADHFE1 RPGRIP1L ARL4D SIRPA CEP55 ITPKB QTRT1 
UBXN11 SCLT1 SYTL2 SYNE1 C2 SOCS1 KGFLP1 FAM66C MESP1 XRN1 IRF2 C7orf63 
SAMD15 BFSP1 MB21D2 COL4A1 CLIP3 C2orf15 DYNC2LI1 CLEC2D N4BP1 CCDC71L 
AGPAT5 PREPL HSBP1L1 MAPK8IP3 KATNAL2 WDR90 SH3BGR CENPK ZNF404 PMS1 
TLE4 NINJ1 TIMP4 ZNF804A RABL5 PSCA DTX3 C3orf55 TMEM56 C20orf96 TRIM36 
C11orf70 RCN2 SAV1 MAST3 LOC100288181 HYAL1 L3MBTL1 SLC44A4 C17orf97 LRP3 
SUSD5 LOC100129534 NID1 RFX5 KCNAB3 EML1 THAP10 NPHP1 FBN2 SLC16A7 
SPATA17 SFR1 LMLN GOLGA2P5 TFCP2L1 FZD2 C12orf61 ZFP69B TNNI3 FAM216A 
DUOX2 ERMP1 DMPK DLL1 ZNF771 C2orf81 CROT HOXA3 SCNN1D ZC3HAV1 ANKRD42 
STEAP4 C4A,C4B_2 DDX26B RNF19B LPCAT2 DUOXA1 FAM83E ZNF792 PARPBP IFNGR2 
KBTBD11 SIPA1L1 PYCR1 SPTBN5 TUB PNRC1 TOM1 CDC20 NMT2 GLI3 BCL2L13 
WASF3 SEPT5-GP1BB ACHE SLC9B2 CXorf38 PVRL2 ENKD1 EPHX2 ELOVL4 PSME1 
MTX3 C1QL4 SCLY TMEM67 WDR31 ZBTB42 SNHG3 ST3GAL2 FAM108C1 SHCBP1 
LOC643669 CC2D2A METAP1D HIVEP2 NUDT11 SYT6 NUBPL PCGF5 FOXRED2 LIFR 
STXBP6 SERPINB1 CCDC80 MMAA ETHE1 AUNIP STRBP RAPGEF3 PNMAL1 CCL28 
FAM188B PC RELA TMEM231 NIPAL3 OGFR TMEM121 MFSD12 LOC339535 CYB5RL 
FAM83D OSCP1 GLRB C6orf132 MORN4 CNP SSX2IP PIP5KL1 TIMM21 MORN2 XYLB 
C15orf38-AP3S2 DDR1 ETV6 RECQL4 MLPH CDKN3 FGD6 PTPN13 SLC18B1 FMN2 
FAM64A MAMLD1 PMS2 GPLD1 
F28  
 
55 MMP2 NR4A2 CA11 MTRNR2L4 CDK1 CDS1 CYP1A1 SRD5A2 C10orf107 MTRNR2L10 
CPVL MTRNR2L8 CHDH TYMS PROS1 KRT34 FRMD4A PDK4 MIRLET7DHG KIF12 NR4A1 
APOD HIST1H2AC SRPX DLGAP5 PALD1 TMEM59L GFRA1 ABCC8 GSTM2 SLC4A4 
REEP2 ATP1A3 PRKCDBP LOC284454 SYNGR3 MTRNR2L1 CADM2 ANXA9 MAP4K1 
LIN7A EDIL3 MTRNR2L2 NCKAP5 VWDE C10orf91 MTRNR2L3 LINC00707 NR1H4 
SMPDL3B CCDC150 HPX MALAT1 ACTA2 PEG10 
 
H37Rv  
125 CMTM8 CSPG4 NAP1L2 GPR143 PCSK1 SNX33 FRY TLR1 HTR7 CABP1 PLIN2 FAM167B 
ZNF239 C1QL1 BIRC7 FAM110C ADAM19 DNAH11 MCOLN2 TPBG SLAIN1 SOWAHB 
GALR2 JPH2 TUBA1A ABCC2 COL5A2 LGALS4 UPK2 OLIG1 PODXL HCG27 DMBX1 
SLC5A3 THEG MYC BEST3 TMEM255B KLHDC7A MPZ FAM153B LOC100507156 C1QL2 
KCNG3 S100A2 ST5 LOC729683 EN2 MAPRE2 ODC1 MYZAP KIRREL3 SH3BP1 SNHG12 
ACACB DOK5 RSPO3 COL11A1 HIST1H1C ADM5 PPARGC1B SOX18 AGR2 EYA2 
MIR137HG HMGB3 DOCK2 FSCN2 LRRC8C LDLRAD4 HIST1H3B HAS2-AS1 CPLX1 PAG1 
STAC2 LOC388942 EGR2 FRMD6 SIRPB1 PDGFB HLA-DMB S1PR4 GPR176 TSPAN33 
TGFBR1 WAS PCDHAC2 MIR3648 SHC3 CUX2 RGS9BP SLC7A8 SNAI3 HMGA2 LYPD6 
GRB10 MOXD1 TGFB3 SRXN1 PYGL MTMR9LP ZBTB1 RAB3B MEG9 FNDC5 EPHX1 
ZDHHC23 KIF15 RGS9 PSORS1C2 MEG3 SYT14 MICALL2 STC2 PPP1R14C ELL2 ZNF30 
DAW1 COL5A1 PTGS1 PMEPA1 PAQR9 SCG5 SFRP1 KRT23 
F15/LAM4/KZN  
 
138 LOC285758 NAALAD2 ATP9B SP140L CERK BBC3 RAB40B FIBCD1 ZMYND15 GHR ING5 
ADAM23 LIF LOC100132707 CPAMD8 OLFML2A PPL RASSF4 CADPS2 XKR9 BAI1 KANK3 
PRRT1 PLA2G4C GGTLC2 CD200 C12orf39 SLC9A2 DNAJC1 IGFN1 BAIAP3 GRTP1 SOCS3 
C10orf114 GPM6A ZNF165 SPEG LOC731424 NXN LRRC32 IL20 PALM ZSCAN12P1 
BTN2A2 ADAMTS15 FSCN1 UPB1 LINC00273 HRASLS2 ARMCX1 TCAP HYAL4 GCKR 
BARX1 HEY1 ADTRP THRA GJC2 SLFN11 FBXL16 MAP4K2 GGTLC1 CELSR2 AGMO 
PGM5 MYCL1 RIMKLA FLJ42875 PMP22 FLT4 KAZN YPEL3 SOX2 SMAD6 TMEM81 
BCL2L14 CBFA2T3 SEC24D PLAU KCNF1 B4GALNT4 NAPSB PLCG1 DNAAF3 GDF6 
C5orf38 DDAH1 RASD2 DUSP2 BDKRB2 SLC4A3 PIGR NRP2 ERAP1 TMPRSS6 CTXN1 
CCL17 CNR1 FAR2 RSPH1 WARS SAMD1 LOC113230 DRAM1 ARRB1 FOXN4 PTX3 
MAST1 TPRA1 JAG2 CLUHP3 PHF17 AQP7P1 LOC100506178 B3GNT4 GAL3ST2 LRCH2 
HAND1 KIFC2 LOC100134368 FGF18 CDK5R1 DKK1 CDKN1C RHBDL2 LYNX1 PITPNM3 







185 AEN KIAA0895L PADI1 UPK1A NOSTRIN AK7 TRIQK TENM4 TSPAN13 PGBD5 PRDM16 
ATOH8 NKX6-1 RAB3A WT1-AS SDC2 ALDH1L2 PCSK6 FN1 MLIP UNC5CL CHRM4 
RRAD TM4SF20 ATP8B4 FYN LXN KLF2 UPK1B NTN4 FLJ35390 CD8A SFTPD F2 CFHR1 
LOC100130357 REPS2 CD83 IGFBP2 UGT2A3 SCNN1B NPNT FGFR4 NTS TMEFF2 MALL 
LOC283710 ZDHHC8P1 SMIM1 FILIP1 RPS6KA2 ITGA10 LGALS2 CHGB VIL1 ASB4 
SLC23A1 ASL ZNF365 ANGPTL4 GDNF FAAH2 CYP27B1 KRT4 GYS2 SERPINI1 NUDT8 
DBI F13B MOCOS SLC3A2 SNCG TMEM97 TMEM200C PRPH SGCD LPPR1 CCDC69 
SLC6A12 F5 OLFML3 NREP GABRA5 PPP1R1A ANKRD33B RORC CPE VGF ST3GAL5 
TPST1 BHLHE41 KCNJ8 ZNF503 CACNA1G PROSAPIP1 SCN3B SLC22A18AS RENBP 
LDHD SERPINA6 VSTM2L SOX21 FAM46B ZNF274 WDR54 GJB6 CHST1 FGG ABCA1 
TSPAN8 IDH2 GPI SCML2 DEGS2 HAL MMAB NPSR1-AS1 EGR1 THSD1 CPB2 TM7SF2 
CERKL ACRBP SCGN MRC2 PNPLA1 CDH6 USP2 ASRGL1 HPGD GCHFR LHPP GLYCTK 
LOC730102 HEG1 CCND3 NEB ASGR1 UGT2B15,UGT2B17 PLIN1 SLC7A2 IRF4 MYLIP 
TMEM45B FUT1 PCDH1 ARHGAP18 TTR C8orf44-SGK3,SGK3 S100A4 MYO1A ADM2 
IL1R2 ERBB3 INSL4 FMO5 C4orf47 ST6GAL2 FAM43A PADI2 PRDX2 CLYBL PCDH9 
TMEM191A CYP2C8 SLC29A2 DHDH FAM162A CHRD TLE6 SCUBE2 4SEP NIM1 ZNF462 


















Supplementary Table 3: Pathways (Kegg and Reactome) associated with each clinical and 













217 Genes involved in Cytokine Signaling in Immune system 
Genes involved in Immune System 
Genes involved in Interferon gamma signaling 
Cytokine-cytokine receptor interaction 
Pathways in cancer 
Genes involved in Interferon Signaling 
Genes involved in Signaling by Interleukins 
Axon guidance 
Jak-STAT signaling pathway 




















52 Terpenoid backbone biosynthesis 
Phenylalanine metabolism 
beta-Alanine metabolism 






3 No overlaps 
F11  
F28  
































91 Genes involved in Metabolism of amino acids and derivatives 
Genes involved in Amino acid synthesis and interconversion (transamination) 
Genes involved in Metabolism of carbohydrates 
Genes involved in Glucose metabolism 
Genes involved in Transmembrane transport of small molecules 
Genes involved in Transport of glucose and other sugars, bile salts and organic acids, 
metal ions and amine compounds 
Genes involved in Glycolysis 
Glycine, serine and threonine metabolism 
Genes involved in SLC-mediated transmembrane transport 











3 No overlaps 
Beijing  
F28  
















































Genes involved in Extrinsic Pathway for Apoptosis 
Genes involved in Apoptosis 








































35 Genes involved in Integrin cell surface interactions 
Genes involved in MyD88:Mal cascade initiated on plasma membrane 
Genes involved in Activated TLR4 signalling 




















5 No overlaps 









4 No overlaps 
Beijing  
F11  




1 No overlaps 
Beijing  
H37Rv  
26 No overlaps 
Beijing  
F15/LAM4/KZN  
3 No overlaps 
Beijing  
Unique  
34 No overlaps 
F11 
F28  








107 Genes involved in Immune System 
Leishmania infection 
Genes involved in Cytokine Signaling in Immune system 
Genes involved in Adaptive Immune System 
Toll-like receptor signaling pathway 
Genes involved in Signaling by the B Cell Receptor (BCR) 
Genes involved in Interferon gamma signaling 
Cytokine-cytokine receptor interaction 
Genes involved in Interferon Signaling 




11 No overlaps 
F28  
H37Rv  
20 No overlaps 
F28  
F15/LAM4/KZN  
31 No overlaps 
F28  
Unique  
11 No overlaps 







16 Genes involved in Glucuronidation 
Ascorbate and aldarate metabolism 
Pentose and glucuronate interconversions 
Porphyrin and chlorophyll metabolism 
Drug metabolism - other enzymes 
Starch and sucrose metabolism 
Steroid hormone biosynthesis 
Retinol metabolism 
Metabolism of xenobiotics by cytochrome P450 
Genes involved in Phase II conjugation 
F15/LAM4/KZN  
Unique  
7 No overlaps 
Beijing  52 No overlaps 
F11  255 No overlaps 
F28  55 No overlaps 
H37Rv  125 Chronic myeloid leukemia 
F15/LAM4/KZN  138 Cytokine-cytokine receptor interaction 
Unique  185 Genes involved in Common Pathway 
Starch and sucrose metabolism 
Genes involved in Developmental Biology 
Pentose and glucuronate interconversions 
Complement and coagulation cascades 
Genes involved in Formation of Fibrin Clot (Clotting Cascade) 
Metabolism of xenobiotics by cytochrome P450 
Drug metabolism - cytochrome P450 






Supplementary Table 1: Top Bio-function induced by clinical strains of M. tuberculosis in pulmonary epithelial cells at 48 hr post-infection 




Diseases and Conditions  
Inflammatory Response  
























































Cellular Movement  
Cellular Function and 
Maintenance  
Cell-To-Cell Signaling 
and Interaction  
Cell Death and Survival  
Cellular Growth and 
Cellular 
Movement  












































































































































Supplementary Table 2: Immune related canonical pathway enrichment by clinical strains of M. tuberculosis in pulmonary epithelial cells at 48 
hr after infection  




2.31 8.58 2.20 0.473 5.77 0.56 












0.784 5.52 1.25 0.376 2.80 0.476 
Cholesterol 
Biosynthesis II (via 
24,25-
dihydrolanosterol) 
0.784 5.52 1.25 0.376 2.80 0.476 
Cholesterol 
Biosynthesis III (via 
Desmosterol) 
0.784 5.52 1.25 0.376 2.80 0.476 




Bacteria and Viruses 
11.60 5.34 7.20 7.99 3.58 6.79 
Communication 
between Innate and 
Adaptive Immune 





Complement System 2.68 
 
3.28 2.05 3.49 3.45 1.52 








of Target Cells 
2.76 2.66 2.20 2.03 0.832 1.62 
Coagulation System 3.22 
 





2.41 6.85 3.06 2.45 4.60 
IL-6 Signaling 4.07 
 
2.09 4.19 3.53 1.64 2.53 
Role of JAK1 and 
JAK3 in Î³c 
Cytokine Signaling 
1.61 1.96 2.84 1.35 0 1.34 
IL-8 Signaling 2.45 1.93 3.10 3.24 2.37 2.03 
IL-12 Signaling and 
Production in 
Macrophages 
5.73 1.88 3.90 2.00 0.953 0.951 




4.62 1.87 3.70 3.42 2.67 3.42 
iNOS Signaling 3.87 1.87 
 
5.53 2.05 1.45 1.98 
Apoptosis Signaling 3.90 
 




Pathway F15/LAM4/KZN Beijing F11 F28 Unique H37Rv 
IL-10 Signaling 2.34 
 
1.75 1.90 1.22 1.64 1.47 
IL-17 Signaling 2.65 
 
1.60 3.31 2.57 0.742 1.47 
JAK/Stat Signaling 2.65 
 
1.60 3.86 2.03 0 0.760 
Inhibition of Matrix 
Metalloproteases 
0.422 1.60 1.67 1.68 2.29 0.81 




1.48 2.66 2.34 0.893 1.67 







2.84 3.32 2.71 2.67 3.89 
Production of Nitric 
Oxide and Reactive 




0.581 1.88 1.77 1.13 0.753 
Chemokine 
Signaling 
0.980 0.622 0.786 0.775 0.464 0.255 
Role of JAK1, JAK2 




0.380 4.65 0.586 0.578 0.444 
STAT3 Pathway 1.28 
 
0.366 1.82 0.741 0 1.04 
TGF-β Signaling 1.25 
 
2.31 3.41 2.52 1.15 3.80 
IL-22 Signaling 1.36 
 
0.783 0.616 1.13 0.578 0.893 





CD40 Signaling 1.98 
 
0.474 2.23 0.889 0 0.909 
IL-9 Signaling 2.60 
 
0.490 1.51 0.787 0 1.52 
IL-15 Production 3.23 
 
1.15 3.37 0.514 0.507 0.782 
IL-15 Signaling 4.83 
 









in Macrophages and 
T Helper Cells by 
IL-17A and IL-17F 
6.77 3.38 4.83 4.24 4.21 5.83 
CCR5 Signaling in 
Macrophages 





Epithelial Cells by 
IL-17A and IL-17F 





Supplementary Table 3: Fold changes of transcriptional factors induced by clinical and 
laboratory strain of M. tuberculosis in pulmonary epithelial cells 
Transcriptional 
factor 
Beijing F11 F28 H37Rv F15/LAM4/KZN Unique 
ANKRD42 -1.31624 -2.224 -0.70367 -1.33518 -0.95399 -0.57043 
ATF3 -1.46846 -1.27407 -1.77016 -2.374 -0.29603 -2.081 
BATF2 6.26566 6.78011 4.74164 5.39188 6.11848 4.47917 
BHLHE41 -1.18292 -1.17118 -0.20386 -1.22901 0.552223 -3.232 
BRCA1 -0.81331 -2.671 -1.27526 -1.57859 -0.79514 -1.44868 
BRCA2 2.50623 3.14293 2.02802 2.15945 2.644 0.719255 
CEBPD 2.113 2.626 2.002 1.06204 2.4 1.73186 
CYLD 1.8499 2.94458 1.87692 1.76919 2.732 0.714753 
DLX2 -1.9363 -2.332 -1.22938 -3.411 -2.0553 -1.50343 
EGR1  1.64209 1.04452 0.462746 -0.14957 0.83448 2.12 
EGR2 0.253242 -0.29562 -1.28717 -2.545 -0.42441 1.25639 
EGR3 -0.76433 -1.81442 -4.6268 -3.762 -1.19186 -1.77984 
EGR4 -1.23919 -1.78827 -3.0126 -2.322 -0.53603 -2.547 
EHF 4.455 3.108 3.449 2.997 3.472 3.697 
EN2  -1.35832 -1.42227 -1.32118 -2.172 -1.20161 -0.84752 
ETV1 -1.3231 -2.738 -2.2817 -1.98439 -2.4835 0.873586 
FOS 2.769 2.055 0.964956 1.33353 1.27653 3.437 
FOSB -0.89998 -2.122 -3.165 -2.508 0.099227 -1.33528 
FOSL1 -1.25557 -1.57015 -1.09346 -1.78749 0.286369 -2.809 
GATA4 -2.628 -3.5262 -1.7942 -3.2236 -2.4977 -1.38942 
GLI2 2.742 1.66535 1.17454 2.582 0.626844 1.77806 





 Beijing F11 F28 H37Rv F15/LAM4/KZN Unique 
GLIS2 -1.50506 -2.099 -1.33223 -1.77808 -1.93927 -1.48243 
HLF -4.2202 -4.8267 -2.454 -5.4084 -2.625 -2.2356 
HLX -3.089 -2.7053 -0.94901 -2.2064 -2.382 -2.242 
HOXA13 -2.687 -3.1311 -2.778 -3.3167 -4.636 -0.96046 
HOXB4 1.25523 2.29782 0.400646 1.44178 2.822 0.111904 
ID1 2.38786 2.38983 0.201078 1.04026 0.222385 4.144 
IFI16 3.383 3.735 2.664 3.018 3.741 1.67682 
IRF1 1.37584 2.612 0.676299 0.617528 2.389 -0.0758 
IRF2 1.53882 2.06 0.971891 1.30886 1.7327 1.02094 
IRF4  -1.40574 -0.16653 -1.88312 -0.35561 -0.96875 -2.766 
IRF7 4.97 5.183 4.394 4.325 4.876 3.783 
IRF8 0.912598 2.433 0.292412 0.224041 4.039 0.836009 
IRF9 2.211 2.475 2.001 2.026 2.523 1.76763 
KLF2 1.64544 1.09368 0.782139 0.689906 1.55768 2.109 
KLF5 2.13 2.65688 1.23915 1.59668 2.255 1.62259 
MEIS1 2.103 2.46205 1.92614 1.87632 2.114 0.127751 
MLXIPL -0.92051 -2.00202 -1.90801 -2.405 -1.15241 -0.86513 
MSX2 4.004 4.36058 3.45555 4.015 3.648 2.289 
MYC -1.61707 -1.81933 -1.36362 -2.098 -0.78508 -1.54251 
NFATC2 -0.04327 -1.54053 -2.293 -1.40233 -2.599 0.116637 
NFIA -1.84496 -2.342 -1.36849 -2.206 -1.07003 -0.55598 
NFκB1 1.8614 2.445 1.31193 1.41108 2.437 0.966108 
NFκBIZ 1.86866 2.451 1.11767 1.44594 2.981 0.655676 





 Beijing F11 F28 H37Rv F15/LAM4/KZN Unique 
NKX3-1 2.146 2.943 1.7856 2.381 2.29 0.322095 
NLRC5 3.483 4.019 2.313 3.026 3.891 1.72056 
NUPR1 -4.086 -3.358 -2.422 -3.716 -1.05337 -3.885 
OLIG1 0.385812 0.458463 0.650469 2.249 -2.71173 -1.04232 
PML 3.735 4.196 3.054 3.118 4.004 2.009 
PPARGC1B -1.67048 -1.78019 -1.35593 -2.823 -1.80411 -1.4299 
RCAN1 -1.99902 -1.25413 -0.03823 -2.361 0.552412 -2.308 
RELA 1.5834 2.452 1.05041 1.20769 1.68582 -0.10485 
RFX5 1.65724 2.195 0.955985 1.20887 1.8343 0.720721 
RUNX2 1.52381 2.352 2.568 2.962 1.56374 0.852909 
SOX2  0.549389 0.871384 0.421959 -0.97818 2.029 1.39203 
SOX8 1.93979 1.25864 -2.072 -0.05618 -2.02072 -0.0038 
SP100 1.9346 2.337 1.31503 2.03 2.194 1.16224 
STAT1 3.859 3.919 3.258 3.598 3.94 3.226 
STAT2 3.255 3.6 2.029 2.954 3.463 2.153 
STAT4 2.245 2.436 3.51 1.78371 3.016 0.506687 
STAT5A 2.822 3.603 3.051 2.55 3.247 0.748591 
TBL1X -2.301 -1.97643 -1.46303 -1.90291 -1.76855 -1.01849 
TFCP2L1 -1.09935 -2.044 -1.76717 -1.75329 -1.90992 -0.91843 
TP63 3.411 3.985 1.3385 1.6377 4.1 3.642 
VDR 3.675 3.816 2.971 3.391 3.261 2.442 
 
Bold numbers-significant transcriptional factors 
Shaded numbers-Strain specific transcriptional factors 
